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Abstract 
 
Removing and inactivating infectious viruses in water is critical in controlling waterborne 
diseases. Studies on the presence of viruses in wastewater and their fate through wastewater 
treatment plants have focused primarily on enteric viruses, which transmit gastrointestinal diseases 
via water. Most enteric viruses are nonenveloped, consisting only of proteins and nucleic acids. 
Enveloped viruses contain an outer lipid membrane in addition to proteins and nucleic acids. 
Certain enveloped viruses are responsible for high-profile diseases, such as severe acute 
respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and influenza. 
Enveloped viruses have often been assumed to be absent from wastewater and rapidly inactivated 
when they are released to water. However, recent studies suggest that certain enveloped viruses 
can enter wastewater, and may survive in water for long periods of time. Our current state of 
knowledge on enveloped viruses in aquatic environments has been limited due to a lack of 
appropriate methods for capturing and detecting infectious enveloped viruses in water. To address 
the knowledge gaps, this dissertation research aims to 1) evaluate the survival, partitioning, and 
recovery of model enveloped viruses in wastewater, 2) characterize the reactivity of enveloped 
viruses with common disinfectants, and 3) develop a new method for monitoring infectious human 
viruses in water samples.  
To evaluate virus survival and partitioning, we applied four model viruses, two enveloped and 
two nonenveloped, and used plaque assays to track the infectivity and partitioning of the model 
viruses in untreated wastewater. We simulated our experimental data with virus sorption and 
 xvi 
inactivation models to quantitatively characterize the fate of model enveloped viruses and model 
nonenveloped viruses. Our results suggest that model enveloped viruses can survive in wastewater, 
especially at cooler temperatures. We also demonstrated that a larger fraction of model enveloped 
viruses partitioned to the wastewater solids than nonenveloped viruses. As a result, we expect that 
enveloped viruses are removed to a greater extent than nonenveloped viruses during primary 
wastewater treatment. With the knowledge gained from the survival and partitioning experiments, 
we optimized an ultrafiltration method for recovering infectious enveloped viruses from 
wastewater. The second portion of this dissertation research characterized the reactivity of 
enveloped viruses in the disinfection process.  The reactions in a model virus lipids, proteins, and 
genome were tracked as a model enveloped virus was treated with disinfectants using quantitative 
lipid and protein mass spectrometry, and molecular PCR techniques. We found that protein 
reactions drive the inactivation of the model enveloped virus by free chlorine, and genome 
reactions drive the inactivation of the model enveloped virus by UV254. Furthermore, our results 
suggest that the model enveloped virus proteins were more susceptible to oxidant attack than the 
proteins of a model nonenveloped virus. The final portion of this dissertation research focused on 
the development of an integrated cell culture-mass spectrometry (ICC-MS) method for detecting 
infectious human viruses in wastewater. In proof of concept experiments, reoviruses were detected 
in samples collected throughout a wastewater treatment plant by applying the ultrafiltration 
concentration method developed in the first study and the ICC-MS detection method. These results 
suggest that ICC-MS is a promising tool for monitoring infectious enveloped or nonenveloped 
viruses in water samples. 
 1 
Chapter 1 Background 
 
1.1 Water environments and virus transmission 
Water resources are essential for every aspect of human life. However, these resources are 
limited, and we are increasingly reusing our water in areas with high populations and limited water 
sources. Maintaining high water quality as water is circled through the urban water cycle is 
challenging due to the introduction of pollutants to the water, such as human viruses. Waterborne 
viruses are responsible for spreading a number of human diseases. Enteric viruses, for example, 
cause infections in human gastrointestinal system and are primarily transmitted via the fecal-oral 
route.1-3 Enteric viruses such as norovirus, coxsackievirus, echovirus, and reovirus have been 
frequently detected in untreated municipal wastewater with infectious concentrations ranging from 
100 to 108 gene copies/L.1 If the wastewater is insufficiently treated, the infectious enteric viruses 
in the final effluent can contaminate surface waters that are used for recreation, agriculture 
irrigation, or serve as drinking water sources.4-6 Enteric viruses are mostly nonenveloped and thus 
consist of nucleic acids and protein capsids (Figure 1.1). Their diameters range in size from 20-
100 nanometers. Previous water treatment research and monitoring efforts have focused primarily 
on removing and inactivating nonenveloped enteric viruses.   
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Table 1.1 Example enveloped viruses detected in human specimens and/or wastewater.  
Family/Genus Virus Diseases Genome type 
Levels in human specimens 
(ref.) 
Levels in 
untreated 
wastewater (ref.) 
Coronaviridae/ 
Torovirus Torovirus Gastroenteritis ss RNA  
Gene positive in 
winter municipal 
wastewater (7) 
Coronaviridae/ 
Coronavirus 
SARS 
coronavirus 
Respiratory 
illness, 
severe 
pneumonia, 
gastroenteritis, 
ss RNA 
30-70% gene positive last 
10 days after disease onset 
(8) 
 
MERS 
coronavirus ss RNA 10
3 gc/g stool (9)  
Human 
coronavirus 
Pneumonia, 
bronchiolitis, 
gastroenteritis, 
ss RNA 2.3% gene positive in stool samples (10)  
Orthomyxoviridae/ 
Influenzavirus A 
Avian influenza 
H5N1 
Severe 
respiratory 
illness 
ss RNA 8.6´10
2-1.5´106 gc/mL in 
rectal swab samples (11)  
Avian influenza 
H7N9 
Severe 
respiratory 
illness 
ss RNA 12/14 gene positive in stool samples (12)    
Seasonal 
influenza A 
virus 
Respiratory 
illness ss RNA 
47% gene positive in stool 
samples, 104-106 gc/g stool 
(13) 
 
Flaviviridae/ 
Flavivirus 
Zika virus 
Microcephaly, 
Guillain-Barre 
syndrome 
ss RNA 
Gene positive in urine 
samples. (14,15) 
Zika-carrying mosquito 
eggs detected in 49% of 
septic tank samples (16) 
 
Dengue virus Severe bleeding, shock ss RNA 
20%-80% gene positive in 
urine, lasting for ~2 weeks 
(17) 
 
West Nile virus Encephalitis, meningitis ss RNA 
44% gene positive in urine 
with acute infection (18)  
Herpesviridae/ 
Cytomegalovirus Cytomegalovirus 
Hearing loss, 
pneumonia, 
microencephaly, 
liver disease 
ds DNA 
Prolonged excretion in 
urine from children with 
congenital infection (19) 
Infectious 
cytomegaloviruses in urine 
isolated in MRC-5 cell lines 
(20) 
 
* gc, gene copies; IU, infectious units; MPNCU, maximum probable number culture unit; PFU, plaque-forming unit; 
FFU, focus-forming unit. 
** Family and genus were based on the 2017 International Committee on Taxonomy of Viruses (ICTV), 
https://talk.ictvonline.org/taxonomy/ 
 
 
Unlike nonenveloped viruses, the presence and fate of enveloped viruses have not been broadly 
studied. Enveloped viruses contain a lipid membrane outside of their nucleic acids and protein 
capsids (Figure 1.1). Enveloped viruses are responsible for a number of high-profile diseases in 
humans, such as severe acute respiratory syndrome (SARS), Middle East respiratory syndrome 
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(MERS), and avian influenza. They are also responsible for less dangerous illnesses such as the 
common cold. Enveloped viruses have widely been assumed to be absent in water environments. 
In fact, some enveloped do enter wastewater, but methods for their detection and an understanding 
of their mechanistic fate is lacking. Some example enveloped viruses that can be released to 
wastewater are described below.  
 
 
Figure 1.1 Structural illustrations of enveloped and nonenveloped viruses. 
 
1.1.1 Coronavirus 
Different coronaviruses can cause both respiratory and gastrointestinal illnesses.21 Some 
strains of human coronaviruses, such as SARS coronavirus and MERS coronavirus, are the 
responsible agents for epidemics of deadly acute pneumonia diseases. The overall case-fatality 
rate for the SARS outbreak in 2003 was 10%,22 and the accumulated case-fatality rate of MERS 
was 35%.23  Infected individuals shed SARS and MERS coronavirus genes in their stool and urine 
samples with high frequency (Table 1.1), and infectious SARS coronaviruses were isolated from 
human stool samples.24 In fact, a SARS outbreak in an apartment complex in Hong Kong was 
attributed to the SARS coronavirus in wastewater forming aerosols when toilets were flushed.25 
Genome shedding was reported for other low pathogenic strains of human coronaviruses (i.e., 
229E, NL63, OC43, and HKU1),10,26 and infectious coronavirus HKU1 was isolated from human 
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stool samples (Table 1.1).21 These human coronaviruses are not deadly like SARS and MERS 
coronaviruses, and cause seasonal outbreaks of the common cold.  
 
1.1.2 Influenza virus 
Infectious avian influenza viruses (AIV) are shed in an extremely high concentrations in bird 
feces (109-1010 infectious units per day)27 and are transmitted primarily via fecal-oral route in 
birds.28 Occasionally, humans can acquire AIV, and the accumulated AIV H5N1 case fatality rate 
of human infection from 2003 to 2017 was 53% as estimated by WHO.29 The transmission route 
of AIV from poultry to human is still elusive, but several transmission routes are hypothesized, 
including direct contact with the infected poultry, and contact with virus-laden fecal matter or 
water.30,31 Despite that the human-to-human transmission has rarely been reported once humans 
acquired AIV, infected individuals can shed AIV genes in their stool samples with high frequency 
(Table 1.1).11,12,32,33 The concentration of avian influenza virus H5N1 genes detected in rectal swab 
samples ranges from 8.6´102 to 1.5´106 gene copies/mL.32,33 Like avian influenza viruses, 
seasonal human influenza virus strains were detected in feces, and the concentrations were 104 – 
106 gene copies/g of stool samples.34  
 
1.1.3 Other enveloped viruses 
Zika virus is an emerging mosquito-borne human pathogenic virus, and Zika virus genes can 
be detected in urine specimens.15 The genes of other mosquito-borne enveloped viruses such as 
dengue virus and West Nile virus were also widely detected in urine,17,18,35 and infectious West 
Nile virus was isolated from the urine of infected individuals with acute infection (Table 1.1).18 
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Alternatively, wastewater is a habitat for mosquito larvae and adults that can carry and transmit 
those enveloped viruses.36-38  
Cytomegalovirus is carried by people of all ages, in most cases, asymptomatically, but can be 
a threat to those who are immunodeficiency or immunocompromised. Infectious 
cytomegaloviruses can be shed in the urine from infants and children who are infected at birth 
(Table 1.1).19,20 Contacting with urine is suspected as one of transmission routes of 
cytomegalovirus. 
Ebola virus, causing deadly hemorrhagic fever, can enter wastewater when patients shed bodily 
fluids that contain high levels of infectious viruses;39-41 however, the environmental transmission 
route for Ebola diseases has been observed.  
 
Currently available clinical and epidemiological evidence therefore suggests that water 
environments can, in fact, be reservoirs for enveloped viruses. This highlights the importance to 
expand our knowledge on the presence and fate of viruses in water beyond nonenveloped viruses 
to include enveloped viruses. To do this, we must first develop reliable methods for capturing and 
monitoring infectious enveloped viruses from water. We must also evaluate the survivability of 
enveloped viruses that enter municipal wastewater. 
 
1.2 Virus survival in wastewater 
To cause infection, viruses in the environment must retain their infectivity until they come into 
contact with the next host. The survivability of viruses is often measured by the length of time to 
lose 90% of their original infectivity (i.e., T90 value). Enveloped viruses have often been assumed 
to be less stable in water, but this assumption is too simplistic. The T90 values available in the 
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literature suggest that enveloped viruses are not necessarily more susceptible to environmental 
conditions than nonenveloped viruses in various water environments42 (Figure 1.2). Some strains 
of coronavirus and avian influenza virus retain their infectivity as long as nonenveloped viruses 
(Figure 1.2). SARS coronavirus and human coronavirus 229E, for example, had T90 greater than 
one day in urine and filtered wastewater samples, respectively.42 For context, one day is the 
maximum retention time of wastewater in a common sewage system. However, the current 
survival studies of enveloped viruses have been less reported for raw wastewater.  
 
 
Figure 1.2 T90 values of viruses in different water matrices and temperatures. Data in this figure 
was replotted from previous research on virus survival.42  
 
If the viruses are able to survive in raw wastewater and then enter the wastewater treatment 
plants, viruses need to be removed or inactivated effectively through the treatment processes. The 
removal efficiency and mechanisms of nonenveloped enteric viruses in wastewater treatment 
plants have been reviewed in previous publications.43,44 For nonenveloped viruses, the removal 
efficiency from wastewater depends on virus partitioning with wastewater solids in primary 
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treatment and the adsorption to activated sludge in secondary treatment.43 Corresponding studies 
have not been conducted for enveloped viruses. We therefore have a limited ability to predict the 
fate of infectious enveloped viruses in wastewater treatment plants.  
Particle interaction theories have been applied for investigating the interactions between 
nonenveloped viruses and solids in water. The DLVO (Derjaguin-Landau-Verwey-Overbekk) 
theory and the extended DLVO (XDLVO) theory can be valid to describe the forces between virus 
particles and solids in water, depending on the solid materials.45,46 In the DLVO and XDLVO 
theories, virus particles present in water are modelled as colloids that carry surface charges as a 
result of their protein and nucleic acid compositions.47,48 To quantitatively characterize virus 
adsorption to solids, Langmuir and Freundlich isotherm adsorption models have been successfully 
applied for nonenveloped viruses in water at an equilibrium state.47 Grant et al.49 integrated the 
isotherm adsorption model with the first-order inactivation kinetics model to describe 
nonenveloped virus inactivation in liquid and on solid surface. We hypothesize that the adsorption 
and inactivation models are still applicable for enveloped viruses, but enveloped viruses would 
behave differently due to their structural differences. Models of enveloped virus partitioning with 
wastewater solids could help in predicting enveloped virus survivability and removal efficiency 
through wastewater treatment processes.  
 
1.3 Virus inactivation by disinfection treatment 
Disinfection is used in both drinking water and wastewater treatment plants, and is intended to 
inactivate pathogenic viruses and other microorganisms. The disinfection efficacy of a number of 
disinfection methods has been widely reported for nonenveloped viruses,50-53 whereas limited data 
is available for enveloped viruses. Here, we focus on reviewing virus inactivation mechanisms by 
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ultraviolet 254 (UV254) and free chlorine, as representative UV light disinfection and chemical 
oxidant disinfection, respectively. 
 
1.3.1 UV disinfection 
UV is one of the most commonly applied disinfection methods. UV light can be subdivided 
into three regions according to wavelength, namely UVA (320-400 nm), UVB (290-320 nm), and 
UVC (100-290 nm). Viruses are most sensitive to UVC due to the high photoreactivity of nucleic 
acids in the UVC region. Low-pressure mercury lamps emit the highest UVC intensity around 254 
nm; therefore, most studies on virus inactivation by UVC focus on this specific region (i.e., UV254).  
Our current knowledge on virus inactivation mechanisms was established primarily with 
nonenveloped model viruses. A study of bacteriophage MS2, for example, suggests that the 
inactivation of a nonenveloped virus by UV254 is majorly attributed to damage in the viral 
genome.54 Follow-up studies on nonenveloped viruses underscore the findings that the UV254 
reactivity of viral genomes correlate to virus susceptibility to UV254.55-59 Two main factors 
determine the UV254 reactivity of viral genomes, namely genome size and genome types (single-
stranded DNA (ssDNA), double-stranded DNA (dsDNA), single-stranded RNA (ssRNA), and 
double-stranded RNA (dsRNA)). Other mechanisms of virus particle damage by UV254 can also 
lead to nonenvelopd virus inactivation. In the MS2 model, protein damage sensitized by adjacent 
viral RNA sequences contributes to 20% of the observed virus inactivation,54 whereas in 
nonenveloped dsDNA viruses, the damaged genome can be repaired in the host cell and this results 
in higher resistance to UV254.60 Compared to nonenveloped viruses, the mechanisms of enveloped 
virus inactivation by UV254 have not been investigated and deserves further investigation. 
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1.3.2 Free chlorine disinfection 
Free chlorine is a strong oxidant that readily inactivates microorganisms. Free chlorine is an 
aqueous solution of the following chlorine species: HOCl, OCl-, Cl2(aq), and Cl2O(aq).61 The 
primary oxidant species is the neutral molecule hypochlorous acid (HOCl). Based on the 
nonenveloped MS2 model, the reactions of free chlorine with virus proteins and genomes impact 
the ability of viruses to bind, enter, and replicate in the host cell.54 The inactivation of enveloped 
viruses with free chlorine have only been compared to nonenveloped viruses in one study. There, 
the enveloped bacteriophage Phi6 and Ebola virus experienced higher levels of inactivation than 
nonenveloped bacteriophages MS2 and M13 in 0.5% sodium hypochlorite solution.62 However, 
that report provided limited information on the chlorine demand of samples and other important 
experimental conditions; consequently, it is impossible to draw general conclusions about whether 
enveloped viruses are more or less susceptible to inactivation by free chlorine than nonenveloped 
viruses.  
 
A bottom-up characterization of enveloped virus inactivation could help identify molecular 
features that drive inactivation. With this information, we would be better equipped to select and 
improve disinfection methods for treating enveloped viruses. This is particularly important during 
outbreak events, when culturing viruses to see how well disinfection are working is often not 
possible.  
 
1.4 Virus concentration and detection  
Monitoring infectious human viruses in water is important for environmental surveillance and 
water quality control. Due to the low concentrations of human viruses in wastewater and drinking 
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water samples, concentration steps are often necessary prior to virus detection. Published virus 
concentration methods have nearly all been developed and optimized for nonenveloped viruses 
and therefore may not be effective for recovering infectious enveloped viruses from water samples. 
In the limited studies that attempted to recover enveloped viruses, low recoveries of infectious 
enveloped viruses were reported. For example, a method employing glass wool and ceramic 
membrane filtration combined with PEG precipitation only recovered of 0.01% to 7.89% of 
infectious enveloped influenza A viruses from lake water and 3.63% to 13.79% from rainwater.63 
A positively charged membrane filtration method recovered 1% of infectious enveloped SARS 
coronaviruses from sewage samples.64 A reliable concentration method is therefore needed for 
recovering infectious enveloped viruses from water. 
Once the infectious viruses have been concentrated, viruses must be detected. The traditional 
culture-based methods detect infectious viruses using host cell lines that are susceptible to virus 
infection. One major drawback of this technique is that it requires long periods of time for clear 
cytopathic effects to appear in the host cells, which is a sign of virus infection. Another drawback 
is that it is usually impossible to discern the virus strain or species responsible for the cytopathic 
effects observed in the cells without further testing.  
To decrease this detection period, virus culturing has been integrated with polymerase chain 
reaction (ICC-PCR) to detect viral genomes that are formed in the culture system before cytopathic 
effects appear.65-68 The success of ICC-PCR, however, depends on the effectiveness of primers, 
and PCR assay optimization can be time-consuming. Moreover, unpredictable genetic variations 
in viruses may result in the failure of PCR methods.69 In recent years, mass spectrometry (MS) 
techniques have been developed to identify viruses in clinical samples.70,71 In those studies, 
infectious viruses in clinical samples were first cultured in cells. Proteins were then extracted from 
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the culturing system, digested into peptide sequences, and sent to mass spectrometry for peptide 
detection.70,71 Mass spectrometry detects the masses and sequences of peptides that are compared 
to those available in viral protein database. The obtained protein sequences are likely to distinguish 
viruses at strain levels. Integrated cell culture-MS (ICC-MS) methods hold promise for detecting 
infectious human viruses in water samples as they can screen for large groups of viruses at once 
and may help avoid tedious method optimization.  
 
1.5 Overview of dissertation chapters 
This dissertation aims to expand our current state of knowledge on the fate and detection of 
nonenveloped enteric viruses in wastewater and drinking water. To evaluate enveloped virus 
survival in wastewater and removal in treatment processes, the inactivation kinetics and solid 
partitioning kinetics were characterized for model viruses (Chapter 2). The initial results guided 
the optimization of a concentration method designed for recovering infectious enveloped viruses 
from wastewater (Chapter 2). To investigate enveloped virus inactivation through disinfection 
processes, the biomolecule reactions in a model enveloped virus were characterized following the 
exposure to free chlorine and UV254 (Chapter 3). Molecular features that contributed to the model 
enveloped virus inactivation by free chlorine and UV254 were identified and compared with a model 
nonenveloped virus (Chapter 3). In the final chapter, a new virus detection method using integrated 
cell culture-mass spectrometry (ICC-MS) was developed for monitoring infective viruses in water. 
A proof-of-concept application of the ICC-MS method was successfully applied to detect human 
viruses in wastewater (Chapter 4). 
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Chapter 2 Survivability, partitioning, and recovery of enveloped viruses in 
untreated municipal wastewater 
Reprinted with permission from Yinyin Ye, Robert M. Ellenberg, Katherine E. Graham, and Krista 
R. Wigginton, Survivability, Partitioning, and Recovery of Enveloped Viruses in Untreated 
Municipal Wastewater, Environmental Science & Technology, 2016, 50, 5077– 5085, © 2016 
American Chemical Society.  
 
2.1 Introduction 
Recent severe disease outbreaks caused by enveloped viruses, such as Ebola, severe acute 
respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and avian influenza 
H5N1 have heightened fears of an imminent deadly viral pandemic. The major transmission routes 
of these viruses involved direct person-to-person contact or indirect contact with contaminated 
objects.1,2 Human enveloped viruses are often presumed to exist in low concentrations in human 
excrement and undergo rapid inactivation in aqueous environments; however, several lines of 
evidence suggest these assumptions are not always correct. The genes of coronaviruses and avian 
influenzas have been detected in the feces of infected individuals,3-9 and some enveloped viruses 
were measured in wastewater biosolid residuals.10 Likewise, some enveloped viruses can survive 
for days to weeks in pasteurized wastewater.11-13 A review of virus T90 values (i.e. time to reach 
90% inactivation) suggests that avian influenza viruses survive just as long, if not longer, than 
nonenveloped enteric viruses in some aqueous environments.14 Based on this information, it is 
therefore feasible that sewage and fecal-contaminated water could serve as vectors for certain 
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enveloped viruses. Indeed, a SARS coronavirus outbreak in an apartment complex in Hong Kong 
was attributed to the transport of viruses in wastewater to the air ducts.15 
The vast majority of studies on the presence and fate of viruses in human waste and municipal 
wastewater have focused on nonenveloped enteric viruses (e.g., adenoviruses, polioviruses, 
enteroviruses, noroviruses and rotaviruses).16-21 These viruses replicate in human gut tissues and 
transmit diseases primarily via the fecal-oral route. Due to the major role of water and food in the 
transmission of enteric viruses, there are a number of established methods for nonenveloped 
enteric virus detection in complex environmental matrices. Enveloped viruses differ structurally 
from nonenveloped viruses due to the presence of a lipid bilayer membrane outside the viral 
protein capsid, which contains proteins or glycoproteins. The different functional groups on the 
outer surface of enveloped viruses compared to nonenveloped viruses likely impact their survival 
and partitioning behavior in aqueous environments.22-24 Likewise, methods to concentrate and 
recover nonenveloped enteric viruses from wastewater and other environmental matrices may not 
be suitable for enveloped viruses. For example, lipid layers are sensitive to the detergents and 
organic solvents25,26 that are commonly used to extract and purify nonenveloped enteric viruses.  
To address the paucity of data on the fate and recovery of enveloped viruses in wastewater 
matrices, we studied the survival and partitioning behavior of the human enveloped virus 
surrogates, murine hepatitis virus (MHV) and Pseudomonas phage Phi6, in pasteurized and 
unpasteurized wastewater. We compared the inactivation kinetics and liquid-solid partitioning of 
the two enveloped viruses with two nonenveloped virus surrogates, Enterobacteria phage MS2 
and T3. Furthermore, we systematically tested the effectiveness of three virus recovery methods—
initially developed for using on enteric viruses—for extracting and concentrating enveloped 
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viruses from both liquid and solid fractions in wastewater. Finally, we proposed an optimized 
ultrafiltration method for detecting both enveloped and nonenveloped viruses.  
 
2.2 Materials and methods 
2.2.1 Wastewater samples  
Wastewater samples were collected from the Ann Arbor Wastewater Treatment plant, an 
activated sludge treatment plant serving roughly 115,000 people with an average flow rate of 19 
million gallons per day (MGD). Grab samples were collected after wastewater equalization, 
screening, and grit removal chambers, and just before the primary settling tanks. All samples were 
collected and sealed in sterile plastic bottles and then immediately transported on ice to 
laboratories at the University of Michigan where they were stored at 4 °C and analyzed within 24 
hours. Wastewater pH, total suspended solids (TSS), volatile suspended solids (VSS), and total 
chemical oxygen demand (COD) were measured with standard methods.27 
 
2.2.2 Virus strains and methods 
We chose to study MHV strain A59 and Pseudomonas phage Phi6 because they are common 
surrogates for human enveloped viruses (Table 2.1).11,13,28 We also studied two nonenveloped 
Enterobacteria phages MS2 and T3 to allow for direct comparisons between enveloped and 
nonenveloped virus inactivation, partitioning, and recovery.29-31  
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Table 2.1 Characteristics of tested viruses. 
Virus Structure Family/Genus Genome Type 
Genome 
Size (Kb) 
Particle Size 
(nm) 
MHV Enveloped Coronaviridae/Coronavirus (+) ssRNA 32 100 
Phi6 Enveloped Cystoviridae/Cystovirus Segmented dsRNA 13.5 80 
MS2 Nonenveloped Leviviridae/Levivirus (+) ssRNA 3.6 25 
T3 Nonenveloped Podoviridae/T7-like viruses dsDNA 38.2 50 × 20 (tail) 
 
MHV strain A59, and its supporting cell lines L2 and DBT, were kindly provided by Dr. 
Leibowitz’s lab at Texas A&M Health Science Center College of Medicine. L2 and DBT cells 
were grown in Dulbecco’s Modified Eagle Medium (DMEM) with 10% newborn calf serum, 1% 
L-glutamine, and 1% penicillin/streptomycin, and incubated at 37 °C with 5% CO2. MHV stocks 
were propagated in DBT and titered by plaque assay on L2 according to a published protocol.32 
After amplification, MHV stocks were centrifuged at 3,000 × g for 10 min, and then filtered 
through a 0.22 μm polyethersulfone (PES) membrane (Millipore, USA), in order to remove cell 
debris and aggregated viruses. The MHV stocks (~106 PFU mL-1) were stored at -80 °C.  
Phi6 and its bacterial host Pseudomonas syringae were kindly provided by Dr. Linsey Marr’s 
lab at Virginia Tech. P. syringae was grown in Luria-Bertani (LB) medium containing 5 g L-1 NaCl 
at 26 °C. To propagate Phi6 stocks, soft LB-agar (0.7% agar) layers were removed from the 
double-layer plates, and dissolved in 3 mL of LB medium.33 The recovered viruses were purified 
with centrifugation at 3,000 × g for 10 min at 4 °C and filtration through 0.22 μm PES membranes. 
The Phi6 stocks (~1010 PFU mL-1) were stored at 4 °C.  
MS2 (ATCC 15597-B1) and T3 (recovered from ATCC 11303-B4), and their corresponding 
Escherichia coli hosts ATCC 15597 and ATCC 11303, respectively, were purchased from 
American Type Culture Collection (ATCC). The MS2 and T3 were propagated and assayed in 
their E. coli hosts based on published methods.34,35 The viruses were purified with an Econo Fast 
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Protein Liquid Chromatography system (Bio-Rad, USA) equipped with a HiPrep Sephacryl S-400 
HR column (GE, USA). The collected viral fraction was concentrated with 100 kDa Amicon 
ultracentrifugal filters (Millipore, USA), and filtered through a 0.22 µm PES membrane filter. The 
final MS2 and T3 stocks (~1011 PFU mL-1) were stored in phosphate buffer (5 mM NaH2PO4 and 
10 mM NaCl, pH 7.5) at 4 °C.  
 
2.2.3 Survivability experiments 
Virus surrogates were spiked into 30 mL samples of unpasteurized and pasteurized wastewater 
to final concentrations of 3 × 104 PFU mL-1 for MHV and 5—8 × 105 PFU mL-1 for Phi6, MS2 and 
T3; the lower MHV concentrations were due to the lower MHV stock concentrations. Wastewater 
was pasteurized by heating to 70 °C for 3 h; this treatment is consistent with previous studies 
involving enveloped virus survival in pasteurized wastewater.11,13 Wastewater samples were 
quickly mixed after viruses were added, titered for the initial virus concentrations, and then 
incubated at 25 °C or 10 °C to mimic typical summer and winter wastewater temperatures. 
Aliquots of wastewater were removed at specific incubation times and infective virus 
concentrations were enumerated with plaque assays. The wastewater samples were diluted at least 
10-fold to minimize wastewater effects on the host cells. Replicate experiments (n = 3) were 
conducted in wastewater samples collected on different days to incorporate potential impacts of 
wastewater variation on virus survivability.  
 
2.2.4 Partitioning experiments 
To evaluate the kinetics and extent of virus sorption to wastewater solids, the virus surrogates 
were spiked into 30 mL samples of untreated wastewater and wastewater with solids removed via 
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centrifugation at 30,000 × g for 10 min. (i.e., solids-removed samples). This centrifugation 
treatment, which was previously shown to remove solids less than 0.3 μm in diameter,36 
consistently removed 85—95% of the TSS in our wastewater samples (Table S2). Samples were 
spiked to achieve final virus concentrations of 5 × 104 PFU mL-1 for MHV, and 6—8 × 105 PFU 
mL-1 for Phi6, MS2, and T3—these were low enough to be feasible concentrations present in 
wastewater (< 106 PFU mL-1) and high enough that more than 99% loss could be quantified with 
plaque assays. The spiked samples were stirred and then incubated at 4 °C; this temperature is at 
the low-end of mean municipal wastewater temperatures in the U.S. (3 °C—27 °C)37 and was 
selected to minimize virus inactivation through the duration of the experiment. At various 
incubation times, aliquots of the untreated and solids-removed samples were centrifuged at 30,000 
× g for 10 min, and the centrates were assayed for infective viruses.  
Virus inactivation and sorption kinetics in wastewater batch reactors were analyzed with an 
approach proposed by Grant et al. that accounts for virus sorption and desorption from sorbents, 
as well as inactivation in the liquid and solid fractions.38 In our system, the solids-containing 
samples were the untreated wastewater influent and the solids-free samples were wastewater 
samples with solids removed via centrifugation. Virus inactivation in the wastewater liquid was 
assumed to be equal to virus inactivation in the solids-removed sample, and to follow first-order 
kinetics:  
  ln !/∗ = −23t	                                                                          (1) 
where, !/∗ is the nondimensional concentration of infective viruses measured in the solids-
removed wastewater samples (!//!/,7), t is the incubation time in hours, and 23 (h-1) is the first-
order virus inactivation constant in the solids-removed wastewater.  
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In a wastewater sample spiked with viruses, the nondimensional concentration of infective 
viruses in the wastewater liquid !/,88∗ is related to the fraction of viruses inactivated in the liquid 
phase (93∗), and the fraction reversibly adsorbed to wastewater solids (9:∗): 
  !/,88∗ = 1 − 93∗ − 9:∗       (2) 
The change of the viral fraction in the liquid and solid phases with time can be described with 
the following set of differential equations:  
  ;<=∗;> = 1 − 93∗ − 9:∗       (3a) 
  ;<?∗;> = *@ A1 − BCDE∗FGH3 − 93∗ − 9:∗ I FGFGH3J + 9L∗ I FCFGH3JM   (3b)   
  ;<N∗;> = *O[QRST∗ + 9:∗ − *R9L∗]      (3c) 
where, 9L∗ is the fraction of viruses inactivated on the solid surface; V is the nondimensional 
time, equal to 23+; QRST∗  is the initial amount of viruses reversibly adsorbed to solids (assumed zero 
in the study); *@ = 2:/23, where 2: (h-1) is the rate constant for reversible virus adsorption; *R =(2L + 2X)/2L, where 2L (h-1) is the rate constant for virus inactivation at the solid surface and 2X 
(h-1) is the rate constant for the conversion of reversibly adsorbed viruses to an irreversibly 
adsorbed state; *O = 2L/23; *Z = [(2:[/2H:\) + 1], where 2H: (g L-1 h-1) is the rate constant 
for virus desorption from solid phase to liquid phase, [ (g) is the mass of solids, and \ (L) is the 
liquid volume. At time zero (V = 0), 93∗ = 9:∗ = 9L∗ = 0.  
The relationship between !/,88∗  and incubation time t was solved from numerical simulations 
of the above differential equation system with the 4th order Runge-Kutta algorithm in 
MATLAB2015. An extensive description of the equation derivations, simplifications, and 
parameter calculations can be found in 38. 
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2.2.5 Virus recovery methods 
Virus recovery methods were tested with wastewater that had been spiked with one enveloped 
virus (MHV) and one nonenveloped virus (MS2). Three approaches for separating and 
concentrating viruses from the liquid fraction of municipal wastewater, including polyethylene 
glycol (PEG) precipitation,39,40 ultracentrifugation,19 and ultrafiltration,18,41 were selected based on 
their previous application in recovering viruses from wastewater. Published enteric virus methods 
that involved steps likely to inactivate the enveloped viruses (e.g., pH adjustment outside 6-8 
range,42-44 organic solvent extractions,25,26 etc.) were avoided. The best-performing method for 
MHV and MS2 was then further validated with the enveloped virus Phi6 and nonenveloped virus 
T3. In the first set of experiments, MHV and MS2 were spiked in wastewater samples to final 
concentrations of 8 × 103 PFU mL-1 and 5 × 105 PFU mL-1, respectively. Samples were then briefly 
mixed and incubated at 4 °C for one hour before they were treated with the 
extraction/concentration techniques; the one-hour incubation time was selected based on the 
results from the partitioning experiments. In each experiment, samples were concentrated 100 ×, 
and infective viruses in the concentrates were measured with plaque assays. Virus recovery was 
calculated based on the following relationship: 
  \^_`,	_abcda_e	(%) = ghEi∙khEigC∙kC × 100%                        (4) 
where (!R ∙ \R) equals the number of infective viruses spiked in, and (!mTB ∙ \mTB) is the number 
of infective viruses measured in the concentrate. 
Polyethylene glycol (PEG) precipitation method. Following incubation with the spiked viruses, 
wastewater samples (250 mL) were centrifuged at 2,500 × g for 5 min at 4 °C to remove large 
solids. The centrate was collected and mixed with 8% (w/v) of PEG 8000 and 0.5 M of NaCl. The 
mixture was incubated for 2 h at 4 °C, and then centrifuged at 10,000 g for 30 min at 4 °C. The 
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PEG pellet was resuspended in 2.5 mL phosphate buffered saline (PBS, pH 7.4; Life Technologies, 
USA) and assayed for infective viruses. 
Ultracentrifugation method. Following incubation with the viruses, wastewater samples (60 
mL) were centrifuged at 100,000 × g for 1 h at 4 °C using a Sorvall WX Ultra centrifuge (Thermo 
Scientific, Germany; SureSpin 630 (36 mL) rotor, P/N 79368; SureSpin swinging bucket, P/N 
79388). The pellet was resuspened in 8 mL of 0.25 M glycine buffer (pH 9.5) and allowed to sit 
on ice for 30 minutes. After neutralizing the solution pH with 16 mL PBS, the solids were removed 
by centrifugation at 10,000 × g for 15 min at 4 °C. The supernatant was collected and centrifuged 
again at 100,000 × g for 1 h at 4 °C to pellet the viruses. The final virus pellet was dissolved in 
600 μL PBS.  
Ultrafiltration method. Following incubation with the spiked viruses, solids in the wastewater 
samples (250 mL) were removed by either centrifuging at 30,000 × g for 10 min at 4 °C, or by 
centrifugation at 2,500 × g for 5 min at 4 °C followed by filtration through 0.22 μm PES membrane 
filters. After the large solids had been removed, the samples were concentrated with Centricon 
centrifugal filters (Millipore, USA) to a final volume of 2.5 mL. Recoveries from centrifugal filters 
with 10 kDa and 100 kDa cut-offs were compared. Centrifugal filter reuse was tested by first 
washing used filters with 100 mL of 0.5 M NaOH and then storing the regenerated filters in 70% 
ethanol. The reused filters were rinsed with 100 mL of Milli-Q water prior to use. 
In an attempt to recover viruses associated with wastewater solids, the solids collected in the 
centrifugation step prior to ultrafiltration were mixed with different elution buffers, including PBS, 
0.05 M glycine buffer (pH 8.5), 0.05 M glycine buffer (pH 9.5), 0.05 M glycine buffer (pH 10.5), 
3% beef extract (pH 7.5), 3% beef extract (pH 9.5), and 3% beef extract with 0.5 M sodium 
chloride (pH 9.5). Suspensions were set on ice for 30 min. and gently shaken every 10 min. The 
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solutions were centrifuged at 10,000 × g for 15 min at 4 °C and the resulting centrate was 
neutralized with PBS (pH 7.4), and then titered for infective viruses.  
 
2.2.6 Statistical analyses 
Non-parametric t-tests were applied to two groups of experimental data to assess statistical 
significance. Two-tailed P values were calculated, and P < 0.05 was considered statistically 
significant.  
 
2.3 Results and discussion 
2.3.1 Comparison of virus survival in wastewater 
Inactivation of the two enveloped viruses (MHV and Phi6) and nonenveloped virus MS2 in 
unpasteurized and pasteurized wastewater at 10 °C and 25 °C followed first-order kinetics (Figure 
2.1; Table A-3), with inactivation proceeding faster for the enveloped viruses. In unpasteurized 
wastewater at 25 °C, the T90 (±s.d.) values for MHV and Phi6 were 13 (±1) and 7 (±0.4) hours, 
respectively, and 121 (±36) hours for MS2 (Table A-3). The nonenveloped T3 virus survived much 
longer than the other virus surrogates with no significant decrease in infectivity observed within 
the 48-hour experiments for both temperatures (Figure 2.1). This is consistent with long survival 
times reported for tailed phages in adverse conditions.45 The inactivation kinetics of the enveloped 
viruses were significantly (P < 0.0001) slower in wastewater at 10 °C compared to 25 °C (Figure 
S4), with T90 (±SD) values of 36 (±5) and 28 (±2) hours for MHV and Phi6 at 10 °C, respectively 
(Table A-3). Like T3, MS2 inactivation was not statistically different at the two temperatures (P 
= 0.1813) within the tested timescale (Figure A-4).  
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Inactivation kinetics of the enveloped viruses MHV, Phi6, and Ebolavirus in pasteurized or 
gamma-irradiated wastewater have been reported previously.11-13 In our experiments, the two 
enveloped viruses lost infectivity at a significantly slower rate in pasteurized wastewater compared 
to unpasteurized wastewater, except for the case of MHV at 25 °C (Figure 2.1; Table A-3). The 
most pronounced effect occurred with Phi6, which had a first-order inactivation rate constant (±s.d.) 
of 0.317 (±0.022) h-1 in unpasteurized wastewater and 0.044 (±0.004) h-1 in pasteurized wastewater 
at 25 °C. A statistically significant difference in the inactivation kinetics of the nonenveloped 
viruses was not observed in pasteurized wastewater and unpasteurized wastewater; this may be 
due to the fact that our experiments were stopped before 90% of the nonenveloped viruses were 
inactivated. Discrepancies in inactivation kinetics in sterilized and non-sterilized wastewater have 
been reported previously for nonenveloped viruses,46 and may be due to bacterial extracellular 
enzyme activity and protozoan or metazoan predation.47,48 Overall, the results suggest that 
unpasteurized wastewater samples should be employed for survivability tests when feasible.  
Wastewater residence times in sewage systems are typically less than 24 hours. Although Phi6 
and MHV had T90 values of 7—13 hours in unpasteurized wastewater at 25 °C, the T90 values 
increase to 28—36 hours at 10 °C. Human enveloped viruses excreted in feces may therefore reach 
wastewater treatment plants in an infective state, especially in cool climates. Local outbreaks and 
global pandemics of enveloped viruses excreted in feces or urine are therefore relevant for 
wastewater utilities.  
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Figure 2.1 Virus survival in wastewater and pasteurized wastewater at 10 and 25 °C. Viruses were 
spiked into wastewater to final concentrations of 3 × 104 PFU mL-1 for MHV and 5—8 × 105 PFU 
mL-1 for MS2, T3 and Phi6. Error bars represent the standard deviations of replicates from 
wastewater samples collected on different days (n = 3). Table S3 summarizes corresponding rate 
constants and estimated T90 values. 
 
2.3.2 Comparison of virus partitioning in wastewater.  
The measured concentrations of infective MHV and Phi6 in the solids-removed wastewater 
samples immediately after spiking, mixing, and centrifuging, were consistently lower than the 
theoretical concentrations based on the amount of viruses spiked into the sample (Figure S1). 
Approximately 47% of the spiked MHV and 77% of the spiked Phi6 were recovered in the centrate 
of the solids-removed wastewater. This is compared to a nearly 100% recovery of the 
nonenveloped viruses MS2 and T3. Nearly all of the MHV was recovered when it was spiked into 
PBS and centrifuged in the same manner (Figure S1). This suggests that a fraction of the enveloped 
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viruses (53% MHV and 23% Phi6) were rapidly inactivated in the solids-removed wastewater. A 
pronounced initial decrease in infective virus concentration was previously observed when Ebola 
virus was added to pasteurized wastewater.12 In those experiments, the number of infective Ebola 
viruses decreased rapidly over the first 24 hours (~2-log loss) and then stabilized at a much slower 
inactivation rate over the subsequent seven days. Similar biphasic inactivation kinetics have also 
been observed with nonenveloped viruses, which were attributed to subpopulations of viruses with 
varied susceptibilities to solution chemistry or temperature.38 In our partitioning experiments, we 
chose to normalize measured concentrations in the wastewater and solids-removed wastewater 
samples over time to concentrations measured in solids-removed samples immediately after they 
were spiked with viruses, mixed, and centrifuged. We felt this approach was justified because the 
behaviors of the persistent subpopulations are of most interest for real wastewater systems.  
MHV, Phi6, and MS2 concentrations decreased significantly over a three-day period in the 
solids-removed wastewater samples (Figure 2.2) and the resulting rate constants were assumed to 
equal virus inactivation rates in the liquid fraction of wastewater (Eq. 1, 23).38 When the viruses 
were spiked in wastewater samples containing solids, the normalized MHV and Phi6 
concentrations in the wastewater liquid phase (in centrate after centrifugation) decreased rapidly 
in the first hour, and then eventually decreased at the same rate as virus inactivation in the solids-
removed sample (Figure 2.2). The MS2 concentration in the wastewater liquid phase decreased 
rapidly at first, and then slowed to a rate that was faster than MS2 inactivation in the solids-
removed sample (Figure 2.2). No significant decay of T3 was observed in the solids-removed 
wastewater samples or the liquid phase of wastewater samples.  
 
 
 30 
 
 
Figure 2.2 Adsorption and inactivation kinetics and model simulations for enveloped viruses 
(MHV and Phi6) and nonenveloped viruses (MS2 and T3) in 4 °C wastewater. Viruses were spiked 
into wastewater and solids-removed wastewater samples to final concentrations of 5 × 104 PFU 
mL-1 for MHV, and 6—8 × 105 PFU mL-1 for MS2, T3 and Phi6. no∗ and no,pp∗  are nondimensional 
concentrations of infective viruses in the solids-removed sample centrates and wastewater sample 
centrates, respectively. Both values were normalized to the initial measured virus concentration in 
the solids-removed sample centrates. No significant decline in T3 infectivity was observed within 
36 hours. Error bars represent the range of data from duplicate experiments conducted in 
wastewater samples collected on different days (n = 2). 
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Based on these results, the MHV and Phi6 sorption kinetics can be best described by a non-
instantaneous quasi-equilibrium adsorption model in which the virus sorption to wastewater solids 
does not occur instantaneously and the inactivation rates in the wastewater solid and liquid phases 
are equal (Table A-4). A similar model was used to describe bacteriophage λ sorption kinetics with 
sand.38 In comparison, MS2 behavior is best described by the non-instantaneous quasi-equilibrium 
adsorption and surface sink model. In this model, virus inactivation is faster in the solid phase than 
in the liquid phase (Table A-4); a similar model was proposed for the interaction of bacteriophage 
MS2 and PRD1 with sediments.49 Bacteriophage T3 could not be modeled due to the non-
significant decreases in infective viruses measured over the experiment timescale. 
These models predict that 26% of MHV, 22% of Phi6, and 6% of MS2 adsorbed to wastewater 
solids at equilibrium (Figure 2.3; Table A-4). Although the T3 virus kinetics could not be modeled, 
< 5% of the spiked T3 had partitioned to the wastewater solids at the end of the 36-hour 
experiment; this suggests that like MS2, T3 partitions overwhelmingly to the liquid fraction of 
wastewater (Figure 2.2). The equilibrium percentages reported here are not representative for all 
wastewaters because wastewater solids concentrations vary widely. It should be noted that our 
wastewater solid concentrations were typical for medium-strength municipal wastewaters37 (Table 
A-1) with an average TSS value of 235 mg L-1.  
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Figure 2.3 Models for adsorption and inactivation kinetics of enveloped viruses (MHV and Phi6) 
and nonenveloped viruses (MS2) in 4 °C wastewater. qr∗  represents the fraction of viruses 
inactivated in liquid fraction of wastewater; qs∗  represents the fraction of viruses reversibly 
adsorbed to wastewater solids; qt∗  represents the fraction of viruses inactivated on the solid surface. 
 
The partitioning results for MS2 and T3 are consistent with an early observation that 
wastewater solids are poor at absorbing enteric viruses.50 Wastewater solids tend to be negatively 
charged, as is MS2 (isoelectric point = 3.9). The isoelectric point for T3 has not been reported, but 
the similar T2 and T4 viruses have isoelectric points < 6.51 A study on the adsorption of four 
nonenveloped viruses to various solid surfaces demonstrated that long-ranged electrostatic 
interactions and hydrophobic effects between the virus capsid proteins and the sorbent surfaces 
dictated adsorption, with short-ranged van der Waals and steric interactions playing less important 
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roles.52 Similar work has not been conducted for enveloped viruses, and the impact that the surface 
phospholipids and various membrane proteins have on partitioning remains elusive.  
Despite the poor sorption of nonenveloped enteric viruses to wastewater solids, some enteric 
viruses have been observed in primary settled solids in high concentrations.36,53 In such cases, the 
viruses were likely released into wastewater within or strongly associated with fecal solids and 
never reached equilibrium between the liquid and solid fractions. When excreted in watery 
diarrhea or urine, the viruses would more likely reach equilibrium. Our results suggest that if 
allowed to reach equilibrium, enveloped viruses more strongly associate with wastewater solids 
than nonenveloped viruses. Consequently, enveloped viruses would be removed to a greater extent 
than nonenveloped viruses in primary wastewater treatment. More enveloped and nonenveloped 
viruses will need to be tested to confirm the results obtained with the two enveloped and two 
nonenveloped model viruses.  
In addition to relaying information on virus partitioning between solid and liquid phases at 
equilibrium, the models also predicted the amount of time it takes for the viruses to reach 
equilibrium. This information is important for virus recovery experiments, where viruses are 
spiked into an environmental sample and then extracted and quantified with various techniques. If 
the spiked viruses are extracted too soon, results may be biased due to the spiked viruses in liquid 
phase. In water with soils and clays, nonenveloped virus adsorption is assumed to reach 
equilibrium within an hour.54 Our models estimated that the viruses in wastewater reached 90% of 
equilibrium concentrations after 0.3—1.5 hours, and 99% of equilibrium concentrations after 
0.4—2.9 hours (Figure 2.3; Table A-4). Based on these results, we allowed samples to equilibrate 
for at least one hour before extraction methods were tested. 
 
 34 
2.3.3 Virus recovery from wastewater.  
According to the simulation results of virus partitioning, greater than 70% of the infective 
model enveloped viruses were associated with wastewater liquids at equilibrium. We therefore 
focused primarily on the wastewater liquid fraction in our virus recovery experiments. Of the three 
methods we tested, the ultrafiltration method and the PEG precipitation methods involved an initial 
step to remove wastewater solids and then focused on recovering the viruses in the liquid phase. 
The ultracentrifugation method, on the other hand, involved pelleting all of the wastewater solids 
and colloids and then extracting the viruses from the pellet.  
The enveloped MHV recoveries were consistently lower than the nonenveloped MS2 
recoveries when the PEG precipitation and ultrafiltration methods were applied (Figure 2.4); this 
was not unexpected given that MHV partitioned to solids to a greater extent than the MS2. Low 
mean recoveries (< 6%) were achieved for both MS2 and MHV with the ultracentrifugation 
method (Figure 2.4). The ultrafiltration method resulted in significantly higher MHV recoveries 
than the PEG precipitation (P = 0.0065) and the ultracentrifugation (P = 0.0084) methods. MS2 
recoveries with the ultrafiltration method were significantly higher than ultracentrifugation 
(p=0.0074), but not significantly different than PEG precipitation (P = 0.4137) method (Figure 
2.4).  
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Figure 2.4 Recoveries for enveloped and nonenveloped viruses from wastewater with PEG 
precipitation, ultracentrifugation, and optimized ultrafiltration method. Viruses were spiked into 
wastewater samples to final concentrations of 8 × 103 PFU mL-1 for MHV, and 2—5 × 105 PFU 
mL-1 for MS2, T3 and Phi6. 
 
Additional experiments suggested that incubation with PEG caused a major drop in infective 
MHV. The T90 for MHV in wastewater with PEG was 16 hours compared to 40 hours in wastewater 
without PEG (Figure A-2). The enveloped influenza viruses were previously recovered from 
surface waters with the PEG method,55 but recoveries were very low (0.2%—0.6%). The low 
recoveries for MHV and influenza with PEG may be due to disruption of their lipid bilayers.56 
Meanwhile, the MS2 recovery obtained here with the PEG method (43.1 ± 16.8%) was comparable 
to the recovery of nonenveloped Echovirus 7 from raw wastewater (78.5 ± 11.0%).57 These results 
suggest that PEG precipitation method, which is effective at recovering infective nonenveloped 
viruses from water samples, is not optimal for recovering infective enveloped viruses.  
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In the ultracentrifugation method, the initial centrifugation (100,000 × g for 1 h) step did not 
effectively pellet bacteriophage MS2, and 63% of the spiked MS2 was detected in the centrate. 
Comparatively, only 1% of the spiked MHV was detected in the centrate. Previously, the 
ultracentrifugation method was successful at recovering rotavirus genes from raw wastewater 
(47% mean recovery), but the infectivity state of the recovered viruses was not tested.19 Our low 
recovery of infective MHV viruses in the pellet may be due to virus inactivation by the large 
ultracentrifuge forces.58 Taken together, this suggests that pelleting wastewater solids with 
ultracentrifugation may be effective at recovering enveloped viruses genes for qPCR detection, 
but not appropriate when infective viruses are desired. 
Additional experiments were conducted to optimize recoveries with the ultrafiltration method 
(description in Appendix A; Figure A-3). The optimized method involves pre-filtering 250 mL of 
wastewater through a 0.22 μm PES membrane to remove solids, followed by concentration of the 
filtrate with 10 kDa centrifugal filters to a final volume of 2.5 mL. Using this method, we achieved 
mean virus recoveries of 25.1% for MHV, 18.2% for Phi6, 55.6% for MS2, and 85.5% for T3 
(Figure 2.4). Ultrafiltration methods have been successfully applied for recovering nonenveloped 
enteric viruses from wastewater, such as polioviruses, adenoviruses, noroviruses, and 
enteroviruses.18,41 Here, we have demonstrated that the method can also be optimized for 
recovering enveloped viruses. In future work, we will test hollow fiber ultrafilters and tangential 
flow ultrafiltration to potentially increase wastewater sample volumes that can be processed, and 
thus decrease the detection limits of infective enveloped viruses in wastewater.  
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2.3.4 Environmental Implications.  
Our results shed light on the behavior of enveloped viruses in wastewater and provide guidance 
on how to recover infective enveloped viruses from raw wastewater. Although the two model 
enveloped viruses were more rapidly inactivated in wastewater, they did survive long enough to 
be of concern for wastewater treatment facilities, stormwater overflow events, and wastewater 
intrusion in drinking water. The results presented here will be particularly important during 
potential future avian influenza or coronavirus outbreaks in humans, as some strains of these 
viruses can be excreted in feces. Future work should examine additional enveloped viruses to 
elucidate the specific virus characteristics that contribute to their survival times and enhanced 
partitioning to solids.  
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Chapter 3 Reactivity of enveloped virus genome, proteins, and lipids with free 
chlorine and UV254 
Reprinted with permission from Yinyin Ye, Pin Hsuan Chang, John Hartert, and Krista R. 
Wigginton, Reactivity of Enveloped Virus Genome, Proteins, and Lipids with Free Chlorine and 
UV254, Environmental Science & Technology, 2018, 52, 7698– 7708, © 2018 American Chemical 
Society.  
 
3.1 Introduction 
Viruses that are transmitted through direct person-to-person contact or in large respiratory 
droplets do not typically survive for very long outside of their host in the environment.1 On the 
other hand, viruses that are transmitted through aerosols or by contact with water, food, and solid 
surfaces tend to survive longer in order to come into contact with their next host.2,3 Survivability, 
often reported as the time necessary for 90% of a population to lose infectivity (T90), can therefore 
vary widely amongst different viruses, and depends on environmental conditions including 
temperature,4-6 relative humidity,4-9 UV radiation,10-12 and oxidants.13-15 Survivability is also 
impacted by virus structures. Nonenveloped viruses are generally considered more stable than 
enveloped viruses in the environment. For example, the T90 values for nonenveloped viruses in 
wastewater range from days to months, whereas the T90 values for enveloped viruses range from 
several hours to days.16-18 In terms of susceptibility to chemical disinfectants, the enveloped Ebola 
and Phi6 viruses experience higher levels of inactivation than the nonenveloped MS2 and M13 
viruses when exposed to 0.5% NaOCl.19 Even closely related enveloped viruses can have varied 
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survivabilities. For example, the T90 of severe acute respiratory syndrome (SARS) coronavirus in 
serum-free culture media is 9 days, whereas the T90 of human coronavirus 229E is less than 1 day 
under the same conditions.20 The mechanistic reasons for the higher susceptibility of enveloped 
viruses to inactivation in aqueous environments are mostly unknown. 
Despite their greater susceptibility to environmental conditions, many enveloped viruses do 
undergo environmental transmission. SARS coronaviruses were transmitted through airflow and 
virus-laden fecal aerosols.21,22 Human influenza viruses retain their infectivity on the nonporous 
surfaces, increasing their chances to infect.23,24 Avian influenza viruses are shed into water, where 
they can survive months before being consumed by their next host.25,26 Porcine reproductive and 
respiratory syndrome viruses can travel several kilometers via aerosols, spreading swine diseases 
from farm to farm.27 Infectious Ebola viruses persist in patient blood, feces and urine, and can 
survive in liquid for several days; however, an environmental transmission route has been 
observed.3,28  
Research on what makes enveloped viruses more or less persistent in the environment and 
through disinfection processes could help with predicting risks posed by newly emerging viruses 
that are difficult or dangerous to culture. For example, in the recent Ebola outbreak, a mechanistic 
understanding of enveloped virus inactivation would have helped scientists predict how long Ebola 
virus remained infective in wastewater, blood, and vomit.29 Comprehensive inactivation 
mechanisms have been published for a limited number of nonenveloped viruses with 
disinfectants,12,15,30,31 but are lacking for enveloped viruses. In general, UV radiation targets 
nonenveloped virus genomes, whereas chemical oxidants inactivate nonenveloped viruses by 
genome or protein reactions, depending on the virus and oxidant.   
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Recent fate and survival studies of enveloped viruses in the environment have adopted 
Pseudomonas virus Phi6 as a model enveloped virus.17,32-36 Phi6 is a double stranded RNA virus. 
The Phi6 particle is 85 nm in diameter37 and contains 11 different viral proteins.38 Like influenza 
viruses, Phi6 is enveloped, has a segmented genome, and contains glycerophospholipids in its 
envelope.39,40 In addition, it is the best studied virus in the family Cystoviridae, which includes the 
only bacteriophages that have a lipid outer layer. Moreover, Phi6 is easier to work with than other 
enveloped viruses and can be propagated to high titers. 
To develop a better mechanistic understanding of enveloped virus inactivation, we employed 
Phi6 in an initial investigation of enveloped virus reactivity with chemical oxidants and UV 
radiation. We characterized the biomolecule reactions in Phi6 following exposure to free chlorine 
and UV254. Phi6 inactivation, genome reactions, and protein and lipid reactions were quantified 
with plaque assays, real-time reverse transcription polymerase chain reactions (RT-qPCR), and 
liquid chromatography-tandem mass spectrometry (LC-MS/MS), respectively. We compared the 
reaction rate constants of the Phi6 genome and proteins to those of nonenveloped viruses reported 
in earlier studies and measured under similar experimental conditions to elucidate the molecular 
features that may impact enveloped virus persistence in aqueous environments.  
 
3.2 Materials and methods 
3.2.1 Virus propagation and purification 
Phi6 and its bacterial host Pseudomonas syringae pv. phaseolicola were kindly provided by 
Dr. Linsey Marr’s lab at Virginia Tech. To propagate Phi6, P. syringae was grown in Luria-Bertani 
(LB) medium containing 5 g L-1 NaCl at 26 °C and 180 rpm to an optical density of 0.10 at 640 
nm (i.e., when the cell density was approximately 1.8 × 108 cells mL-1). At that point, Phi6 was 
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added to the bacteria at a multiplicity of infection equal to 2 (i.e., ratio of Phi6 plaque-forming 
units (PFU) to P. syringae colony forming units (CFU)), and then incubated under the same 
conditions for 7 to 9 hours. Cells and debris were removed from the virus suspension by filtering 
it through 0.22 m polyethersulfone (PES, Millipore) membranes. 
The filtered virus suspensions (~1 L) were concentrated to approximately 20 mL (i.e., ~50´ 
concentration) in a lab-scale tangential flow filtration system (Millipore) outfitted with a 30 kDa 
cellulous filter. The concentrate was purified in a 10-40% (w/v) step sucrose gradient (average 
65,700 × g, 1.5 h, 4 °C), then in a 40-60% (w/v) linear sucrose gradient (average 65,700 × g, 15 h, 
4 °C). The phage band was collected with a needle and the buffer was exchanged for 5 mM 
phosphate buffer (PBS; 10 mM NaCl, pH 7.4) with a 100 kDa Amicon Ultra-15 centrifugal filter 
(Millipore). Virus purity was confirmed by SDS-PAGE with 8-16% TGXTM precast protein gels 
(Bio-Rad), according to the manufacturer’s instructions (Figure B-1). The final Phi6 stocks (1012 
PFU mL-1) were filter-sterilized with 0.22 µm PES membranes, aliquoted, and stored at -80 °C 
until use.  
 
3.2.2 Free chlorine and UV254 experiments 
Experimental virus solutions were prepared by diluting Phi6 in PBS. All free chlorine and 
UV254 experiments were conducted at room temperature. Infectious virus concentrations (PFU mL-
1) were measured immediately before and after the viruses were exposed to chlorine and UV254 via 
plaque assays on LB agar plates.41 Samples were stored on ice during the plaque assays. Following 
free chlorine and UV treatment, samples were immediately stored at -80 °C prior to nucleic acid, 
protein, and lipid analyses. 
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Free chlorine experiments. Free chlorine was prepared by diluting NaClO stock solution 
(Sigma-Aldrich) in PBS. At pH 7.4, HOCl and OCl— are equal in molar concentrations. Free 
chlorine disinfection was conducted in a modified continuous quench-flow system that was 
described previously for ozone reactions (Figure B-2).42 In brief, free chlorine and Phi6 solutions 
were continuously mixed in a PEEK micro static mixing tee (IDEX Health & Science) at flow 
rates of 0.125 mL min-1 each to reach initial reaction conditions of 2 mg L-1 free chlorine as Cl2 
and 4-5 × 1010 PFU mL-1 Phi6. The reacting mixture then passed through sample loops with varied 
volumes to reach contact times of 0.3, 0.6, 2, 4, 8 and 11 s. The reactions were quenched with 550 
mM Tris-HCl (pH 7.4) at a flow rate of 0.025 mL min-1. Control experiments demonstrated that 
the addition of Tris-HCl as a quenching agent for free chlorine effectively halted Phi6 inactivation 
(Figure B-3). Approximately 2.4 mL of the quenched samples were collected for nucleic acid, 
protein, and lipid analyses. After each experiment, the quench-flow system was thoroughly rinsed 
with chlorine-demand-free water. Free chlorine concentrations in reaction solutions were 
measured with the N,N-diethyl-p-phenylenediamine (DPD) ferrous titrimetric method and the 
DPD colorimetric method according to the standard method.43 The percentage of free chlorine 
consumed through the experiments was kept below 20% in order to maintain pseudo-first order 
conditions. Negative controls for the free chlorine experiments were run in the continuous quench-
flow system in the same manner as the free chlorine samples, but with PBS rather than free 
chlorine.   
UV254 experiments. The UV254 experimental solutions consisted of 2.4 mL of Phi6 (4-5 × 1010 
PFU mL-1) in PBS continuously stirred in 10 mL glass beakers. Samples were exposed to UV254 in 
a collimated beam reactor44 with 0.16 mW cm-2 lamps (model G15T8, Philips) that were regularly 
measured with chemical actinometry.45 The average UV254 intensity was corrected based on the 
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solution absorbance at UV254 and the sample depth. After correcting for shielding, the UV254 
intensity was 0.14 mW cm-2. Samples were exposed to UV254 for 0, 5, 15, and 25 min, which 
corresponded to UV254 doses of 0, 42, 130, 210 mJ cm-2. Negative controls for the UV254 
experiments were prepared in the same manner as the experimental samples, but were stirred in 
dark to capture any background virus inactivation and biomolecule reactions. 
Virus inactivation kinetics by free chlorine and UV254 were calculated based on the Chick-
Watson model:46 
ln I !!7J = −2u 
where ! is the infectious titer (PFU mL-1), !7 is the initial infectious titer (PFU mL-1), 2 is the 
inactivation rate constant (L mg-1 s-1 or cm2 mJ-1), and u is the free chlorine concentration (mg L-
1) ´ contact time (s) or UV dose (mJ cm-2). 
 
3.2.3 RT-qPCR assays.  
Following the UV254 and free chlorine reactions, the viral genomes were extracted by QIAamp 
viral RNA mini kits (Qiagen). The Phi6 dsRNA genome consists of three segments designated as 
small (S), medium (M), and large (L) based on their relative sizes. Three primer sets for the Phi6 
genome were designed and tested individually, each targeting a different genome segment. The 
sum of the three amplicons (~1500 bp) covered approximately 10.5% of the Phi6 genome (Table 
B-1). The extracted viral genomes were mixed with 10 mM forward primer and 10 mM reverse 
primer at a ratio of 10:1.5:1.5 (v/v/v) in Tris-EDTA buffer (10 mM Tris-HCl, 0.1 mM EDTA, pH 
7.7), and then heated at 99 °C for 5 min, and quickly chilled on ice for 5 min before mixing with 
RT-qPCR reagents. RT-qPCR reactions were prepared in 96-well plates (Eppendorf) and 
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conducted in duplicates on a Mastercycler ep RealPlex 2 system (Eppendorf) with Gotaq OneStep 
RT-qPCR kits (Promega). The 20-µL RT-qPCR reactions consisted of 10 µL 2´ qPCR master 
mix, 0.4 µL 50´ RT mix, 5.2 µL template-primer mixture, 4 µL 5 M Betaine (Sigma-Aldrich), and 
0.4 µL nuclease-free water. The RT reaction was conducted at 40 °C for 15 min, followed by an 
initial PCR activation step at 95 °C for 10 min. The PCR reaction included 40 cycles of DNA 
denaturation at 95 °C for 15 s, primer annealing at 59 °C for 30 s, and extension at 72 °C for 40 s. 
Melting curves were conducted by increasing the temperature from 60 °C to 95 °C over 10 min. 
RNA standards used for the RT-qPCR calibration curves consisted of Phi6 genomes extracted 
from the purified stock and quantified with a Qubit Fluorometer 2.0 (ThermoFisher Scientific). 
The amplification efficiencies (mean ± standard deviation) of RT-qPCR reactions targeting S, M, 
and L genome segment were 0.82 ± 0.10, 0.81 ± 0.05, and 0.81 ± 0.07, respectively. The mean R2 
were ≥ 0.99. The reaction kinetics of RT-qPCR target regions were modeled with first-order 
reactions:  
ln v *	O*7,Ow = −2x,Ou 
The reactions of the whole genome were predicted by extrapolating RT-qPCR results from the 
~1500 bp covered by the three target regions:47  
log37 I**7J = v ∑ |OO}~,,Ä∑ |ÅÇÉ.OO}~,,Ä w Ö log37 v *	O*7,OwO}~,,Ä  
where *	O is the concentration of the RT-qPCR target region i (copies mL-1, i = S, M, and L 
genome segment), *7,O  is the mean concentration of the RT-qPCR target region i in controls 
(copies mL-1), 2x,O is the reaction rate constant of the RT-qPCR target region i (L mg-1 s-1 or cm2 
mJ-1), u is the free chlorine concentration (mg L-1) ´ contact time (s) or UV dose (mJ cm-2), 
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log37 Ü FFáà is the log10 decay of the whole Phi6 genome, |O is the size of the entire genome segment 
i (bp), and |ÅÇÉ.O is the size of the RT-qPCR amplicon i (bp). In this extrapolation, we assumed a 
“single-hit inactivation model” and that the damage measured in the 10.5% of the genome by RT-
qPCR was representative of damage in the whole genome.47 
 
3.2.4 Peptide LC-MS/MS and quantification.  
Following free chlorine or UV254 treatment, virus samples were combined with equal amounts 
of 15N-labeled Phi6 internal standards (see Appendix B for 15N-metabolic labeled Phi6), and the 
mixture was digested with trypsin (Worthington) or chymotrypsin (Worthington) at 37 °C 
overnight (see Appendix B for protein digestion). The digests were then analyzed by liquid 
chromatography-tandem mass spectrometry (LC-MS/MS). Specifically, 20 µL aliquots of the 
virus protein digests were loaded on an Accucore aQ column (50 ´ 2.1 mm, 2.6 µm particle size, 
ThermoFisher Scientific) attached to an Accucore aQ Defender guard column (ThermoFisher 
Scientific) at a flow rate of 200 µL min-1. The mobile phase was first maintained at 94% solution 
A (Milli-Q water with 0.1% formic acid) and 6% solution B (LC-MS grade methanol with 0.1% 
formic acid) for 3 min, and the ratio then increased linearly to 80% B over 30 min, at which point 
it was maintained at 80% B for 7 min, and then equilibrated at 6% B for 5 min. Full mass 
spectrometry (MS) scans and data-dependent tandem mass spectrometry (dd-MS2) scans were 
conducted with a Q Exactive Orbitrap high resolution mass spectrometer (ThermoFisher 
Scientific) in positive ion mode (Table B-2). Raw mass spectrometric results were searched against 
a customized Phi6 protein database with Mascot Distiller (2.6.2.0) on a local Mascot server. The 
following search parameters were employed for peptide identification: cysteine 
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carbamidomethylations (+C2H4ON) as a fixed modification due to the reactions of iodoacetamide 
with intact cysteine thiol groups during the protein digestion. When searching for potential 
oxidation products, we set variable modifications based on oxidation products that were reported 
previously with LC-MS/MS systems,48 namely methionine oxidations (+O, +2O), cysteine 
oxidations (+O, +2O, +3O), and chlorotyrosines (+Cl-H, +2Cl-2H). All searches were set with a 
10 ppm mass tolerance for MS scans, and a 0.3 Da mass tolerance for MS2 scans. False discovery 
rates of less than 1% and significant P-values of less than 0.05 were employed in each search. Peak 
areas of all detected peptides and their corresponding 15N-labelled peptides were integrated in 
TraceFinder 3.2 (ThermoFisher Scientific), and the relative abundance of each peptide was 
calculated by the peak areas of the 14N-peptide and 15N-labelled peptide:49  
âä = âã3XFHÉåÉ.,äâã3çéHèêëíèíì	ÉåÉ.,ä 
Where âä is the relative abundance of peptide j; âã3XFHÉåÉ.,ä is the peak area of the 14N-peptide 
j; âã3çéHèêëíèíì	ÉåÉ.,ä is the peak area of the corresponding 15N-labelled peptide j.  
Calibration curves of peptides were analyzed to determine limits of quantification (LOQ) and 
limits of detection (LOD) (see Appendix B for determination of peptide LOQ and LOD). If the 
relative abundance of a peptide replicate value was below its LOQ but above its LOD, this value 
was replaced by an expected number between the LOQ and LOD based on the assumption of 
normal distribution.50 Peptide reactions were modeled with first-order reaction kinetics: 
ln v â	äâ7,äw = −2É,äu 
where â	ä is the relative abundance of peptide j, â7,ä is the mean relative abundance of peptide 
j in control samples, 2É,ä is the reaction rate constant of peptide j (L mg-1 s-1 or cm2 mJ-1), and u is 
the free chlorine concentration (mg L-1) ´ contact time (s) or UV dose (mJ cm-2). 
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3.2.5 Lipid LC-MS/MS and quantification 
Phi6 lipids were extracted following a methyl-tert-butyl ether (MTBE) protocol (see Appendix 
B, lipid extraction).51 Lipid extracts (20 µL) were injected on an Accucore aQ column (50 ´ 2.1 
mm, 2.6 µm particle size) attached to an Accucore aQ Defender guard column at a flow rate of 
200 µL min-1. The column temperature was maintained at 55 °C. Mobile phases C (60% LC-MS 
grade acetonitrile and 40% Milli-Q water with 0.1% formic acid) and D (90% LC-MS grade 
isopropanol and 10% LC-MS grade acetonitrile with 0.1% formic acid) were used for lipid 
separations. The gradient started at 25% D for 3 min, then linearly increased to 70% D over 15 
min, and then to 97% D over 3 min. It was held at 97% D for 4 min, and then decreased to 25% D 
over 5 min. Full MS and dd-MS2 scans were operated in negative ion mode (Table B-2). Lipids 
were identified with LipidXplorer software52 based on a Phi6 lipid database reported previously,39 
and peak areas were measured with TraceFinder 3.2 (ThermoFisher Scientific). Eight of the most 
abundant phosphatidylethanolamine (PE) and phosphatidylglycerol (PG) compounds in the Phi6 
lipid database were quantified (Figure B-4). Their relative abundances (L/L0) in the samples were 
calculated using calibration curves developed from Phi6 lipid extracts (Figure B-4).  
 
3.2.6 Statistical analyses 
Rate constants were calculated by pooling all experimental data together and modeling the 
combined data with linear regressions. Analysis of covariance (ANCOVA) was applied to test 
whether rate constants were significantly different from zero, and whether two rate constants were 
significantly different from each other. The corresponding null hypotheses were that the rate 
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constants were equal to zero or that the two rate constants were identical. Student’s unpaired t-
tests were used to assess if mean virus inactivation levels (C/C0) at two chlorine contact times were 
significantly different. The null hypotheses were that the mean C/C0 values were the same. A null 
hypothesis was rejected if the P-value was less than 0.05. Statistical analyses were conducted in 
GraphPad Prism 7 software.  
 
3.3 Results and discussion  
3.3.1 Phi6 inactivation by free chlorine and UV254  
Free chlorine inactivation. Phi6 was rapidly inactivated by free chlorine (Figure 3.1), and a 
continuous quench-flow system was necessary to characterize disinfection while maintaining 
pseudo-first order conditions. The inactivation displayed significant tailing, which in other viruses 
has been ascribed to virus aggregation,53 adsorption to particles,53,54 and accumulation of oxidation 
products on the surface of viral particles.55 In order to minimize the presence of aggregated virus 
particles, virus stocks were always filtered through 0.22 µm membranes (Phi6 virion is ~85 nm in 
diameter). Interestingly, the inactivation plateau occurred at lower doses when Phi6 stocks were 
stored at 4 °C after purification, suggesting that the enveloped viruses aggregated during storage 
(Figure B-5). Consistent inactivation curves were only possible when Phi6 stocks were purified, 
filtered through 0.22 µm membranes, and then stored at -80 °C until use. Even then, inactivation 
nearly levelled off after 4-log10 inactivation by free chlorine (Figure 3.1). We modelled the first 2-
log10 inactivation, and obtained an inactivation rate constant equal to 4.6 ± 0.5 (mean ± standard 
error) L mg-1 s-1. For comparison, this rate constant is approximately 30´ larger than that of ssRNA 
MS2 under the same reaction conditions (0.17 L mg-1 s-1).56  
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Figure 3.1 Inactivation of Phi6 by 2 mg L-1 free chlorine (FC) and UV254 (UV). Data includes n ³ 
5 replicates for each chlorine contact time and n = 3 replicates for each UV254 dose. Student’s 
unpaired t-tests were used to determine statistical differences of Phi6 infectivity (C/C0) by free 
chlorine at two contact times. ** indicates P < 0.01, and thus that Phi6 infectivity was significantly 
different at the two time points; ns indicates Phi6 infectivity was not significantly different at the 
two time points (P > 0.05). 
 
UV254 inactivation. Inactivation of Phi6 by UV254 followed first-order reactions over the entire 
measured 6-log10 inactivation, with an inactivation rate constant of 0.067 ± 0.005 cm2 mJ-1. 
Compared to other enveloped viruses reported in the literature, Phi6 is quite resistant to UV254. For 
example, it is approximately 15 to 30´ more resistant to UV254 than influenza A virus (~1 cm2 mJ-
1)11,57 and vesicular stomatitis virus (VSV) (~2.3 cm2 mJ-1).58 When compared to nonenveloped 
viruses, which are better characterized in the literature, Phi6 UV254 inactivation kinetics were 
similar to MS2 (~0.06 cm2 mJ-1)30,56,59 and adenovirus (~0.046 cm2 mJ-1).12 
3.3.2 Reactions in Phi6 genome 
Free chlorine reactions. When Phi6 was treated with free chlorine up to 6-log10 inactivation, 
the reaction rate constants of the three ~500 bp regions in the genome were significantly different 
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from zero as detected by RT-qPCR (Figure 3.2A; Table B-3). The reaction rate constants of the 
three RT-qPCR regions did not differ significantly from one another following free chlorine 
treatment (P > 0.05 for all the three ANCOVA comparisons). We extrapolated the damage 
measured in the RT-qPCR regions to the entire genome in order to compare genome damage with 
inactivation.47 We note that by measuring ~1500 bp with our RT-qPCR analysis (i.e., 10.5% of the 
entire Phi6 genome), we aimed to minimize the impact that specific bases and base sequences have 
on the reactivity of small RNA regions.47 Based on the RT-qPCR extrapolation results, the fraction 
of viruses with damaged genomes was less than the fraction that was inactivated (Figure 3.2B). 
These results suggest that in Phi6, genome damage may not drive Phi6 inactivation by free 
chlorine. For comparison, genome damage did drive free chlorine inactivation in bacteriophage 
MS2.56  
To directly compare the nucleic acid reactivity of two viruses with different genome sizes and 
types, we normalized the genome reaction rate constants of MS2 (0.066 L mg-1 s-1)56 and Phi6 (0.26 
L mg-1 s-1) to the total number of bases in their genomes. This approach assumes that the genomes 
have the same proportion of reactive bases. In fact, MS2 and Phi6 do have similar proportions of 
bases that are reactive to free chlorine and UV254 (Table B-4).  Interestingly, the normalized MS2 
ssRNA genome reaction rate constant with free chlorine (1.8 ´ 10-5 L mg-1 s-1 base-1) is similar to 
the normalized value measured here for the Phi6 dsRNA genome (9.4 ´ 10-6 L mg-1 s-1 base-1).  
UV254 reactions. Statistically significant decreases in the concentrations of RT-qPCR target 
regions were detected following 6-log10 inactivation by UV254 (Figure 3.2A; Table B-3), and the 
reaction rate constants of the three regions were not significantly different from one another (P > 
0.05 for each ANCOVA comparison). When the RT-qPCR results were extrapolated to the entire 
genome, the approximated reaction rate constant of the Phi6 genome (0.063 ± 0.012 cm2 mJ-1) was 
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not significantly different from the rate constant of Phi6 inactivation (0.067 ± 0.005 cm2 mJ-1) (P 
> 0.05). This suggests that genome reactions drive UV254 inactivation of the enveloped virus Phi6. 
Although this type of analysis has not been previously reported for enveloped viruses, our finding 
is consistent with previous research on nonenveloped viruses.12,30,56,60 A comparison with the per 
base reaction rate constants measured here with those reported previously suggests that the dsRNA 
genome of Phi6 (2.4´ 10-6 cm2 mJ-1 base-1) is more resistant to UV254 than the dsDNA genome of 
adenovirus (11 ´ 10-6 cm2 mJ-1 base-1)61 and the ssRNA genome of MS2 (24 ´ 10-6 cm2 mJ-1 base-
1).56 It is worth noting that in the case of adenovirus, the modified bases detected by PCR can be 
repaired by the host cell;12 a similar repair mechanism has not been reported for the RNA viruses. 
 
Figure 3.2 Phi6 genome reactions when the viruses were reacted with 2 mg L-1 free chlorine (FC) 
and UV254 (UV). A: Reactions in three ~500 bp regions (Ni/N0,i) as measured by RT-qPCR with 
respect to chlorine contact time and UV254 doses. Data includes n ³ 2 replicates for each chlorine 
contact time and n = 3 replicates for each UV254 dose; B: Reactions in the entire Phi6 genome 
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(N/N0). This data was extrapolated from the three RT-qPCR regions presented in A, and is 
presented with respect to virus infectivity (C/C0) as measured by plaque assays. 
 
We note that using RT-qPCR to estimate genome damage misses a fraction of the RNA 
modifications that can be detected by mass spectrometry.44 Work on the photolysis of MS2 by 
UV254, however, demonstrated that a single-hit inactivation model was appropriate for damage 
detected with RT-qPCR; in other words, every modification in MS2 RNA that causes virus 
inactivation can be detected by RT-qPCR.47 Our ongoing work aims to better characterize the 
chemistry and biological impact of RNA and DNA modifications detected by reverse 
transcriptases, polymerases,  and mass spectrometry.  
 
3.3.3 Reactions in Phi6 proteins 
The Phi6 virion contains 11 distinct proteins that are assembled into three layers, including 
viral membrane proteins (P3, P6, P9, P10, P13), nucleocapsid proteins (P5, P8), and polymerase 
complex proteins (P1, P2, P4, P7) (Figure B-6).38 The functions of these proteins in the Phi6 life 
cycle have been reviewed in previous literature and are briefly described in the SI (Figure B-6).38 
Our LC-MS/MS method was capable of detecting a total of 184 pairs of 14N- and 15N-labelled Phi6 
peptides. Protein coverage was over 60% for all proteins except for P6 and P2 (Figure B-7). The 
repeated poor coverage of P6 and P2 was likely due to the low number of P6 and P2 protein copies 
in the viral particles (Figure B-7).  
Free chlorine reactions. We tracked Phi6 protein degradation over the first 2-log10 Phi6 
inactivation in order to model the peptide reactions with first-order kinetics. Free chlorine reacted 
with all Phi6 peptides with reaction rate constants ranging from 0.41 to 6.3 L mg-1 s-1 (Figure 3.3; 
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Table B-6). As expected, the most reactive peptides contained Met or Cys residues (Table B-6). 
Despite the similar reactivity of Met and Cys in the free amino acid form (Table B-5), the most 
reactive Cys-containing peptide C257-F267 in Phi6 P4 (2.8 ± 0.3 L mg-1 s-1) reacted slower than 
the most reactive Met-containing peptide D448-R463 (6.3 ± 0.9 L mg-1 s-1) in Phi6 P1 (Table B-
6). Furthermore, the rate constants of peptides containing Met varied. For example, in the Phi6 P1, 
the rate constant of M198-K208 (1.1 ± 0.1 L mg-1 s-1) was approximately 3 ´ smaller than that of 
peptide L53-Y66 (3.1 ± 0.5 L mg-1 s-1) and 4 ´ smaller than that of peptide M209-K215 (4.5 ± 0.7 
L mg-1 s-1), despite the three peptides having spatially adjacent Met residues (Figure B-8). The 
variation in reactivity of peptides containing Met and Cys is likely related to the accessibility of 
free chlorine to the amino acids.30 Indeed, the Cryo-EM model (PDB ID: 5muu) of Phi6 suggests 
that in the P1 complex, the dimethyl sulfide of M198 in M198-K208 is protected by surrounding 
amino acid residues, whereas the M65 in L53-Y66 and M209 in M209-K215 have higher solvent-
accessible surface areas (SASA, Figure B-8). It is also worth noting that oxidized Met residues 
were the only products in Phi6 proteins detected following 2-log10 inactivation by free chlorine 
(Figure B-9).  
 58 
 
Figure 3.3 Heatplot of Phi6 protein peptide abundances following Phi6 exposure to free chlorine 
(FC) and UV254 (UV). Each row in the heatplot represents one peptide. Peptides were arranged 
based on their sequential order in proteins, and the undetected peptides are shown in grey. Peptide 
concentrations (P/P0) in this heatplot were averaged from 3 independent experiments. Detailed 
information of peptide sequences, reaction rate constants and standard errors are provided in Table 
B-6. 
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We initially hypothesized that the increased susceptibility of Phi6 to free chlorine inactivation 
compared to nonenveloped viruses, such as MS2, was due to reactions in the membrane proteins. 
These proteins play critical roles in the early steps of virus infection, and are located on the 
outermost layer of the viral particle (Figure B-6). In fact, our results showed that in Phi6, some 
membrane proteins (e.g., P6, P9, P10, P13) reacted slower than the nucleocapsid proteins (e.g., 
P8) and polymerase complex proteins (e.g., P1, P2, P4) (Figure 3.3; Table B-6). This suggests that 
free chlorine molecules readily penetrate the lipid membrane and react with proteins in the 
nucleocapsid and polymerase complex. Similar findings were reported in bacteria, where the non-
dissociated HOCl molecules could penetrate the negatively-charged bacterial membrane to react 
with intracellular structures.62  
The 8 most reactive peptides found in Phi6 proteins P3, P8, P1, P2, and P4 had rate constants 
that were comparable to the Phi6 inactivation rate constant (Figure 3.4; Table B-6), forming Met 
oxidations as the main products (Figure B-9). Consequently, one or several of these protein 
reactions may drive Phi6 inactivation by free chlorine. Given the protein reactivity and the Phi6 
life cycle, Phi6 inactivation may be due to the direct interruption of the ability to bind host cell 
(P3) or to penetrate plasma membrane (P8).63,64 Alternatively, damage to proteins P2, P4, and P7 
may indirectly inactivate Phi6 by causing changes in the vial structure.48,64,65  
Peptides in Phi6 proteins were more reactive with free chlorine than peptides in the 
nonenveloped MS2 proteins. The two most reactive peptides D448-R463 (6.3 ± 0.9 L mg-1 s-1) and 
I678-R697 (5.9 ± 1.0 L mg-1 s-1) in Phi6 were approximately 150´ more reactive than the fastest 
reacting peptide S373-R388 in the MS2 A protein (0.033 L mg-1 s-1).56 The marked discrepancies 
in reactivity of Phi6 and MS2 peptides may be due to the relative solvent accessibilities of their 
reactive amino acids.30 The average SASAs of the M456 and M680 residue in the Phi6 peptide are 
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95 Å2 and 77 Å2, respectively, as calculated by YASARA software.66 Unfortunately, the SASA 
cannot be estimated for the Met in the most reactive MS2 peptide due to the fact that the crystal 
structure of the MS2 A protein has not been resolved.  
 
Figure 3.4 Decay of the 8 most reactive Phi6 peptides (P/P0) by free chlorine with respect to virus 
infectivity (C/C0). Data below the LC-MS/MS limit of quantification is shown in grey.  
 
UV254 reactions. All Phi6 peptides reacted following UV254 exposure, but much less than they 
reacted with free chlorine at the same levels of inactivation. Peptide concentrations decreased by 
less than 50% following 4.2-log10 Phi6 inactivation (Figure 3.3), with rate constants ranging from 
0.0009 to 0.0048 cm2 mJ-1 (Table B-6). Similar reaction rate constants were reported for peptides 
in bacteriophage MS2, fr, and GA proteins with UV254.30,56 Certain peptides in membrane protein 
P3 and RNA polymerase P2 reacted with faster kinetics, likely due to the presence of one or more 
UV-reactive amino acids in their sequences, including Trp (W), Tyr (Y), or Phe (F) (Table B-6).67 
Indirect photoreactions with nucleic acids may also play a role in the enhanced photoreactivity of 
certain viral peptides as reported in MS2.68 
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3.3.4 Reactions in Phi6 lipids  
Phi6 lipid membranes consist of glycerophospholipids, including phosphatidylethanolamine 
(PE), phosphatidylglycerol (PG), and cardiolipin (CL) compounds at a molar ratio of 58:38:4.39 
Here, we measured the relative abundances of the eight most prevalent PE and PG compounds in 
Phi6 membranes. 
Free chlorine reactions. The PE and PG relative concentrations did not decrease significantly 
over 9.1-log10 Phi6 inactivation by free chlorine (Figure B-10; P > 0.05 for all tests). A number of 
products were detected in the LC-MS spectra, including monochloramine products of PE 
(16:0/16:1) and PE (18:1/16:1) (Figure 3.5). The peak intensities of PE monochloramine products 
increased with increasing chlorine contact time, although at the highest inactivation level (i.e., 9.1-
log10 Phi6 inactivation), the product peak intensities were still three orders of magnitude smaller 
than the parent PE peaks (Figure 3.5). The low PE monochloramine product concentration within 
the Phi6 inactivation timeframe was not surprising given that the reported rate constant for this 
reaction (1.8 ´ 104 M-1s-1) is three orders of magnitude lower than the rate constants for free 
chlorine reacting with Met and Cys residues.69 Other lipid products were detected following free 
chlorine treatment, with peak intensities no greater than 1% of the parent compound peak 
intensities (Figure 3.5). The chemical compositions and structures of these products did not 
correspond to commonly reported lipid oxidation products, such as lipid hydroperoxides and 
chlorohydrins.70,71 
UV254 reactions. Statistically significant reductions in the relative concentrations of the eight 
major lipid compounds were not detected following UV254 doses resulting in 8.5-log10 Phi6 
inactivation (Figure B-10; P > 0.05 for all tests). Likewise, no major products were detected in the 
LC-MS spectra of samples following UV254 treatment (Figure 3.5). Previous research on UV254 
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reactions with the membrane of VSV suggest that the lipid envelope do not protect VSV from 
inactivation.72 
 
Figure 3.5 Phi6 lipids data collected by LC-MS before and after free chlorine (FC) and UV254 
(UV) treatments. Arrows identify specific lipid products [M-H]- following free chlorine treatment, 
including the following accurate masses (1) 775.513; (2) 779.464; (3) 710.477; (4) 684.461; (5) 
846.588; (6) 820.572; (7) 804.541; (8) 778.525; (9) 748.469 (monochloramine of PE(16:0/16:1)); 
(10) 722.454 (monochloramine of PE(18:1/16:1)). 
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The lipid compositions of eukaryote enveloped viruses are more diverse than those of 
bacteriophage Phi6. Influenza virus membranes, for example, contain not only PE and PG, but 
also cholesterol and phosphatidylserine (PS).40 The kinetics of these lipids with HOCl, however, 
are not markedly faster than the lipids in the Phi6 membrane.73,74 In summary, based on our Phi6 
lipid results and what has been reported for other lipids found in virus membranes, we anticipate 
that reactions in membrane lipids do not drive enveloped virus inactivation by free chlorine or 
UV254.  
 
3.3.5 Environmental implications 
Enveloped viruses are often assumed to be more susceptible than nonenveloped viruses to 
inactivation in the environment, but mechanistic descriptions of their differing inactivation 
mechanisms are lacking in the literature. Our preliminary work with enveloped virus Phi6 sheds 
light on how a model enveloped virus reacts with chemical oxidants and UV radiation. We found 
that Phi6 was 30´ more susceptible to free chlorine inactivation than the commonly studied 
nonenveloped virus MS2. Our work suggests that unlike MS2, the overall Phi6 particle reactivity 
with free chlorine is driven more by protein reactions than by genome and lipid reactions. Free 
chlorine reactions in the most reactive Phi6 peptides were orders of magnitude faster than reactions 
in the most reactive MS2 peptides, specifically for Phi6 peptides that contain solvent-accessible 
Met and Cys residues. Consequently, the relatively high number of solvent-accessible Met and 
Cys residues in the Phi6 proteins may be responsible for its fast inactivation kinetics with free 
chlorine. In contrast to chlorine, UV254 inactivates Phi6 primarily by reacting with the genome. 
This is consistent with previous research on nonenveloped viruses. It is therefore unlikely that 
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enveloped viruses are more susceptible than nonenveloped viruses to direct photolysis via sunlight 
or UV disinfection processes.  
Looking beyond this initial comparison of enveloped Phi6 with nonenveloped MS2, this work 
raises a number of hypotheses about virus reactivity and inactivation that can be tested with 
additional viruses. For example, future work should explore whether proteins in enveloped viruses 
are generally more susceptible to oxidants than proteins in nonenveloped viruses, and if this is the 
reason that enveloped viruses tend to be more susceptible to inactivation by chemical oxidants. 
Related to this, research should explore the link between the presence of solvent-accessible 
reactive amino acids in viral proteins with virus inactivation by oxidants. UVC inactivation should 
be tested with additional enveloped viruses that contain various genome sizes and genome types. 
Possible enveloped viruses to study in the future include vesicular stomatitis virus and avian 
influenza viruses. These are animal viruses with particle diameters and genome types that differ 
from Phi6 and can be propagated to stocks with high titers. This last point is important for cases 
in which researchers wish to apply the LC-MS/MS methods described in this study. Finally, 
enveloped viruses in open air may undergo reactions and inactivation mechanisms similar to 
viruses in water. Future studies should aim to compare aqueous virus reactivity with aerosolized 
virus reactivity.  
Enveloped viruses are structurally diverse, ranging in size, envelope composition, genome 
type, and shape. These variations are likely reflected in a range of reactivities and inactivation 
mechanisms. That being said, the structure and composition of the Phi6 are not especially unique 
amongst the enveloped viruses. We are therefore confident that this study on Phi6 reactivity with 
free chlorine and UV254 will be a valuable benchmark for future studies on enveloped virus fate in 
disinfection processes. 
 65 
3.4 References 
(1) Pica, N.; Bouvier, N. M. Environmental factors affecting the transmission of respiratory 
viruses. Curr. Opin. Virol. 2012, 2 (1), 90–95. 
(2) Wigginton, K. R.; Ye, Y.; Ellenberg, R. M. Emerging investigators series: The source and 
fate of pandemic viruses in the urban water cycle. Environ. Sci.: Water Res. Technol. 2015, 
1, 735–746. 
(3) Osterholm, M. T.; Moore, K. A.; Kelley, N. S.; Brosseau, L. M.; Wong, G.; Murphy, F. 
A.; Peters, C. J.; LeDuc, J. W.; Russell, P. K.; Van Herp, M.; et al. Transmission of Ebola 
viruses: What we know and what we do not know. mBio 2015, 6 (2), 1–9. 
(4) Memarzadeh, F. Literature review of the effect of temperature and humidity on viruses. 
ASHRAE Trans. 2012, 118, 1049–1060. 
(5) Welliver, R. C. Temperature, humidity, and ultraviolet B radiation predict community 
respiratory syncytial virus activity. Pediatr. Infect. Dis. J. 2007, 26, S29–S35. 
(6) Casanova, L. M.; Jeon, S.; Rutala, W. A.; Weber, D. J.; Sobsey, M. D. Effects of air 
temperature and relative humidity on coronavirus survival on surfaces. Appl. Environ. 
Microbiol. 2010, 76 (9), 2712–2717. 
(7) Songer, J. R. Influence of relative humidity on the survival of some airborne viruses. Appl. 
Microbiol. 1967, 15 (1), 35–42. 
(8) Weber, T. P.; Stilianakis, N. I. A note on the inactivation of influenza A viruses by solar 
radiation, relative humidity and temperature. Photochem. Photobiol. 2008, 84 (6), 1601–
1602. 
(9) Yang, W.; Elankumaran, S.; Marr, L. C. Relationship between humidity and influenza A 
viability in droplets and implications for influenza’s seasonality. PLoS ONE 2012, 7 (10), 
e46789. 
(10) Chumpolbanchorn, K.; Suemanotham, N.; Siripara, N.; Puyati, B.; Chaichoune, K. The 
effect of temperature and UV light on infectivity of avian influenza virus (H5N1, Thai 
field strain) in chicken fecal manure. Southeast Asian J. Trop. Med. Public Health 2006, 
37 (1), 102–105. 
(11) Sagripanti, J. L.; Lytle, C. D. Inactivation of influenza virus by solar radiation. Photochem. 
Photobiol. 2007, 83 (5), 1278–1282. 
(12) Bosshard, F.; Bosshard, F.; Armand, F.; Armand, F.; Hamelin, R.; Hamelin, R.; Kohn, T. 
Mechanisms of human adenovirus inactivation by sunlight and UVC light as examined by 
quantitative PCR and quantitative proteomics. Appl. Environ. Microbiol. 2012, 79 (4), 
1325–1332. 
(13) Ehrlich, R.; Miller, S. Effect of NO2 on airborne Venezuelan equine encephalomyelitis 
virus. Appl. Microbiol. 1972, 23 (3), 481–484. 
(14) Tseng, C. C.; Li, C. S. Ozone for inactivation of aerosolized bacteriophages. Aerosol Sci. 
Technol. 2006, 40, 683–689. 
(15) Wigginton, K. R.; Kohn, T. Virus disinfection mechanisms: The role of virus composition, 
structure, and function. Curr. Opin. Virol. 2012, 2 (1), 84–89. 
(16) Ye, Y.; Ellenberg, R. M.; Graham, K. E.; Wigginton, K. R. Survivability, partitioning, and 
recovery of enveloped viruses in untreated municipal wastewater. Environ. Sci. Technol. 
2016, 50, 5077–5085. 
(17) Casanova, L. M.; Weaver, S. R. Inactivation of an enveloped surrogate virus in human 
sewage. Environ. Sci. Technol. Lett. 2015, 2, 76–78. 
 66 
(18) Bibby, K.; Fischer, R.; Casson, L.; Stachler, E. Persistence of Ebola virus in sterilized 
wastewater. Environ. Sci. Technol. Lett. 2015, 2, 245–249. 
(19) Gallandat, K.; Lantagne, D. Selection of a Biosafety Level 1 (BSL-1) surrogate to evaluate 
surface disinfection efficacy in Ebola outbreaks: Comparison of four bacteriophages. 
PLoS ONE 2017, 12 (5), 1–10. 
(20) Rabenau, H. F.; Cinatl, J.; Morgenstern, B.; Bauer, G.; Preiser, W.; Doerr, H. W. Stability 
and inactivation of SARS coronavirus. Med. Microbiol. Immunol. 2005, 194 (1-2), 1–6. 
(21) Chan, K. H.; Poon, L. L. L. M.; Cheng, V. C. C.; Guan, Y.; Hung, I. F. N.; Kong, J.; Yam, 
L. Y. C.; Seto, W. H.; Yuen, K. Y.; Peiris, J. S. M. Detection of SARS coronavirus in 
patients with suspected SARS. Emerg. Infect. Dis. 2004, 10 (2), 294–299. 
(22) Yu, I. T. S.; Li, Y.; Wong, T. W.; Tam, W.; Chan, A. T.; Lee, J. H. W.; Leung, D. Y. C.; 
Ho, T. Evidence of airborne transmissionof the severe acute respiratory syndrome virus. 
N. Engl. J. Med. 2004, 350, 1731–1739. 
(23) Tellier, R. Review of aerosol transmission of influenza A virus. Emerg. Infect. Dis. 2006, 
12 (11), 1657–1662. 
(24) Bean, B.; Moore, B. M.; Sterner, B.; Peterson, L. R.; Gerding, D. N.; Balfour, H. H. 
Survival of influenza viruses on environmental surfaces. J. Infect. Dis. 1982, 146 (1), 47–
51. 
(25) Webster, R. G. Influenza: an emerging disease. Emerg. Infect. Dis. 1998, 4 (3), 436–441. 
(26) Stallknecht, D. E.; Goekjian, V. H.; Wilcox, B. R.; Poulson, R. L.; Brown, J. D. Avian 
influenza virus in aquatic habitats: what do we need to learn? Avian Dis. 2010, 54 (s1), 
461–465. 
(27) Albina, E. Epidemiology of porcine reproductive and respiratory syndrome (PRRS): An 
overview. Veterinary microbiol. 1997, 55, 309–316. 
(28) Piercy, T. J.; Smither, S. J.; Steward, J. A.; Eastaugh, L.; Lever, M. S. The survival of 
filoviruses in liquids, on solid substrates and in a dynamic aerosol. J. Appl. Microbiol. 
2010, 109 (5), 1531–1539. 
(29) Bibby, K.; Aquino de Carvalho, N.; Rule Wigginton, K. Research needs for wastewater 
handling in virus outbreak response. Environ. Sci. Technol. 2017, 51, 2534–2535. 
(30) Sigstam, T.; Gannon, G.; Cascella, M.; Pecson, B. M.; Wigginton, K. R.; Kohn, T. Subtle 
differences in virus composition affect disinfection kinetics and mechanisms. Appl. 
Environ. Microbiol. 2013, 79 (11), 3455–3467. 
(31) Gall, A. M.; Shisler, J. L.; Mariñas, B. J. Characterizing bacteriophage PR772 as a 
potential surrogate for adenovirus in water disinfection: A comparative analysis of 
inactivation kinetics and replication cycle inhibition by free chlorine. Environ. Sci. 
Technol. 2016, 50 (5), 2522–2529. 
(32) Lee, M. T.; Pruden, A.; science, L. M. E.; 2016. Partitioning of viruses in wastewater 
systems and potential for aerosolization. J. Chem. Eng. 2016, 3 (5), 210–215. 
(33) Lin, K.; Marr, L. C. Aerosolization of Ebola virus surrogates in wastewater systems. 
Environ. Sci. Technol. 2017, 51 (5), 2669–2675. 
(34) Wolfe, M. K.; Gallandat, K.; Daniels, K.; Desmarais, A. M.; Scheinman, P.; Lantagne, D. 
Handwashing and Ebola virus disease outbreaks: A randomized comparison of soap, hand 
sanitizer, and 0.05% chlorine solutions on the inactivation and removal of model 
organisms Phi6 and E. coli from hands and persistence in rinse water. PLoS ONE 2017, 
12 (2), e0172734. 
 67 
(35) Aquino de Carvalho, N.; Stachler, E. N.; Cimabue, N.; Bibby, K. Evaluation of Phi6 
persistence and suitability as an enveloped virus surrogate. Environ. Sci. Technol. 2017, 
51 (15), 8692–8700. 
(36) Gallandat, K.; Wolfe, M. K.; Lantagne, D. Surface cleaning and disinfection: Efficacy 
assessment of four chlorine types using escherichia coli and the Ebola surrogate Phi6. 
Environ. Sci. Technol. 2017, 51 (8), 4624–4631. 
(37) Cytoviridae. Virus Taxonomy: Ninth Report of the International Committee on Taxonomy 
of Viruses; King, A. M. Q., Adams, M. J., Carstens, E. B., Lefkowitz, E. J., Eds.; Elsevier: 
Oxford, 2011; pp 515–518. 
(38) Poranen, M. M.; Tuma, R.; Bamford, D. H. Assembly of double-stranded RNA 
bacteriophages. Adv. Virus Res. 2005, 64, 15–43. 
(39) Laurinavičius, S.; Käkelä, R.; Bamford, D. H.; Somerharju, P. The origin of phospholipids 
of the enveloped bacteriophage Phi6. Virology 2004, 326 (1), 182–190. 
(40) Gerl, M. J.; Sampaio, J. L.; Urban, S.; Kalvodova, L.; Verbavatz, J.-M.; Binnington, B.; 
Lindemann, D.; Lingwood, C. A.; Shevchenko, A.; Schroeder, C.; et al. Quantitative 
analysis of the lipidomes of the influenza virus envelope and MDCK cell apical membrane. 
J. Cell Biol. 2012, 196 (2), 213–221. 
(41) Bamford, D. H.; Ojala, P. M.; Frilander, M.; Walin, L.; Bamford, J. K. H. Isolation, 
purification, and function of assembly intermediates and subviral particles of 
bacteriophages PRD1 and Phi6. Methods Mol. Genet. 1995, 6, 455–474. 
(42) Dodd, M. C.; Vu, N. D.; Ammann, A.; Le, V. C.; Kissner, R.; Pham, H. V.; Cao, T. H.; 
Berg, M.; Gunten, von, U. Kinetics and mechanistic aspects of As(III) oxidation by 
aqueous chlorine, chloramines, and ozone:  Relevance to drinking water treatment. 
Environ. Sci. Technol. 2006, 40 (10), 3285–3292. 
(43) Standard Methods for Examination of Water & Wastewater, 20 ed.; Clescerl, L. S., 
Greenberg, A. E., Eaton, A. D., Eds.; American Public Health Assocaition: Washington, 
DC, 1999. 
(44) Qiao, Z.; Wigginton, K. R. Direct and indirect photochemical reactions in viral RNA 
measured with RT-qPCR and mass spectrometry. Environ. Sci. Technol. 2016, 50 (24), 
13371–13379. 
(45) Rahn, R. O. Potassium iodide as a chemical actinometer for 254 nm radiation: Use of 
iodate as an electron scavenger. Photochem. Photobiol. 1997, 66 (4), 450–455. 
(46) Gyürék, L. L.; Finch, G. R. Modeling water treatment chemical disinfection kinetics. J. 
Environ. Eng. 1998, 124 (9), 783–793. 
(47) Pecson, B. M.; Ackermann, M.; Kohn, T. Framework for using quantitative PCR as a 
nonculture based method to estimate virus infectivity. Environ. Sci. Technol. 2011, 45 (6), 
2257–2263. 
(48) Choe, J. K.; Richards, D. H.; Wilson, C. J.; Mitch, W. A. Degradation of amino acids and 
structure in model proteins and bacteriophage MS2 by chlorine, bromine, and ozone. 
Environ. Sci. Technol. 2015, 49 (22), 13331–13339. 
(49) Goshe, M. B.; Smith, R. D. Stable isotope-coded proteomic mass spectrometry. Curr. 
Opin. Biotechnol. 2003, 14, 101–109. 
(50) Gleit, A. Estimation for small normal data sets with detection limits. Environ. Sci. Technol. 
1985, 19 (12), 1201–1206. 
 68 
(51) Matyash, V.; Liebisch, G.; Kurzchalia, T. V.; Shevchenko, A.; Schwudke, D. Lipid 
extraction by methyl-tert-butyl ether for high-throughput lipidomics. J. Lipid Res. 2008, 
49 (5), 1137–1146. 
(52) Herzog, R.; Schwudke, D.; Schuhmann, K.; Sampaio, J. L.; Bornstein, S. R.; Schroeder, 
M.; Andrej Shevchenko. A novel informatics concept for high-throughput shotgun 
lipidomics based on the molecular fragmentation query language. Genome Biol. 2011, 12, 
1–25. 
(53) Kahler, A. M.; Cromeans, T. L.; Metcalfe, M. G.; Humphrey, C. D.; Hill, V. R. 
Aggregation of adenovirus 2 in source water and impacts on disinfection by chlorine. 
Food Environ. Virol. 2016, 8 (2), 148–155. 
(54) Gerba, C. P.; Betancourt, W. Q. Viral aggregation: Impact on virus behavior in the 
environment. Environ. Sci. Technol. 2017, 51 (13), 7318–7325. 
(55) Sigstam, T.; Rohatschek, A.; Zhong, Q.; Brennecke, M.; Kohn, T. On the cause of the 
tailing phenomenon during virus disinfection by chlorine dioxide. Water Res. 2014, 48, 
82–89. 
(56) Wigginton, K. R.; Pecson, B. M.; Sigstam, T.; Bosshard, F.; Kohn, T. Virus inactivation 
mechanisms: Impact of disinfectants on virus function and structural integrity. Environ. 
Sci. Technol. 2012, 46 (21), 12069–12078. 
(57) Powell, W. F.; Setlow, R. B. The effect of monochromatic ultraviolet radiation on the 
interfering property of influenza virus. Water Res. 1956, 2, 337–343. 
(58) Bay, P. H.; Reichmann, M. E. UV inactivation of the biological activity of defective 
interfering particles generated by vesicular stomatitis virus. J. Virol. 1979, 32 (3), 876–
884. 
(59) Battigelli, D. A.; Sobesey, M. D.; Lobe, D. C. The inactivation of hepatitis A virus and 
other model viruses by UV irradiation. Water Sci. Technol. 1993, 27, 339–342. 
(60) Simonet, J.; Gantzer, C. Inactivation of poliovirus 1 and F-specific RNA phages and 
degradation of their genomes by UV irradiation at 254 nanometers. Appl. Environ. 
Microbiol. 2006, 72 (12), 7671–7677. 
(61) Beck, S. E.; Rodriguez, R. A.; Linden, K. G.; Hargy, T. M.; Larason, T. C.; Wright, H. B. 
Wavelength dependent UV inactivation and DNA damage of adenovirus as measured by 
cell culture infectivity and long range quantitative PCR. Environ. Sci. Technol. 2013, 48 
(1), 591–598. 
(62) Dodd, M. C. Potential impacts of disinfection processes on elimination and deactivation 
of antibiotic resistance genes during water and wastewater treatment. J. Environ. Monit. 
2012, 14, 1754–1771. 
(63) Lewis, A. K.; Dunleavy, K. M.; Senkow, T. L.; Her, C.; Horn, B. T.; Jersett, M. A.; 
Mahling, R.; McCarthy, M. R.; Perell, G. T.; Valley, C. C.; et al. Oxidation increases the 
strength of the methionine-aromatic interaction. Nat. Chem. Biol. 2016, 12 (10), 860–866. 
(64) Ogata, N. Inactivation of influenza virus haemagglutinin by chlorine dioxide: oxidation 
of the conserved tryptophan 153 residue in the receptor-binding site. J. Gen. Virol. 2012, 
93, 2558–2563. 
(65) Liu, D.; Ren, D.; Huang, H.; Dankberg, J.; Rosenfeld, R.; Cocco, M. J.; Li, L.; Brems, D. 
N.; Remmele, R. L. Structure and stability changes of human IgG1 Fc as a consequence 
of methionine oxidation. Biochemistry 2008, 47 (18), 5088–5100. 
(66) Krieger, E.; Vriend, G. New ways to boost molecular dynamics simulations. J. Comput. 
Chem. 2015, 36 (13), 996–1007. 
 69 
(67) Mihalyi, E. Numerical values of the absorbances of the aromatic amino acids in acid, 
neutral, and alkaline solutions. J. Chem. Eng. 1968, 13, 179–182. 
(68) Wigginton, K. R.; Menin, L.; Sigstam, T.; Gannon, G.; Cascella, M.; Hamidane, H. B.; 
Tsybin, Y. O.; Waridel, P.; Kohn, T. UV radiation induces genome-mediated, site-specific 
cleavage in viral proteins. ChemBioChem 2012, 13 (6), 837–845. 
(69) Pattison, D. I.; Davies, M. J. Reactions of myeloperoxidase-derived oxidants with 
biological substrates: Gaining chemical insight into human inflammatory diseases. Curr. 
Med. Chem. 2006, 13, 3271–3290. 
(70) Spickett, C. M. Chlorinated lipids and fatty acids: An emerging role in pathology. 
Pharmacol. Ther. 2007, 115 (3), 400–409. 
(71) Frankel, E. N. Lipid oxidation: Mechanisms, products and biological significance. J. Am. 
Oil. Chem. Soc. 1984, 61 (12), 1908–1917. 
(72) Anderson, R.; Daya, M.; Reeve, J. An evaluation of the contribution of membrane lipids 
to protection against ultraviolet radiation. Adv. Virus Res. 1987, 905, 227–230. 
(73) Ghanbari, H. A.; Wheeler, W. B.; Kirk, J. R. Reactions of aqueous chlorine and chlorine 
dioxide with lipids: Chlorine incorporation. J. Food Sci. 1982, 47, 482–485. 
(74) Carr, A. C.; van den Berg, J. J. M.; Winterbourn, C. C. Chlorination of cholesterol in cell 
membranes by hypochlorous acid. Arch. Biochem. Biophys. 1996, 332 (1), 63–69. 
 70 
Chapter 4 Development of an integrated cell culture-mass spectrometry 
method for monitoring infectious viruses in environmental samples 
 
Yinyin Ye1, Krista R. Wigginton1 
1 Department of Civil and Environmental Engineering, University of Michigan, Ann Arbor, 
Michigan, USA 
4.1 Introduction 
Human pathogenic viruses in water are responsible for a number of waterborne human 
diseases. Compared to other waterborne pathogens (e.g., bacteria, protozoa), virus detection in 
water is especially challenging due to their small dimensions and low abundances. Sensitive 
methods have been developed to detect viral nucleic acid sequences, including polymerase chain 
reaction (PCR) and genome sequencing. These methods alone, however, are not able to 
differentiate infectious and noninfectious viruses. Culture-based methods, including plaque assays, 
detect only infective viruses. In culture-based methods, virus replication in their host cells can 
result in the formation of cytopathic effects (CPEs). These CPEs are often the endpoints used for 
detection and quantification. However, the formation of clear CPEs requires time, sometimes up 
to weeks. Furthermore, environmental samples can cause CPEs in the absence of viruses when 
materials in the samples are toxic to the cells.1,2 Yet another issue with culture-based methods is 
that several different viruses can often infect the same cultured cell system. It is therefore often 
impossible to identify the viruses responsible for the cytopathic effects.  
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To address the issue of molecular methods detecting noninfective viruses, and the issue of 
culture-based methods not identifying specific viruses, methods that integrate cell cultures with 
polymerase chain reaction (integrated cell culture-PCR; ICC-PCR) were developed. This approach 
has been used to detect many different viruses in environmental samples,3-6 including enteroviruses 
in wastewater samples. As few as one infectious virus can be detected by ICC-PCR earlier than 
the formation of clear CPEs.6 The other advantage of ICC-PCR over culture-based method alone 
is that multiple viruses can be detected with a number of primer sets. Hwa Kyung Lett et al. 7 used 
virus specific primers to monitor adenoviruses, enteroviruses, and reoviruses in water samples with 
ICC-PCR methods. 
Although ICC-PCR methods addressed some of the issues of culture methods and PCR 
methods alone, it still requires primer design and PCR assay optimization. In most ICC-PCR 
applications, two rounds of PCR amplifications are optimized to improve assay sensitivity and 
confirm positive results.8 If virus strain-level identification is necessary, strain-specific primer sets 
are required, and it may need further characterization by sequencing of PCR products.9 Another 
challenge associated with PCR methods is that viruses rapidly evolve, and this can occasionally 
cause pre-designed PCR primers to fail due to the newly evolved sequences.10 
Recently-developed mass spectrometry (MS) techniques may be capable of virus detection 
while alleviating some of the limitations of other techniques.11 MS instruments can scan peptide 
ions present in a sample and fragment peptide ions, ultimately making de novo peptide sequencing 
possible.12,13 Genetic information carried on proteins can then be used for microorganism 
identification. For instance, in a shotgun proteomics method for bacterial identification, bacterial 
proteins were digested into peptides, and the peptide sequences were analyzed on a liquid 
chromatography tandem mass spectrometry system. The detected peptides were then compared 
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with sequences in protein database to identify bacteria.14,15 The most obvious advantage of MS 
methods over PCR methods is the lack of necessary primer design and method optimization. 
Moreover, MS is able to detect single amino acid mutations based on the peptide fragments.16 
Methods that integrate cell culture and mass spectrometry (ICC-MS) have been applied for 
detecting viruses in clinical samples.17-19 Here, the detected peptide sequences could correctly 
distinguish viruses at the strain-level.19 To date, however, ICC-MS methods have not been applied 
for detecting viruses in environmental samples. Environmental matrices are often more complex 
than clinical samples, and virus concentrations are typically much lower.  
Here, we report on an ICC-MS method for detecting infectious human viruses in environmental 
water samples. Sample preparation methods and MS detection protocols were developed and 
optimized with a model virus culture system (i.e., murine hepatitis virus and its host L2 cells). The 
effects of virus concentrations and the potential toxicity of wastewater samples on the culture 
system were evaluated. Two monkey kidney cell cultures (i.e., Vero and BSC-1 cells) were then 
employed to demonstrate the ICC-MS method could detect infectious viruses in samples collected 
throughout a full-scale wastewater treatment plant. Our results suggest that the ICC-MS method 
is able to detect multiple infectious viruses in wastewater, and identifies viruses at the strain-level 
rapidly. The ICC-MS method can be easily adopted for detecting other viruses in water samples. 
 
4.2 Materials and methods 
4.2.1 Wastewater samples and concentration 
Municipal wastewater primary influent, effluent pre-UV disinfection, and final effluent 
samples were collected from autosamplers at the Ann Arbor Wastewater Treatment Plant between 
June and September in 2018. Samples were collected in sterile containers and transported on ice 
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to the laboratory at the University of Michigan, Ann Arbor. Wastewater samples were concentrated 
with ultrafiltration methods, which have achieved higher recoveries of both enveloped and 
nonenveloped viruses than other virus concentration methods.20, 21 In brief, wastewater samples 
were concentrated 50 ´ in volume with an REXEED 25S dialysis filter (Asahi Kasei Medical) or 
a Pellicon XL 30 kDa ultrafilter (Millipore). The concentrates were filter sterilized with 0.22 µm 
poly(ether sulfone) (PES) membranes (Millipore) to remove bacteria contamination that can be 
potentially introduced to cell culture. The final concentrated wastewater samples were aliquoted 
and stored at -80 °C before use. 
 
4.2.2 Viruses and cell lines 
Murine hepatitis virus (MHV) strain A59 and its host L2 cell lines (Table C-1) were used as a 
model system for detection by an integrated cell culture/mass spectrometry (ICC-MS) method. L2 
cells were maintained in Dulbecco’s Modified Eagle Medium (DMEM, Life Technologies 11960) 
supplemented with 10% newborn bovine serum (Life Technologies), 2 mM of L-glutamine (Life 
Technologies), 1% (v/v) of penicillin/streptomycin (Life Technologies) at 37 °C, 5% CO2. MHV 
was propagated in DBT cell lines according to a previously published method. Briefly, DBT cells 
were grown to 80% confluency, and infected by MHV at a multiplicity of infection (MOI) of 0.1 
plaque forming units (PFU) per DBT cell. Infected cells were incubated in DMEM (Life 
Technologies 11960) with 2% newborn bovine serum at 37 °C and 5% CO2 for 48 h. After 
incubation, cells were frozen and then thawed. Cell debris was removed by centrifuging the sample 
at 3,000 ´ g for 5 min. The supernatant was collected and filtered through a 0.22 µm PES 
membrane. The final MHV stocks (~106 PFU mL-1) were aliquoted and stored at -80 °C. 
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Monkey kidney cells include Vero cells and BSC-1 cells (Table C-1) were used as generic cell 
lines for culturing human viruses in wastewater concentrates. Vero and BSC-1 cells were grown 
in DMEM (Life Technologies 12430) with 10% newborn bovine serum, 1% (v/v) 
penicillin/streptomycin at 37 °C and 5% CO2.  
 
4.2.3 Virus infection and culturing 
Initial proof-of-concept experiments were conducted in the MHV-L2 culture systems. For 
these, MHV stock was added to DMEM with 2% newborn bovine serum to reach final 
concentrations of 300, 30, and 3 PFU mL-1. At the time of infection, cells were first washed with 
ice-cold PBS (Life Technologies 10010). 1.2 mL of each concentration was then inoculated into 
cells grown to ~80-90% confluency in culture plates (~23 cm2). Consequently, the total inoculated 
MHV was 360 PFU, 36 PFU, and 3.6 PFU per 23 cm2, and the ratio of the infectious MHV particles 
to cells was approximately 0.001, 0.0001 and 0.00001, respectively. The inoculated samples were 
incubated with cells for 1 h at 37 °C, with manually rocking every 15 min. The inoculum was then 
removed, and fresh DMEM containing 2% newborn bovine serum was added to sustain minimum 
cell growth. After culturing, protein samples were extracted (see Protein extraction) between 12 to 
42 hours post infection at intervals of 6 hours.  
To test the impact of wastewater components on the performance of the ICC-MS method, 
MHV stock was spiked into wastewater concentrates to reach the same final concentrations of 300, 
30, and 3 PFU mL-1. The control experiments in the MHV-L2 culture systems were then conducted 
in the same procedures of cell infection. Proteins were extracted at 18 and 24 hours post infection 
from the cells inoculated with 360 PFU, 30 and 36 hours post infection from the cells inoculated 
with 36 PFU, and 42 and 48 hours post infection from the cells inoculated with 3.6 PFU. 
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For experiments to detect viruses in wastewater samples, wastewater concentrates without 
further purification were directly added to cell monolayers of monkey cell culture systems, using 
the same procedures of virus inoculation. Cytopathic effects (CPE) were observed daily. Vero and 
BSC-1 cells were replenished with fresh DMEM containing 2% newborn bovine serum at the 7 
days post infection, and incubated for a total of 14 days. Negative controls were inoculated with 
virus-free PBS rather than wastewater extract. 
 
4.2.4 Protein extraction 
Proteins were collected from the cell monolayer at various times post inoculation with the 
MHV viruses or the wastewater extracts. Briefly, liquid culture media in the culture systems was 
removed, and cells were washed with ice-cold PBS. 100 µL of Triton X-114 buffer (20 mM Tris-
HCl, 150 mM NaCl, 0.5% Triton X-114, pH 8) was added to lyse cells on ice. Cell lysates vortexed 
and centrifuged at 3000 ´ g for 5 min at  4 °C to pellet nuclei. The supernatant was collected for 
phase separation to harvest hydrophilic proteins in the aqueous phase and amphiphilic proteins 
(i.e., integral proteins) in the detergent phase according to a previously published method.22 The 
hydrophilic portion of the proteins was precipitated with 25% (v/v) trichloroacetic acid by 
centrifuging at 14 000 ´ g for 10 min at 4 °C and then washed twice with cold (-20 °C) acetone. 
Protein pellets were saved at -80 °C until they were protease digested. 
 
4.2.5 Protein digestion and LC-MS/MS analysis 
Protein pellets were dissolved in a reducing buffer (8 M urea, 100 mM dithiothreitol, 50 mM 
Tris-HCl, pH 8), and denatured by boiling for 3 min. The undissolved fraction was removed by 
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centrifuging at 14, 000 ´ g for 5 min. The supernatant was transferred to a Microcon 10 kDa 
centrifugal filter unit (Millipore), and proteins were protease treated based on a filter-aided sample 
preparation protocol.23 After overnight digestion with trypsin (Worthington), peptides were 
analyzed on a liquid chromatography-tandem mass spectrometry (LC-MS/MS) system. 
Specifically, peptides were separated in a Dionex UltiMate 3000 LC system (ThermoFisher 
Scientific) equipped with an Accucore aQ column (50 nm ´ 2.1 mm, 2.6 µm particle size, 
ThermoFisher Scientific) protected by an Accucore aQ Defender guard column (ThermoFisher 
Scientific). 20 µL samples were loaded onto the system at a flow rate of 200 µL min-1. The solvent 
gradient began at 94% solution A (Milli-Q water with 0.1% formic acid) and 6% solution B (LC-
MS grade acetonitrile with 0.1% formic acid) for 3 min. Solution B was then linearly increased to 
40% over 30 min, followed by a linear increase to 80% over 2 min, and then maintained at 80% B 
for 5 min. B was then decreased to 6% and maintained there for 5 min to equilibrate the column. 
Eluted peptides were analyzed with a Q Exactive Orbitrap high-resolution mass spectrometer 
(ThermoFisher Scientific) in positive ion mode. Settings for the full mass spectrometry (MS) scans 
and data-dependent tandem mass spectrometry (dd-MS2) scans are provided in Table C-2. 
 
4.2.6 MS data analysis 
Raw MS data was analyzed with MASCOT Distiller software (2.6.1.0) connected to a local 
server. Protein database of Homo sapiens (174238 sequences, released on September 14th, 2018) 
and Mus musculus (83937 sequences, released on September 14th, 2018) in the FASTA format 
were downloaded from the UniProtKB. The viral protein database was downloaded from the 
UniProtKB taxonomic divisions as uniport_sprot_viruses.dat (28453 sequences, modified on 
September 12th, 2018), and converted to FASTA format with InSilicoSpectro::Databanks modules. 
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All databases were uploaded to the MASCOT local server. MS results related to the L2 culture 
system were searched against the Mus musculus database and the SwissProt virus database. MS 
results related to Vero and BSC-1 culture systems were searched against the Homo sapiens 
database and the SwissProt virus database. Carbamidomethylation of cysteine residues was 
selected as a fixed modification. N-terminal acetylation and methionine oxidation were set as 
variable modifications. The peptide mass tolerance was set at less than 10 ppm and the fragment 
mass tolerance was set at less than 0.3 Da. The false discovery rate (FDR) was calculated with a 
decoy database, and an FDR of less than 0.01 was set for all searches. The significance of peptide 
sequence (p-values) was defined as less than 0.01, and the peptide expectation (E) value was set 
at less than 0.001. Protein identification was considered positive when at least two distinct peptides 
from that protein were detected. 
The sequence coverage of a target protein was calculated based on the detected peptide 
sequences that were assigned to the protein and the length of the protein reported in database:  
Protein sequence coverage (´ 100%) = #	TZ	ÅÇOBT	ÅmO;R	;åñåmñå;	OB	ÉåÉñO;åRóTñÅ/	#	TZ	ÅÇOBT	ÅmO;R	OB	ñòå	Zô//	/åBxñò	TZ	ÉSTñåOB	RåöôåBmå. 
 
4.3 Results and discussion 
4.3.1 Identification of MHV by LC-MS/MS in culture media 
Proteins associated with host cells were the most identified in all samples (Data not shown). 
MHV nucleoproteins were positively detected at 18 hours post infection (hpi) when cells were 
inoculated with 360 PFU of MHV, at 24 hpi when cells were inoculated with 36 PFU, and at 36 
hpi when inoculated with 3.6 PFU (Figure 4.1). Higher sequence coverage of MHV nucleoproteins 
was observed as the culturing period extended (Figure 4.1; Table C-3). Approximately 30% 
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coverage was observed for the inoculation of 360 PFU at 27 hpi and 36 PFU at 38 hpi (Figure 4.1). 
For the 3.6 PFU inoculation, only 12% of nucleoproteins were detected at 42 hpi. At this low MHV 
inoculation, if cells infection is assumed to follow Poisson probability distribution,24 majority of 
cells may not have received an infectious MHV particle (>99.999%), thus explaining why the 
overall viral protein synthesis was slower. In addition to nucleoproteins, coronavirus spike 
glycoproteins were also detected at greater hpi in one sample (Table C-3). However, the protein 
sequence coverage of spike glycoproteins was lower compared to that of nucleoproteins. No viral 
proteins were detected in negative controls where cells were inoculated with virus-free PBS. These 
control experiments with the MHV model demonstrated that the ICC-MS method could detect 
viruses and that the time required for detection depends on the number of infectious viruses in the 
sample.  
 
 
Figure 4.1 Sequence coverage of MHV nucleoproteins detected by LC-MS/MS with respect to 
hours post infection. MHV was suspended in growth culture media. Negative controls consisted 
of cells infected with virus-free PBS.  
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Interestingly, the detected peptide sequences of MHV nucleoproteins made it possible to 
identify the MHV virus at the strain level. Specifically, the peptide SFVPGQENAGGR with an 
acetylation modification at the N-terminus was detected early, and this peptide is unique to MHV 
strain A59 (P03416) and MHV strain 3 (P18447) (Table C-3; Figure C-1). The nucleoproteins of 
other MHV strains possess peptide SFVPGQENASGR (Figure C-1) at the same position with an 
S residue at position 11 rather than a G residue. At higher MHV nucleoprotein coverage (i.e., at 
greater hpi), another unique peptide, namely LGTSDPQFPILAELAPTVGAFFFGSK, helped 
differentiate strain A59 and strain 3 from other strains (Table C-3; Figure C-1). However, the 
polymorphisms in nucleoproteins may limit the strain identification to some extent. The detected 
peptides were not able to distinguish strain A59 from strain 3. This is because the nucleoprotein 
sequences of these two strains have a similarity of 99.8%, and only vary by one amino acid residue 
at position 17.  
 
4.3.2 Identification of MHV in concentrated wastewater samples 
To test the impact of wastewater samples on the ICC-MS method, we suspended MHV in 
concentrated influent and effluent wastewater samples and conducted follow-up experiments. We 
hypothesized that if the wastewater inhibits protein synthesis, fewer viruses will be propagated in 
the culture system. Infectious MHV propagated and released into the liquid media was first tracked 
post inoculation by plaque assays. MHV propagation curves were similar when the cells were 
inoculated with MHV in concentrated wastewater or with MHV in growth media (Figure C-2). 
This suggests that virus infection was not affected by components in the concentrated wastewater 
samples.  
 80 
The cell systems inoculated with MHV in wastewater concentrates were also analyzed with 
the ICC-MS method. Consistent with the results when MHV in media was added to cells, 
nucleoproteins of MHV strains A59 and 3 were positively identified in all samples except for the 
sample collected at 42 hpi of 3.6 PFU inoculation in wastewater influent (Table C-4). 
Approximately 30% to 40% coverage of MHV nucleoproteins was observed for the inoculation of 
360 PFU at 24 hpi, 36 PFU at 36 hpi, and 3.6 PFU at 48 hpi (Figure 4.2). The sequence coverage 
for MHV in wastewater concentrates was also comparable to the experiments conducted in culture 
media. These results demonstrate that protein synthesis was not inhibited when the cells were 
exposed to the concentrated wastewaters.  
 
 
Figure 4.2 MHV nucleoprotein coverage detected by LC-MS/MS at hours post infection. MHV 
was suspended in concentrated wastewater influent (ww inf) and concentrated wastewater effluent 
(ww eff). Negative controls were fake infected with virus-free PBS. 
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observe bacterial contamination when the wastewater was pre-filtered through 0.45 µm pores 
rather than 0.22 µm pores (data not shown). Previous studies have conducted organic solvent 
extractions to remove wastewater toxicity (e.g., Freon, chloroform), but we avoided these steps 
due to their impact on enveloped viruses.25,26 
The experiments with MHV in wastewater suggest that the ICC-MS can detect infectious 
viruses in wastewater samples. Here, we used the nucleoproteins for identification due to the 
consistent detection and high sequence coverage compared to other viral proteins (i.e., spike 
glycoproteins) identified in our experiments. In MHV, nucleoproteins are the most abundant 
proteins.27 The peptides from the most abundant viral proteins are more likely to be captured earlier 
by MS. Work on MS-based detection of influenza A viruses in clinical samples reported the correct 
strains with nucleoprotein peptides when the protein sequence coverage was 30-40%.19 
Evolutionary analyses on the abundant viral capsid proteins of iridoviruses suggests that major 
capsid proteins are highly conserved but also diverse enough to distinguish close isolates.28 These 
findings suggest that the abundant proteins such as nucleoproteins and major capsid proteins are 
suitable for virus identification. 
 
4.3.3 Identification of infectious viruses in wastewater samples by ICC-MS/MS method 
Two monkey kidney cell lines (Vero and BSC-1) were used to detect infectious viruses in the 
concentrated wastewater samples by the ICC-MS method. Vero and BSC-1 cells have been used 
to isolate polioviruses, coxsackieviruses, echoviruses, reoviruses, and adenoviruses from sewage 
samples in a previous study.25 Here, sewage samples were inoculated to cell cultures and incubated 
10 days for the observation of cytopathic effects. Supernatants were collected from the cells with 
positive cytopathic effects and passaged for another two rounds of 10-day culturing for the 
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confirmation of positive cytopathic effects. Viruses were finally identified based on immuno-based 
clinical assays.25 
We applied the same inoculation procedures as we did in the MHV proof-of-concept 
experiments to infect Vero and BSC-1 cells with concentrated wastewater samples. Throughout 
the 14-day culture period, cells did not show clear cytopathic effects, and no cells were observed 
detaching from the culture plates. The same protein extraction method that was developed in the 
MHV culture system was applied to extract proteins from Vero and BSC-1 cells at 14 days post 
infection (dpi). Control cells were inoculated with virus-free PBS.  
 
Virus detection in the influent samples  
In both Vero and BSC-1 culture systems, proteins associated with homo sapiens are the most 
identified (data not shown). In addition, in the Vero cell extracts, a number of reovirus proteins 
were detected (Table 4.1). Reovirus proteins mu-1 and sigma-3 had consistently high sequence 
coverage (30%-40%) from the cells inoculated with influent samples, followed by sigma-2, sigma-
NS and mu-NS proteins of approximately 20% sequence overage. The coverage of lambda-1 and 
mu-2 varied significantly in two influent samples. Proteins lambda-2, and lambda-3 had sequence 
coverage less than 10%. Contrary to the Vero samples, no viral proteins were detected in the BSC-
1 cell extracts. 
A reovirus particle contains 8 distinct virion proteins that assemble into an outer protein capsid 
containing mu-1, sigma-1, sigma-3, lambda-2 proteins and an inner protein capsid containing 
proteins lambda-1, lambda-3, sigma-2, mu-2.29 Three nonstructural proteins are involved in the 
virus replication cycle,30-32 namely sigma-NS, mu-NS, and sigma-1s. The consistently high 
sequence coverage of mu-1 and sigma-3 proteins in our study suggests that these two proteins were 
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the most abundant in the cell culture system. Indeed, mu-1 and sigma-3 proteins are the major 
outer capsid proteins in reoviruses, with 600 copies in one reovirus particle (Table C-5). Based on 
the results in MHV control experiments, we would use the mu-1 and sigma-3 proteins for the 
strain-level identification of reoviruses. Protein mu-1 and sigma-3 of both type 1 and type 3 strains 
were identified, suggesting the coexistence of infectious reovirus type 1 and type 3 in the influent 
samples. Reovirus type 2 was detected in the influent samples based on peptides in protein sigma-
3 (coverage = 16 % in average), but peptides from protein mu-1 were not detected. This may be 
because the protein mu-1 sequences of the three reovirus strains have higher similarities than the 
three sigma-3 sequences (Figure C-3; Figure C-4); consequently, the chances of detecting unique 
peptides from protein mu-1 are lower. These results suggest that reovirus type 1, type 2, and type 
3 are present in the influent wastewater samples.  
 
Virus detection in the effluent samples 
In contrast to the influent samples, only three reovirus proteins were detected in the cells 
inoculated with the effluent pre-UV treatment (Table 4.1). Sigma-3 proteins of reovirus type 2 and 
type 3 were detected with sequence coverage of 7% and 15%, respectively. Mu-1 protein of 
reovirus type 1 was detected with sequence coverage of 6%. Although this assay is not yet 
quantitative, these results suggest a lower concentration of infectious reoviruses in the effluent 
samples than in the influent samples. Reovirus proteins were not detected in the cells infected with 
final effluent, suggesting that the concentrations of infectious reoviruses decreased further through 
the UV disinfection treatment. These negative results can be interpreted that infectious reoviruses 
in the final effluent was too low to capture in 1.2 mL of the wastewater concentrate samples that 
were used for inoculation. In this concentrate sample, 1.2 mL of the concentrate corresponded to 
 84 
60 mL of the effluent, which suggests that the infectious concentrations of reoviruses in the final 
effluent are no higher than 16.7 infectious particles/L if single infectious reovirus can be detected 
by the ICC-MS method after 14-day culturing. 
Contrary to the Vero culture system, negative results were observed for all effluent samples in 
the BSC-1 culture system. BSC-1 cells have been more applied for polioviruses surveillance in 
water;33 polioviruses, however, are unlikely to be present in Ann Arbor wastewater samples. This 
result highlights the importance of the cell types used for an ICC-MS method, because only the 
viruses that can grow in the cell lines will be detectable by mass spectrometry. Our ongoing work 
is exploring the application of other cell lines in this method. 
By applying the ICC-MS method, we detected infectious reovirus type 1, type 2, and type 3 in 
the primary influent samples, and we found peptides from reovirus type 1, type 2, and type 3 in 
the effluent pre-UV samples. This suggests that infectious reoviruses persist after primary and 
secondary treatment. As mentioned above, no infectious reoviruses were detected in the 60 mL of 
disinfected effluent.  
 
Table 4.1 Proteins detected in extracts from Vero cells. Vero cells were inoculated with different 
wastewater samples, and incubated for 14 days. 
Primary influent 1, 50´ concentrate 
Accession 
number Protein description 
Sequence 
coverage 
(%) 
Protein 
score 
P11077 mu-1, Reovirus type 1 (strain Lang) 32 1287 
P11078 mu-1, Reovirus type 3 (strain Dearing) 28 918 
P03527 sigma-3, Reovirus type 3 (strain Dearing) 24 695 
P30211 sigma-3, Reovirus type 2 (strain D5/Jones) 13 503 
P07939 sigma-3, Reovirus type 1 (strain Lang) 25 489 
P03525 sigma-2, Reovirus type 3 (strain Dearing)  25 204 
P11314 sigma-2, Reovirus type 1 (strain Lang) 26 193 
P07940 sigma-NS, Reovirus type 1 (strain Lang) 19 418 
P03526 sigma-NS, Reovirus type 3 (strain Dearing) 17 384 
P12419 mu-NS, Reovirus type 3 (strain Dearing) 17 601 
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Q9PY83 mu-NS, Reovirus type 1 (strain Lang) 13 428 
Q9WAB2 lambda-1, Reovirus type 1 (strain Lang) 7 453 
P15024 lambda-1, Reovirus type 3 (strain Dearing) 7 453 
P11079 lambda-2, Reovirus type 3 (strain Dearing) 3 128 
Q00335 mu-2, Reovirus type 1 (strain Lang) 3 90 
P12418 mu-2, Reovirus type 3 (strain Dearing) 3 90 
Primary influent 2, 50´ concentrate 
Accession 
number Protein description 
Sequence 
coverage 
(%) 
Protein 
score 
P11077 mu-1, Reovirus type 1 (strain Lang) 40 1765 
P11078 mu-1, Reovirus type 3 (strain Dearing) 36 1400 
P03527 sigma-3, Reovirus type 3 (strain Dearing) 43 1234 
P07939 sigma-3, Reovirus type 1 (strain Lang) 38 1029 
P30211 sigma-3, Reovirus type 2 (strain D5/Jones) 27 862 
Q9WAB2 lambda-1, Reovirus type 1 (strain Lang) 29 1975 
P12419 mu-NS, Reovirus type 3 (strain Dearing)  24 1165 
Q9PY83 mu-NS, Reovirus type 1 (strain Lang) 19 931 
P12418 mu-2, Reovirus type 3 (strain Dearing) 17 619 
P03526 sigma-NS, Reovirus type 3 (strain Dearing) 22 720 
P07940 sigma-NS, Reovirus type 1 (strain Lang) 24 684 
P03525 sigma-2, Reovirus type 3 (strain Dearing) 17 323 
P11314 sigma-2, Reovirus type 1 (strain Lang) 19 318 
Q91RA6 lambda-2, Reovirus type 1 (strain Lang) 9 516 
P11079 lambda-2, Reovirus type 3 (strain Dearing) 7 330 
P0CK32 lambda-3, Reovirus type 1 (strain Lang) 3 105 
Effluent pre-UV, 50´ concentrate 
Accession 
number Protein description 
Sequence 
coverage 
(%) 
Protein 
score 
P03527 sigma-3, Reovirus type 3 (strain Dearing) 15 199 
P30211 sigma-3, Reovirus type 2 (strain D5/Jones) 7 118 
P11077 mu-1, Reovirus type 1 (strain Lang) 6 160 
Final effluent, 50´ concentrate 
No viral protein hit 
Negative control, inoculated with virus-free PBS 
No viral protein hit 
 
4.3.4 Environmental implications 
Results from this proof-of-concept work on the development of an ICC-MS method suggests 
that it holds promise for the detection of infectious viruses in environmental water samples. The 
ICC-MS method identifies viruses more directly than ICC-PCR methods, as it avoids the need of 
primer design and assay development for each strain detected. In our study, the sample preparation 
and MS detection protocols that have been developed with a mouse virus and its host cells can be 
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easily adopted for other virus detection in different culture systems. Moreover, the MS technique 
can readily identify multiple virus strains, given their sequences are present in the database. We 
were able to detect three reovirus strains in wastewater with Vero cells that displayed no apparent 
cytopathic effects, and demonstrated the virus removal/inactivation through a full-scale 
wastewater treatment. Compared to sequencing methods, which can also identify viruses without 
designing specific primers, the ICC-MS method has the advantage of needing much less data 
processing. In our study, the MS data analysis took less than an hour, while metagenomic 
sequencing data may take several days or weeks to process. Furthermore, since metagenomic 
methods sequence all of the DNA in a sample, much of the data recovered is not relevant.  
Consequently, numerous copies of a specific gene need to be present for the organism of interest 
to be detected. Here, we were able to detect MHV in our wastewater samples when as few as 3 
infectious particles were present.  
Further research will be required before this method can be broadly applied. Specifically, the 
ICC-MS method will need to be optimized for different cell lines so that a range of viruses can be 
detected. Ideally, cell lines that can detect several human viruses at once would be selected for 
environmental monitoring. The impact of multiple virus infection will need to be assessed as it is 
possible that only the fastest replicating viruses will be identified. Finally, it is worth pointing out 
that at this point the method is qualitative or semi-quantitative. We believe the method could be 
readily modified to become quantitative by developing a most-probable-number type method. 
Here, sequential dilutions of the wastewater are assessed simultaneously, and statistics performed 
on the positive/negative replicates can provide a value of the infective viruses present in the 
sample.   
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Chapter 5 Significance and implications 
5.1 Overview 
This dissertation research seeks to advance our current state of knowledge on the detection 
and fate of nonenveloped viruses in water environments. The outcomes help fill the knowledge 
gaps of treating enveloped viruses in wastewater and monitoring infectious viruses in water 
samples. This dissertation begins to explore the survivability and partitioning of model enveloped 
viruses in municipal wastewater (Chapter 2). Lab-scale experiments and computational 
simulations were used to quantitatively characterize the inactivation of model viruses in liquid and 
solids fractions of wastewater and the partitioning of model viruses to wastewater solids. The 
knowledge obtained from the experiments facilitated the optimization of an ultrafiltration method 
for concentrating infectious enveloped viruses from wastewater with high recovery rates (Chapter 
2). Chapter 3 focuses on the inactivation of enveloped viruses with common disinfectants. 
Considering the difficulties with studying the inactivation kinetics of highly pathogenic enveloped 
viruses and viruses that are nonculturable, we developed a framework to understand the 
inactivation of enveloped viruses on a molecular basis. Virus infectivity, reactions in lipids and 
proteins, and reactions in nucleic acids following the treatment by common disinfectants were 
tracked by cell culture assays, quantitative mass spectrometry, and molecular polymerase chain 
reaction (PCR) techniques. Finally, Chapter 4 reports an integrated cell culture-mass spectrometry 
(ICC-MS) method for detecting infectious viruses. This ICC-MS method was developed and 
optimized with an enveloped murine coronavirus and its culture system, and was then validated 
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by applying it to detect infectious viruses in wastewater samples collected throughout a full-scale 
municipal wastewater treatment plant. Major findings from this dissertation research and their 
implications for water quality control and viral disease control are discussed in detail below. 
 
5.2 Implications for operations of wastewater treatment plants  
Our findings from the survivability of enveloped viruses underscore that enveloped viruses can 
persist in wastewater, especially at cooler temperatures.1-3 Considering that outbreaks of certain 
enveloped virus diseases peak during the winter, higher concentrations of infectious enveloped 
viruses may be present in wastewater during winter. Further studies on enveloped virus removal 
throughout wastewater treatment plants should focus more on removal during conditions of cooler 
temperatures.  
Enveloped viruses tended to partition to a greater extent to wastewater solids than 
nonenveloped viruses. Consequently, a larger fraction of enveloped viruses is expected to be 
removed by primary treatment settling. The models developed here were built based on the 
partitioning experiments at 4 °C. Wastewater temperatures, however, can range from 3 °C to 27 
°C.4 We would expect higher levels of enveloped virus sorption to solids in wastewater at higher 
temperatures. Another limitation to our sorption study is that when viruses are shed, any can be 
within fecal solids, whereas we spiked purified model enveloped viruses into the wastewater and 
observed their partitioning between solids and liquids. The fraction of enveloped viruses that are 
associated with solids at equilibrium may therefore be underestimated in our study. Given these 
two points, the fraction of enveloped viruses that are removed in the primary settling tank in real 
systems is likely to be greater than the fraction estimated in our study.  
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Our models also indicate that the inactivation kinetics of enveloped viruses in the liquid 
fraction of wastewater is similar to the inactivation kinetics of enveloped viruses sorbed on the 
solid surfaces, suggesting that infectious enveloped viruses may persist in sediments. The presence 
of enveloped virus genes in the sludge of anaerobic reactors have been reported previously.5 More 
research regarding the fate of enveloped viruses in solids needs further investigation.  
 
5.3 Implications for predict enveloped virus reactivity with disinfectants 
To understand virus susceptibility to disinfectants, culture-based infectivity assays have been 
used widely to track the loss of virus infectivity following disinfection treatments. However, some 
enveloped viruses are too dangerous to work with, and many viruses are not culturable. A 
molecular-based understanding of virus inactivation could help in predicting virus reactivity with 
disinfectants. The framework developed in our study identifies the molecular features in a model 
enveloped virus that drive virus inactivation by common disinfectants. Our results demonstrate 
that the presence of reactive amino acids in viral proteins that are easily accessible by solvents 
correlate with high virus reactivity with free chlorine. Genome reactions, on the other hand, drive 
virus inactivation by UV254. The molecular-based understanding of virus inactivation explains the 
discrepancies of inactivation kinetics among viruses. For example, we were able to identify that 
the higher resistance of nonenveloped virus MS2 to free chlorine compared to the enveloped virus 
Phi6 is due to the different reactivities of their proteins. The most reactive peptide in MS2 is 150´ 
less reactive to free chlorine than the most reactive peptide in Phi6. Before generalizations about 
enveloped virus mechanisms versus non-enveloped virus mechanisms are possible, similar 
investigations with other model enveloped and nonenveloped viruses must be conducted.  
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5.4 Implications for virus environmental surveillance 
Human viruses are generally at very low concentrations in water environments. It is therefore 
challenging to monitor their presence and infectivity in water. In this dissertation, we optimized 
an ultrafiltration method for concentrating infectious viruses from water samples with high 
recovery rates for both enveloped and nonenveloped viruses. To follow up the concentration 
method, we developed a new virus detection method that integrates cell culture and mass 
spectrometry (ICC-MS) for detecting infectious viruses in the concentrated water samples. This 
ICC-MS method has a number of advantages over other currently available virus detection 
methods; most notably, the sample preparation and mass spectrometry protocols can be easily 
adopted for detecting multiple viruses at once, as long as they are propagated in the same culture 
system. This would not be possible for PCR-based detection methods, which require primer design 
and PCR assay optimization for different viruses. The ICC-MS detects the most abundant viral 
proteins that carry conservative but diverse genetic information suitable for virus identification. 
Data processing by comparing the detected peptide sequences with the sequences available in viral 
protein database takes less than one hour. This is an advantage over viral genome sequencing, for 
which data processing may take several days or weeks and requires a supercomputer.  
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Appendices 
 
Appendix A.  Supplementary Information for Chapter 2 
 
Optimization of Ultrafiltration Method. A higher MHV recovery was achieved when the 
wastewater solids removal step was carried out with filtration through 0.22 μm PES membranes 
rather than centrifugation at 30,000 × g for 10 min (P = 0.0046; Figure A-3A). Employing 10 kDa 
ultra-filters for the concentration step resulted in higher and more consistent MHV recoveries 
compared to 100-kDa ultra-filters (Figure A-3B). In comparison, the specific solids-removal 
techniques and the 10 kDa versus 100 kDa filter sizes did not impact the MS2 recoveries. 
Following ultra-filter regeneration, the mean recovery of MHV decreased and the mean recovery 
of MS2 increased, although neither change was significant (P = 0.2444; Figure S3B).  
Recovery of MHV from Wastewater Solids. When solids were collected from the wastewater 
with centrifugation at 30,000 × g for 10 min., the extraction solution consisting of pH 9.5 glycine 
buffer resulted in the highest recovery of MHV (3.7% of spiked MHV; Figure A-3C) from the 
wastewater solids; this recovery was low considering that nearly a quarter of spiked MHV were 
reversibly adsorbed to solids after incubating for one-hour, and therefore should have been 
recoverable. The limited recovery may be due to viruses losing infectivity as they are detached 
from the soil surface, as reported elsewhere.1 MS2 recoveries were ~2% for all of the tested 
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extraction solutions; this was not surprising based on the low percentage (6%) of MS2 associated 
with the wastewater solids at equilibrium.  
 
 
 
Figure A-1 Virus recovery immediately after viruses were spiked into samples at 4 °C (t = 0) and 
after 1-hour incubation at 4 °C. Here, õú  (PFU) represents the amount of infective viruses 
measured at time T; õù  (PFU) is the amount of infective viruses in the spiked aliquots. Bars 
indicate the mean recovery for each tested viruses. 
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Figure A-2 Virus inactivation in 4 °C wastewater with and without the presence of PEG. Error 
bars represent the ranges of replicates from wastewater samples collected on different days (n = 
2). 
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Figure A-3 Method optimization for enveloped virus (MHV) and nonenveloped virus (MS2) in 
liquid and solid phases: (A) Virus recoveries in liquid fraction of wastewater following solids 
removal by centrifuging at 30,000 × g for 10 min at 4 °C (Cen), or by centrifugation at 2,500 × g 
for 5 min at 4 °C followed by 0.22 μm filtration (Fil); (B) Ultrafiltration method tested with pre-
filtration and pre-centrifugation, with filter cut-off sizes of 100 kDa and 10 kDa, and with filter 
reuse. (C) Virus recoveries from wastewater solids collected from wastewater samples by 
centrifuging at 30,000 × g for 10 min at 4 °C. Tested elution buffers include PBS (pH 7.4), 0.05 
M glycine buffer (0.05 M GB, pH 8.5, pH 9.5, and pH 10.5), 3% beef extract (3% BE, pH 7.5 and 
pH 9.5), and 3% beef extract with 0.5 M sodium chloride (3% BE + 0.5 M NaCl, pH 9.5). Bars 
represent the average infective virus recoveries of the replicate experiments (n≥3). 
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Figure A-4 Statistical significance analysis of virus inactivation kinetics under different 
conditions. 
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Table A-1 Wastewater parameters 
TSS (mg L-1) a 235 ± 97 
VSS (mg L-1) a 205 ± 85 
VSS/TSS a 0.87 ± 0.13 
pH a 7.63 ± 0.25 
Total COD (mg COD L-1) b 300—768 
Background bacteriophage concentrations tested 
with E. coli ATCC 15597 (PFU mL-1) b 
800—1000 
aResults from 34 wastewater samples. 
bRanges of 3 wastewater samples. 
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Table A-2 TSS and VSS removal by centrifugation at 30,000 × g for 10 min. 
 
TSS (VSS) of 
wastewater samples 
(mg L-1) 
TSS (VSS) after centrifugation 
(mg L-1) 
TSS (VSS) 
Removal (%) 
1 327 (297) 50.0 (43.3) 85 (85) 
2 213 (183) 15.0 (10.0) 95 (95) 
3 237 (193) 16.7 (16.7) 93 (91) 
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Table A-3 Inactivation rates of enveloped and nonenveloped virus surrogates in unpasteurized and 
pasteurized wastewater. 
  Temp. 
First order rate 
constant (h-1) 
(avg±s.d.) 
Estimated 
T90 (h) 
(avg±s.d.) 
R2  
(avg)  
Wastewater 
MHV (enveloped) 25 °C 0.142 ± 0.015 13 ± 1 0.88 10 °C 0.059 ± 0.006 36 ± 5 0.95 
Phi6 (enveloped) 25 °C 0.317 ± 0.022 7 ± 0.4 0.99 10 °C 0.091 ± 0.010 28 ± 2 0.96 
MS2 (nonenveloped) 25 °C 0.022 ± 0.006 121 ± 36 0.85 10 °C 0.014 ± 0.003 175 ± 33 0.78 
T3 (nonenveloped) 25 °C n.a. n.a. n.a. 10 °C 
Pasteurized 
wastewater 
MHV (enveloped) 25 °C 0.120 ± 0.037 19 ± 8 0.97 10 °C 0.021 ± 0.012 149 ± 103 0.84 
Phi6 (enveloped) 25 °C 0.044 ± 0.004 53 ± 8 0.95 10 °C 0.017 ± 0.005 146 ± 43 0.86 
MS2 (nonenveloped) 25 °C 0.020 ± 0.007 121 ± 55 0.95 10 °C 0.013 ± 0.006 212 ± 88 0.73 
T3 (nonenveloped) 25 °C n.a. n.a. n.a. 10 °C 
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Table A-4 Simulation results for virus sorption and inactivation kinetics in wastewater at 4 °C. 
Virus k1 (h-1)a k2 (h-1)b k3 (h-1)c 
Viruses 
adsorbed 
at 
equilibriu
m (%) 
T (90% 
equilibriu
m, h) 
T (99% 
equilibriu
m, h) 
MHV (enveloped) 0.048 2.8 0.048 26.3 0.3 0.4 
Phi6  (enveloped) 0.026 0.33 0.026 22 1.5 2.9 
MS2 (nonenveloped) 0.0013 0.13 0.037 6.0 1.1 2.5 
T3 (nonenveloped)d n.a. n.a. n.a. n.a. n.a. n.a. 
a 23 is the virus inactivation rate constant in the liquid fraction of wastewater, equal to the virus 
inactivation rate constant in solids-removed wastewater; 
b 2: is the rate constant for reversible adsorption from the liquid to solid phase; 
c 2L is the virus inactivation rate constant on solid surfaces. In our model, the rate constant for 
reversibly adsorbed viruses transitioning to irreversible adsorption (2X) was assumed to equal zero. 
d No significant decline of the T3 infectivity was observed in wastewater and solids-free 
samples within the experimental time-scale. 
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Appendix B.  Supplementary Information for Chapter 3 
 
Protein digestion. The virus samples (2.4 mL, ~1011 PFU) were concentrated with 100 kDa 
Amicon Ultra-0.5 centrifugal filters (Millipore), washed three times with 50 mM Tris-HCl buffer 
(pH 8) and eventually collected at a final volume of approximately 40 µL. Protein concentrations 
were measured in a Qubit Fluorometer 2.0 with Protein Assay Kits (ThermoFisher Scientific). 
Total protein concentrations of 28.6 ± 2.2 µg per 1011 PFU were consistently measured in the 
concentrated virus samples. Each of the 40 µL concentrate was equally split into two portions, and 
the two 20 µL samples were digested with trypsin and chymotrypsin, respectively. In brief, the 
virus concentrates were denatured by submerging the sealed centrifuge tube in boiling water for 
5-6 min. Following the denaturing step, iodoacetamide was added to a final concentration of 10 
mM in order to prevent the formation of disulfide bonds, and the sample was incubated in the dark 
at 37 °C for 1 h. Unreacted iodoacetamide was deactivated by adding L-cysteine to a final 
concentration of 16.7 mM and incubating the solution in the dark at room temperature for 30 min. 
Finally, calcium chloride was added to a final concentration of 1 mM and trypsin or chymotrypsin 
was added to achieve a protein-to-enzyme ratio of 50:1. Samples were gently vortexed and then 
incubated at 37 °C overnight. After incubation, samples were injected directly onto the LC-MS/MS 
system without further purification.  
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15N-Metabolic labeled Phi6. To prepare a stock of 15N-labeled Phi6, the Phi6 host P. syringae 
was first cultured in 15N-M9 medium (1g L-1 15NH4Cl, 48 mM Na2HPO4, 22 mM KH2PO4, 8.5 mM 
NaCl, 2 mM MgSO4, 0.1 mM CaCl2, and 0.4% (v/v) glucose, pH 7.4). 14N-Phi6 was then added to 
15N-labeled P. syringae at an OD640 of ~0.1 and at a MOI of 2, and incubated at 26 °C while shaking 
at 180 rpm. Propagation was stopped 12-17 hours after infection. The Phi6 propagation in 15N-
labeled P. syringae was repeated for two generations in 15N-M9 medium to obtain a stock with 
over 99% 15N. The virus concentration and purification techniques used for the 15N-labeled Phi6 
were the same as those used for the 14N-Phi6. The final 15N-labeled Phi6 stocks (8 × 1011 PFU mL-
1) were filtered through 0.22 μm PES membranes, aliquoted, and stored at -80 °C until use.  
Determination of peptide limit of quantification (LOQ) and limit of detection (LOD). The 
LOQ of each Phi6 peptide measured by LC-MS/MS was determined from its calibration curve. In 
brief, 14N-Phi6 samples were serially diluted and mixed with equal amounts of 15N-labeled Phi6 to 
yield PFU ratios of 3:1, 1:1, 0.3:1 and 0.1:1. The mixtures were digested with trypsin and 
chymotrypsin (see digestion procedure above), and were analyzed with LC-MS/MS. The ratios of 
peak areas of the 14N-peptides and 15N-labelled peptides (Y) were plotted as a function of PFU 
ratios (X). The linear regression model and the LOQ, LOD of peptide j were expressed as:1 Y = 	üäX + °ä LOQä = 10Sê¶/bä LODä = 3Sê¶/bä 
Where 	°ä  and bä  are the intercept and slope of the linear curve, and  Sê¶  is the standard 
deviation of the intercept °ä. 
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Lipid extraction. For lipid analysis, virus samples (2.4 mL, ~1011 PFU) were freeze-dried 
(FreeZone 6, Labconco) to a final volume of 200 µL. Viral lipids were then extracted with methyl-
tert-butyl ether (MTBE) as described previoulsy.2 In brief, the 200 µL samples were mixed with 
1.5 mL methanol and 5 mL MTBE, and were shaken at room temperature for 1 h. After the addition 
of 1.25 mL Milli-Q water, the mixture was centrifuged at 1000 ´ g for 10 min. The upper organic 
phase, where the lipids partitioned, was collected and dried under nitrogen gas. The dried lipids 
were then resuspended in 400 µL of acetonitrile/isopropanol/water (6.5:3:0.5, v/v/v) prior to lipid 
analysis.  
 
 
 
 
 
 
 
 
 
 
 107 
 
Figure B-1 SDS-PAGE of purified Phi6 stock. Electrophoresis was conducted in 8-16% TGXTM 
precast gels (Bio-Rad).  
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Figure B-2 Lab-scale continuous quench-flow system for free chlorine treatment. The system was 
modified from a previous study on ozone reactions.3 
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Figure B-3 Effect of Tris-HCl quenching on Phi6 inactivation. Phi6 inactivation was compared 
when samples sit on ice in 5 mM phosphate buffer (PBS; 10 mM NaCl, pH 7.4) added with Tris-
HCl (no chlorine control) and when samples sit on ice in free chlorine solution quenched with 
Tris-HCl. The Phi6 inactivation was effectively quenched with Tris-HCl for up to 30 min (i.e., the 
time that samples sit on ice following the addition of Tris-HCl in the experiments). 
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Figure B-4 Calibration curves of eight the most abundant Phi6 lipid compounds. The relative peak 
areas of lipids (PA/PA0) were determined by lipid LC-MS/MS method, and the relative lipid 
concentrations (L/L0) were prepared from Phi6 lipid extracts that were not exposed to free chlorine 
or UV254. 
PE(16:0/16:1): Y=0.623X+0.382 (R2=0.990),  
PE(18:1/14:1): Y=0.986X+0.012 (R2=0.998),  
PE(18:0/16:1): Y=0.859X+0.144 (R2=0.994),  
PE(18:1/16:1): Y=0.662X+0.341 (R2=0.995),  
PG(16:1/16:0): Y=0.989X+0.009 (R2=0.994),  
PG(16:1/16:1): Y=1.048X-0.054 (R2=0.988),  
PG(16:1/18:0): Y=1.029X-0.033 (R2=0.994),  
PG(16:1/18:1): Y=0.993X+0.005 (R2=0.994). 
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Figure B-5 The impact of storage at 4 °C for 48 hours on Phi6 resistance to free chlorine. Here, 
the “unstored Phi6” refers to an experiment where the stock was thawed from -80 °C and treated 
with free chlorine on the same day of the experiments. The “stored Phi6” refers to an experiment 
in which the stock was thawed from -80 °C and stored at 4 °C for 48 hours before the chlorine 
treatment was conducted. 
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Figure B-6 Schematic of Phi6 structure.4 For the early infection steps, the Phi6 viral particle binds 
to the pilus of Psudomonas syringae with spike protein P3. Then P6 initiates the virus membrane 
fusion with the host membrane. P5 is responsible for the penetration of the nucleocpasid and 
polymerase complex through the peptidoglycan layer. Finally, nucleocapsid protein P8 helps the 
polymerase complex continuously penetrate the cytoplasmic membrane, delivering the viral 
genome into the cytoplasm for replication.4 
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Figure B-7 Phi6 protein coverage captured with the LC-MS/MS method. Error bars represent the 
standard deviations of protein coverage in free chlorine and UV254 experiments, n=18. NA 
indicates information not available.  
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Figure B-8 Cryo-EM structure of Phi6 protein P1 (PDB ID: 5muu) and close-up of residues Met 
65, Met 198, Met 209 within P1. Sulfur atoms in Met 65, Met 198, and Met 209 are colored in red. 
Solvent-accessible surface areas of Met 65, Met 198, and Met 209 are identified with transparent 
red coloring. 
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Figure B-9 Relative abundances of Met oxidation products of the fastest reacting peptides 
following chlorine treatments. The peak areas of the oxidized peptide ions (PAM[O]) were 
normalized to the peak areas of the corresponding 15N-labeled peptide ions (PA15N). Unpaired 
student’s t tests were used to identify statistical difference in the relative abundances of oxidation 
products at two levels of Phi6 inactivation. ** indicates P < 0.01 and ns indicates not significant 
(P > 0.05). 
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Figure B-10 Relative abundances (L/L0) of eight major Phi6 lipid compounds with respect to Phi6 
inactivation (C/C0) by free chlorine (FC) and UV254 (UV).  
 
 
 
 
 
 
 
 
 
 
10-1010-810-610-410-2100
0.8
0.6
1.2
0.7
0.9
1.0
1.1
0.5
0.4
0.3
C / C0
L  
/ L
0
PE 16:0/16:1
PE 18:1/14:1
PE 18:0/16:1
PE 18:1/16:1
FC
10-1010-810-610-410-2100
0.8
0.6
1.2
0.7
0.9
1.0
1.1
0.5
0.4
0.3
C / C0
L  
/ L
0
PG 16:0/16:1
PG 16:1/16:1
PG 18:0/16:1
PG 18:1/16:1
UV
 117 
 
Table B-1 Phi6 primers and amplicon sizes. 
Primer 
set ID 
Genome 
segment 
Genome 
segment  
size (kbp) 
Direction Primer sequence (5’-3’) Nucleotide position 
RT-qPCR 
amplicon 
size (bp) 
Amplicon size 
relative to 
genome segment 
size (%) 
S Segment S 2.95 
F GCAGACCCAGCTGACTTCTT 1141-1160 499 16.9 R AAGGCGCTATCCTTGGACAC 1639-1620 
M Segment M 4.06 
F CCTGAGGAAACGGCTCAACT 1307-1326 472 11.6 R CATAGCCAACGAACTGCTGC 1778-1759 
L Segment L 6.37 
F GCCTACCAGCTCCACCAAAT 1510-1529 484 7.6 R CGTACCCCATGTTGAGCAGT 1993-1974 
 
 
 
 
 
Table B-2 Q Exactive settings for Phi6 protein and lipid analysis. 
 Protein (positive mode) Lipid (negative mode) 
Sheath gas flow rate 24 24 
Auxiliary gas flow rate 8 8 
Sweep gas flow rate 1 1 
Spray voltage 3 kV 2.8 kV 
Capillary temp. 300 °C 250 °C 
S-len RF level 50.0 50 
Aux gas heater temp. 275 °C 275 °C 
Column temperature 25 °C 55 °C 
 Full MS settings 
Resolution 70,000 70,000 
AGC target 5e5 1e6 
Max IT 200 ms 200 
Scan range 400-1800 m/z 400-1800 m/z 
dd-MS2 settings 
Resolution 35,000 35,000 
AGC target 2e5 2e5 
Max IT 100 ms 100 ms 
Loop count 20 5 
Isolation window 1.6 Da 3 Da 
NCE 30 30 
Intensity threshold  2e4 2e4 
Charge exclusion:  Unassigned, 1 Unassigned, 5-8, >8 
Dynamic exclusion 20 sec 30 sec 
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Table B-3 Reaction rate constants (kg) of three RT-qPCR regions on S, M, and L segments 
measured by RT-qPCR and extrapolated rate constants of the entire Phi6 genome following free 
chlorine and UV254 treatments. Errors represent standard errors of the reaction rate constants. 
ANCOVA analyses were applied to test whether the reaction rate constants were significantly 
different from zero. The results of ANCOVA analyses were shown in the table. 
 Size of RT-qPCR 
amplicon or Phi6 gnome in 
base pairs 
Free chlorine 
(L mg-1 s-1) 
UV254 
(cm2 mJ-1) 
S segment 499 0.0070 ± 0.0027* 0.0027 ± 0.0007** 
M segment 472 0.0127 ± 0.0032*** 0.0014 ± 0.0003*** 
L segment 484 0.0109 ± 0.0032** 0.0027 ± 0.0007** 
Genome (extrapolated) 13380 0.26 ± 0.06 0.063± 0.012 
 All rate constants were significantly different from zero, where * indicates P < 0.05; ** indicates P < 0.01; *** indicates P < 0.001. 
 
 
 
  
Table B-4 UV-reactive and chlorine-reactive bases in Phi6 and MS2 genomes, and the fraction 
these bases make up in the entire genome sequence. 
Bases that are reactive with UV254 5 
 Genome size 
Bases in 
genome U C UU 
Total reactive bases (U+C+UU) 
per genome base a 
Phi6, dsRNA 13.4 kbp 26.8 kb 5914 7471 1120 0.54 
MS2, ssRNA 3.6 kb 3.6 kb 901 909 185 0.55 
 
Bases that are reactive with free chlorine6,7 
 Genome size 
Bases in 
genome U C A 
Total reactive bases (U+C+A) 
per gnome base b 
Phi6, dsRNA 13.4 kbp 26.8 kb 5922 7471 5922 0.72 
MS2, ssRNA 3.6 kb 3.6 kb 901 909 827 0.73 
 a The proportion of UV-reactive bases in Phi6 and MS2 genomes is similar. 
 b The proportion of chlorine-reactive bases in Phi6 and MS2 genomes is similar. 
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Table B-5 Number of reactive amino acid residues in Phi6 proteins, and literature values for 
second-order rate constants of individual amino acids reaction with HOCl at pH 7.4, 22 °C.8 
Protein 
location Protein 
UniProt 
Accession 
Amino acids (AA)  
(Second-order reaction rate constant, M-1 s-1) Total 
AAs Meta 
(3.8´107) 
Cys 
(3.0´107) 
His 
(1.0´105) 
Trp 
(1.1´104) 
Lys 
(5.0´103) 
Tyr 
(4.4´101) 
Membrane 
P3 P11129 17 9 7 17 24 22 648 
P6 P11128 0 0 0 7 10 2 168 
P9 P07581 0 0 1 1 5 1 90 
P10 P11127 0 0 0 0 4 1 42 
P13 P11130 0 0 0 0 3 2 72 
Nucleo-
capsid 
P8 P07579 4 0 1 0 6 6 149 
P5 P07582 0 0 3 2 10 10 220 
Polymerase 
complex 
P1 P11126 19 3 18 11 25 23 769 
P2 P11124 24 7 14 12 37 28 665 
P4 P11125 10 3 5 2 13 7 332 
P7 P11123 4 0 5 3 5 3 161 
 a The first Met residue in the protein sequence was not counted. 
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Table B-6 Detailed information of Phi6 peptides, reaction rate constants following inactivation by UV254 and free chlorine. 
 
Table S6. Detailed information of Phi6 peptides, and reaction rate constants of Phi6 peptides following inactivation by free chlorine and UV254.
P j : the relative abundance of peptide j
P0,j : the mean initial relative abundance of peptide j
K p,j : first-order rate constant of peptide j
na: not available
Data in red: value below the limit of quantification, and was replaced by an expected number.
The 8 most reactive Met-containing peptides with free chlorine
The most reactive Cys-containing peptides with free chlorine
The 8 most reactive peptides with UV254
Uncovered Peptide
0
mg s/L
0.6
mg s/L
1.2
mg s/L
0
mg s/L
0.6
mg s/L
1.2
mg s/L
0
mg s/L
0.6
mg s/L
1.2
mg s/L
0
mJ/cm2
42
mJ/cm2
130
mJ/cm2
0
mJ/cm2
42
mJ/cm2
130
mJ/cm2
0
mJ/cm2
42
mJ/cm2
130
mJ/cm2
pep_seq Pro_
ID
pep_formula z m/z_14N m/z_15N Retention 
time
pep_s
tart
pep_e
nd
-0.024
log10
0.99
log10
2.4
log10
0.052
log10
0.84
log10
1.9
log10
-0.024
log10
1.7
log10
2.8
log10
0.11
log10
1.8
log10
4.2
log10
-0.053
log10
1.6
log10
4.2
log10
-0.039
log10
1.7
log10
4.2
log10
YQGINEWLGGAK P3 C61H90N16O18 2 668.338 676.313 18-19.5 3 14 1.066 0.521 0.348 0.999 0.617 0.361 0.935 0.485 0.308 0.90 0.07 0.96 1.112 1.047 0.908 0.894 0.656 0.597 0.994 0.906 0.506 0.0033 0.0013 0.47
LTTANGEIGAIYLSAAPPTDAAR P3 C99H161N27O34 2 1137.092 1150.550 20.5-22 16 38 1.101 0.565 0.344 0.982 0.587 0.338 0.917 0.440 0.292 0.94 0.08 0.95 1.067 1.054 0.903 0.886 0.666 0.582 1.047 0.958 0.464 0.0037 0.0014 0.48
LSAAPPTDAARADAKAVDF P3 C82H131N23O28 3 629.658 637.301 17-20 28 46 1.252 0.575 0.374 0.944 0.725 0.467 0.804 0.541 0.372 0.75 0.11 0.87 1.208 1.095 0.990 0.865 0.721 0.593 0.928 0.844 0.489 0.0032 0.0015 0.38
TAGWPSAIVDCADATRAKQNY P3 47 67
QNYLWVGDNVVHIGAK P3 65 80
LDLWGGTGDAW P3 C55H75N13O17 2 595.777 602.258 22-24 85 95 1.379 0.466 0.286 0.787 0.488 0.315 0.834 0.405 0.283 0.99 0.13 0.89 1.108 1.013 0.846 0.989 0.509 0.493 0.903 0.803 0.500 0.0039 0.0016 0.44
ACPMLDLCRAW P3 102 112
ASASVTTGSLQGY P3 C52H84N14O21 2 621.304 628.283 14-15.5 117 129 1.124 0.529 0.368 1.004 0.658 0.338 0.872 0.482 0.326 0.89 0.08 0.95 1.150 1.098 0.949 0.857 0.697 0.619 0.993 0.842 0.499 0.0031 0.0014 0.41
LDVEQQQF P3 135 142
AKDNLNLY P3 C42H67N11O14 2 475.751 481.234 13.5-14 143 150 1.098 0.541 0.353 0.982 0.607 0.323 0.919 0.482 0.309 0.93 0.06 0.97 1.107 1.057 0.896 0.893 0.696 0.607 1.001 0.916 0.461 0.0036 0.0014 0.50
DNLNLYGDNCLDLATSSSAQR P3 C94H151N29O38S1 3 776.357 785.663 19.2-20 145 165 1.130 0.567 0.256 1.065 0.379 0.119 0.805 0.209 0.161 1.47 0.25 0.84 1.151 1.066 0.960 0.893 0.702 0.630 0.956 0.814 0.566 0.0027 0.0013 0.39
AFLEQCMGCALPEDCIFGWYVK P3 166 187
MDWEGSAVADAYAAIR P3 C75H112N20O25S1 2 863.399 873.368 21-28 188 203 1.289 0.124 na 0.785 0.070 na 0.926 0.070 na 4.07 0.40 0.96 1.181 1.195 0.955 0.800 0.686 0.606 1.019 0.940 0.633 0.0026 0.0014 0.32
AAIRVQGF P3 C39H64N12O10 2 431.251 437.232 15-16.5 200 207 1.067 0.560 0.414 1.009 0.642 0.378 0.924 0.514 0.353 0.80 0.06 0.96 1.116 1.089 1.009 0.885 0.701 0.618 0.999 0.920 0.478 0.0032 0.0015 0.38
VQGFATVMAPWQSVGGAGYVYAR P3 C111H163N29O30S1 3 805.735 815.375 22.8-33.5 204 226 1.226 0.398 0.255 0.682 0.449 0.305 1.092 0.503 0.128 1.25 0.21 0.84 0.658 0.631 0.606 0.750 0.670 0.621 1.592 0.892 0.326 0.0048 0.0021 0.42
ARVPQKGAW P3 225 233
MGVNLLAY P3 C40H65N9O11S1 1 880.460 889.432 20.7-21.3 234 241 1.113 0.392 0.119 0.887 0.256 0.062 2.04 0.24 0.95 1.110 0.989 1.043 0.882 0.664 0.557 1.008 0.891 0.473 0.0033 0.0016 0.37
VHGTSGQPAYGIPM P3 C62H95N17O19S1 2 707.843 716.317 15.1-16.5 242 255 1.192 0.370 0.072 0.970 0.426 0.104 0.838 0.270 0.052 2.17 0.19 0.95 1.124 1.028 0.872 0.884 0.692 0.583 0.992 0.899 0.472 0.0037 0.0013 0.53
TLSGFTGNMGQVASKWLM P3 256 273
LMIVDPHVVQIL P3 C64H109N15O16S1 2 688.902 696.379 24-25.5 276 287 1.083 0.510 0.309 0.992 0.611 0.340 0.924 0.469 0.281 0.98 0.07 0.97 1.098 1.070 0.930 0.901 0.702 0.627 1.002 0.895 0.491 0.0032 0.0013 0.46
IVDPHVVQIL P3 C53H89N13O14 2 566.840 573.320 20.1-21 280 289 1.080 0.533 0.333 1.003 0.621 0.343 0.917 0.496 0.300 0.94 0.06 0.97 1.131 1.085 0.951 0.886 0.701 0.600 0.983 0.916 0.496 0.0033 0.0014 0.44
RGTKSDPR P3 295 302
TTDVYADPK P3 C44H68N10O17 2 505.245 510.230 8.2-9 303 311 1.085 0.532 0.351 0.995 0.615 0.360 0.920 0.475 0.304 0.90 0.07 0.96 1.130 1.055 0.923 0.875 0.629 0.579 0.995 0.914 0.508 0.0033 0.0014 0.43
ADPKVPASRISGPM P3 C61H104N18O19S1 3 475.922 481.904 12-14.5 308 321 1.062 0.314 0.071 0.985 0.382 0.078 0.953 0.219 0.034 2.38 0.21 0.95 1.127 1.046 0.914 0.887 0.696 0.606 0.986 0.939 0.490 0.0034 0.0013 0.48
INGTVAPPATIPATIPVPL P3 322 340
APLGGAGGPGAQGF P3 341 354
QVYPVFTW P3 C53H70N10O12 2 520.266 525.251 21.5-23 355 362 1.284 0.470 0.326 0.900 0.592 0.355 0.816 0.442 0.310 0.91 0.12 0.90 1.077 1.004 0.905 0.835 0.750 0.639 1.088 0.945 0.459 0.0035 0.0014 0.48
MTDVTIEGTVTADSNGL P3 366 384
HVVDDVRNY P3 C48H73N15O16 2 558.775 566.253 12.3-13.5 385 393 1.216 0.100 na 1.165 0.475 na 0.619 0.100 na 2.90 0.94 0.70 1.248 1.363 1.595 0.787 0.841 0.515 0.965 0.927 0.492 0.0024 0.0026 0.12
NYVWNGTALAAIEQVNAADGR P3 C97H149N29O32 3 745.038 754.675 22-24 392 412 1.153 0.545 0.335 1.035 0.629 0.375 0.812 0.414 0.280 0.92 0.12 0.90 1.157 1.143 0.993 0.785 0.585 0.503 1.058 0.928 0.513 0.0034 0.0019 0.33
VTLTDSER P3 C37H65N11O16 2 460.738 466.221 8.5-9.7 413 420 1.081 0.534 0.366 0.993 0.613 0.364 0.926 0.477 0.310 0.88 0.07 0.96 1.111 1.054 0.919 0.884 0.642 0.592 1.005 0.931 0.523 0.0032 0.0014 0.44
AQLASLTVR P3 C41H75N13O13 2 479.788 486.268 14-15.5 421 429 1.093 0.531 0.364 0.994 0.609 0.361 0.913 0.469 0.315 0.88 0.07 0.95 1.118 1.052 0.927 0.873 0.642 0.587 1.009 0.912 0.518 0.0032 0.0014 0.43
QQLSVGADPLSK P3 C53H91N15O19 2 621.838 629.315 14-15.5 435 446 1.083 0.529 0.353 0.994 0.605 0.375 0.923 0.472 0.309 0.89 0.07 0.95 1.123 1.068 0.920 0.887 0.642 0.588 0.990 0.912 0.511 0.0033 0.0014 0.44
SVGADPLSKTSIW P3 C61H97N15O20 2 680.859 688.336 19.5-20.5 438 450 1.432 0.457 0.326 0.809 0.552 0.312 0.759 0.421 0.294 0.94 0.15 0.85 1.170 1.087 0.985 0.901 0.664 0.610 0.929 0.932 0.502 0.0031 0.0015 0.37
ADYDLLSQQIIEADTVK P3 C84H136N20O31 2 961.491 971.461 21-23 456 472 1.095 0.543 0.354 1.017 0.627 0.372 0.889 0.487 0.310 0.88 0.07 0.95 1.093 1.043 0.922 0.894 0.635 0.579 1.014 0.912 0.508 0.0033 0.0014 0.45
SQQIIEADTVKNLPAVTF P3 C88H144N22O29 2 987.531 998.497 22.4-23.5 462 479 1.077 0.503 0.340 0.962 0.634 0.343 0.961 0.509 0.328 0.91 0.06 0.97 1.116 1.063 0.930 0.852 0.680 0.607 1.032 0.921 0.473 0.0034 0.0015 0.44
NLPAVTFAQANK P3 C57H92N16O17 2 637.349 645.324 16-17.5 473 484 1.044 0.524 0.344 1.035 0.639 0.375 0.920 0.481 0.305 0.90 0.07 0.95 1.126 1.045 0.924 0.871 0.636 0.574 1.004 0.915 0.509 0.0033 0.0014 0.44
AQANKAAGGQSETLW P3 C65H102N20O23 2 766.379 776.348 13.5-15 480 494 1.064 0.529 0.365 1.009 0.663 0.389 0.927 0.532 0.362 0.82 0.06 0.96 1.099 1.041 0.955 0.903 0.706 0.612 0.997 0.915 0.491 0.0032 0.0014 0.45
AAGGQSETLWHQMYR P3 C75H111N23O23S1 3 578.939 586.582 15-17 485 499 1.008 0.491 0.271 0.986 0.568 0.309 1.006 0.431 0.210 1.12 0.09 0.96 1.142 1.080 0.921 0.865 0.647 0.565 0.994 0.911 0.486 0.0035 0.0015 0.44
VNDIAGDQVTAIQITGTMATGIR P3 C98H169N29O35S1 3 782.409 792.046 23.7-24.5 500 522 1.110 0.443 0.168 0.780 0.324 0.360 1.11 0.29 0.79 1.083 1.049 0.952 0.921 0.758 0.682 0.996 0.740 0.577 0.0024 0.0011 0.40
WSATAGGLVVDADEQDAVIAISSGKPVK P3 C122H198N32O42 3 928.819 939.453 25-28 523 550 1.194 0.702 0.501 1.260 0.850 0.456 0.545 0.441 0.339 0.66 0.22 0.55 1.315 1.326 1.443 0.722 0.799 0.857 0.963 0.670 0.415 0.0015 0.0026 0.04
NSSDLPTADAVNYLFGITADDMPGIVSSQK P3 C135H212N34O49S1 3 1042.836 1054.135 28-29 551 580 1.170 0.359 0.057 0.882 0.281 0.126 0.948 0.285 0.057 2.16 0.19 0.95 0.888 0.751 0.606 0.972 0.740 0.636 1.140 1.013 0.511 0.0042 0.0008 0.79
GITADDMPGIVSSQKEM P3 C73H123N19O28S2 2 889.919 899.390 18-20 566 582 1.051 0.345 0.092 0.988 0.432 0.113 0.961 0.265 0.074 1.99 0.13 0.97 1.077 1.009 0.879 0.910 0.699 0.617 1.013 0.910 0.503 0.0034 0.0012 0.54
EMNSEFEEGFLQK P3 C69H102N16O25S1 2 794.353 802.329 18-19.5 581 593 1.099 0.471 0.177 0.974 0.554 0.211 0.927 0.378 0.140 1.46 0.11 0.96 1.112 1.052 0.906 0.883 0.653 0.590 1.005 0.903 0.489 0.0035 0.0014 0.47
LWNPR P3 596 600
LVENVQNAYFLMVYAR P3 C89H136N22O24S1 3 644.001 651.312 23-24.5 602 617 1.648 0.414 0.311 0.701 0.488 0.287 0.651 0.184 0.032 1.55 0.54 0.54 1.378 1.115 1.141 0.765 0.604 0.547 0.857 0.878 0.524 0.0026 0.0021 0.18
QFHSLVASSLAMAK P3 C66H108N18O19S1 3 497.266 503.248 17.75-21.8 621 634 1.211 0.575 0.364 1.191 0.691 0.370 0.598 0.347 0.227 0.93 0.22 0.72 1.161 1.068 0.886 0.840 0.783 0.595 0.999 0.820 0.403 0.0041 0.0015 0.50
LGVSTR P3 635 640
ACKESYGC P3 641 648
SIFSSLFK P6 1 9
KVIKKVISKVVATLKKIF P6 9 26
KKIWPLLLIVAIIYF P6 27 41
APYLAGF P6 42 48
FTGIGGIF P6 54 61
SSIATTITPTLTSF P6 C64H106N14O23 2 720.385 727.363 23.3-24.3 62 75 1.326 0.604 0.455 0.856 0.560 0.356 0.819 0.457 0.330 0.79 0.13 0.83 1.206 1.138 0.961 0.905 0.777 0.649 0.889 0.864 0.583 0.0026 0.0012 0.38
SGVGSLASTAW P6 C45H70N12O16 2 518.259 524.240 19.1-19.8 81 91 1.088 0.619 0.464 0.989 0.704 0.411 0.924 0.526 0.401 0.71 0.07 0.94 1.097 1.051 0.929 0.964 0.784 0.669 0.939 0.840 0.600 0.0025 0.0010 0.50
SGFQSL P6 92 97
GMGTQLAVVSGAAAL P6 C57H100N16O19S1 2 673.361 681.337 21.7-22 98 112 1.553 0.747 0.255 0.830 0.457 0.176 0.617 0.295 0.103 1.43 0.30 0.77 1.262 1.068 1.028 0.859 0.734 0.589 0.879 0.887 0.601 0.0025 0.0014 0.31
IAPEETAQL P6 113 121
VTEIGTTVGDIAGTIIGGVAKAL P6 122 144
ALPGWIWIAAGGLAVWALWPSSDSK P6 C129H186N30O31 3 884.804 894.774 33.1-33.8 143 167 1.323 0.708 0.442 0.938 0.605 0.390 0.739 0.443 0.285 0.81 0.16 0.79 1.317 1.262 1.209 0.870 0.691 0.557 0.813 0.764 0.499 0.0027 0.0021 0.18
MPFPLVK P9 C41H66N8O8S1 2 416.243 420.231 18.0-18.6 1 7 1.296 0.642 0.421 0.966 0.225 0.126 0.738 0.247 0.151 1.32 0.35 0.67 1.426 1.342 1.162 0.784 0.636 0.565 0.790 0.733 0.543 0.0023 0.0023 0.13
PFPLVKQDPTSKAF P9 C75H115N17O20 2 787.932 796.406 17.8-19.4 2 15 1.165 0.626 0.451 0.939 0.719 0.484 0.896 0.634 0.460 0.63 0.06 0.94 1.064 1.037 0.959 0.974 0.812 0.771 0.962 0.910 0.678 0.0018 0.0007 0.45
AFTEASER P9 C38H59N11O15 2 455.717 461.200 7.2-8.2 14 21 1.017 0.682 0.483 1.017 0.767 0.514 0.966 0.654 0.446 0.61 0.04 0.97 1.081 1.064 0.966 0.957 0.801 0.760 0.962 0.911 0.697 0.0017 0.0008 0.41
STGTQILDVVK P9 C50H89N13O18 2 580.830 587.310 18.1-18.6 22 32 1.025 0.688 0.485 1.019 0.762 0.517 0.957 0.650 0.442 0.61 0.04 0.97 1.089 1.073 0.968 0.949 0.794 0.753 0.961 0.919 0.703 0.0017 0.0008 0.40
APIGLFGDDAK P9 C50H78N12O16 2 552.290 558.272 16.5-17.5 33 43 1.025 0.685 0.484 1.014 0.760 0.510 0.961 0.655 0.447 0.61 0.04 0.97 1.081 1.061 0.965 0.948 0.790 0.749 0.971 0.918 0.699 0.0017 0.0008 0.41
GDDAKHEF P9 C39H55N11O15 2 459.701 465.184 5.9-7.0 39 46 1.040 0.703 0.521 1.006 0.762 0.526 0.954 0.672 0.507 0.55 0.03 0.98 1.086 1.064 0.969 0.958 0.834 0.786 0.956 0.908 0.676 0.0017 0.0008 0.41
VTRQEQAVSVVSW P9 C65H105N19O21 2 744.894 754.366 17.2-18.5 47 59 1.079 0.706 0.528 0.981 0.740 0.534 0.940 0.670 0.520 0.53 0.03 0.97 1.090 1.097 1.026 0.963 0.859 0.817 0.947 0.903 0.708 0.0014 0.0008 0.29
AVAAGLIGELIGY P9 C58H95N13O17 2 623.856 630.336 26.1-26.9 60 72 1.052 0.693 0.520 1.006 0.751 0.536 0.942 0.662 0.506 0.54 0.03 0.97 1.096 1.083 0.995 0.956 0.845 0.782 0.948 0.902 0.693 0.0016 0.0008 0.36
KAILANIPFLA P9 C57H95N13O13 2 585.866 592.346 24.4-25.0 80 90 1.021 0.691 0.500 1.011 0.762 0.511 0.968 0.654 0.452 0.60 0.04 0.97 1.098 1.068 0.964 0.935 0.787 0.739 0.967 0.916 0.692 0.0018 0.0008 0.40
MDNILDPLK P10 C46H79N11O15S1 2 529.781 535.264 19.6-20.6 1 9 0.901 0.212 0.127 1.114 0.189 0.061 0.986 0.091 0.058 2.14 0.32 0.87 0.957 0.921 0.790 1.012 0.792 0.732 1.032 0.950 0.698 0.0023 0.0004 0.82
APFSSEAAAK P10 C43H67N11O15 2 489.748 495.231 8.5-9.4 10 19 1.072 0.718 0.512 0.993 0.761 0.485 0.935 0.621 0.421 0.63 0.06 0.94 1.121 1.125 1.047 0.925 0.781 0.754 0.954 0.917 0.696 0.0015 0.0010 0.25
IAVVYALVGLVGGLLLTK P10 C87H151N19O21 2 900.074 909.545 34.8-35.8 25 42 1.201 0.900 0.690 0.938 0.660 0.496 0.861 0.551 0.492 0.49 0.13 0.66 1.085 1.078 1.007 0.980 0.837 0.829 0.935 0.857 0.762 0.0011 0.0007 0.25
ISTLESQLQPLVK P13 C65H114N16O21 2 728.425 736.400 20.6-21.0 6 18 1.269 0.794 0.687 0.890 0.606 0.483 0.841 0.604 0.434 0.52 0.14 0.68 1.349 1.272 1.199 0.814 0.653 0.629 0.837 0.789 0.604 0.0018 0.0020 0.10
VKLVATETPGAL P13 C54H95N13O17 2 599.856 606.336 17.4-18.0 17 28 1.330 0.809 0.712 0.870 0.602 0.500 0.800 0.588 0.451 0.49 0.15 0.60 1.366 1.266 1.087 0.731 0.605 0.489 0.903 0.882 0.682 0.0024 0.0021 0.15
VAYARGL P13 29 35
GLSSADRSRLYRLLR P13 34 48
SLEQAIPK P13 C39H68N10O13 2 443.256 448.240 13.5-13.9 49 56 1.234 0.778 0.700 0.906 0.607 0.477 0.859 0.574 0.440 0.52 0.13 0.68 1.348 1.303 1.212 0.810 0.660 0.645 0.842 0.797 0.633 0.0016 0.0020 0.08
LSSAVVSATTLAAR P13 C57H103N17O20 2 673.886 682.359 17.1-17.6 57 70 1.277 0.852 0.750 0.926 0.662 0.499 0.797 0.564 0.450 0.48 0.15 0.58 1.387 1.325 1.216 0.776 0.672 0.647 0.838 0.768 0.600 0.0017 0.0021 0.08NaN NaN
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MLLPVVAR P8 C41H75N11O9S1 2 449.781 455.264 17.3-21.8 1 8 1.004 0.254 0.105 1.041 0.290 0.099 0.954 0.214 0.095 1.92 0.10 0.98 1.090 1.056 0.907 0.948 0.771 0.700 0.962 0.893 0.614 0.0024 0.0009 0.52
AAVPAIESAIAATPGLVSR P8 9 27
VSRIAAAIGSKVSPSAIL P8 25 42
AAVKSNPVVAGL P8 C50H88N14O15 2 563.335 570.313 15.2-16.2 43 54 1.034 0.441 0.203 1.028 0.580 0.228 0.938 0.444 0.209 1.29 0.07 0.98 1.113 1.101 0.967 0.936 0.803 0.744 0.951 0.907 0.638 0.0020 0.0009 0.40
SNPVVAGLTLAQIGSTGYDAYQQLLENHPEVAEMLK P8 C170H270N44O56S1 4 964.991 975.957 31.3-32.2 47 82 1.070 0.188 na 1.013 0.218 na 0.918 0.077 na 3.20 0.55 0.89 1.105 1.037 0.911 0.933 0.776 0.685 0.963 0.871 0.595 0.0026 0.0009 0.52
SFKADEIQPDFIGNLGQY P8 C93H136N22O30 3 681.334 688.644 22.7-24 85 102 0.965 0.400 0.168 0.996 0.556 0.198 1.038 0.435 0.185 1.41 0.07 0.98 1.076 1.058 0.916 0.978 0.853 0.750 0.946 0.881 0.595 0.0024 0.0009 0.52
ADEIQPDFIGNLGQYR P8 C81H122N22O27 2 918.450 929.416 21.3-21.9 88 103 1.009 0.414 0.177 1.038 0.558 0.208 0.953 0.429 0.184 1.39 0.07 0.98 1.106 1.100 0.960 0.940 0.775 0.729 0.954 0.905 0.651 0.0020 0.0009 0.40
ADEIQPDFIGNLGQYREELELVEDAAR P8 C134H208N36O48 3 1030.839 1042.801 26.4-30.0 88 114 0.951 0.517 0.248 1.191 0.752 0.254 0.857 0.470 0.203 1.20 0.13 0.92 1.185 1.187 1.040 0.917 0.711 0.760 0.897 0.887 0.642 0.0017 0.0013 0.19
FVGGMSNLIR P8 C48H80N14O13S1 2 547.295 554.273 17.6-19.0 115 124 1.032 0.447 0.183 1.029 0.565 0.194 0.939 0.394 0.147 1.46 0.10 0.97 1.108 1.107 0.970 0.932 0.767 0.718 0.961 0.908 0.649 0.0020 0.0010 0.38
QALELDIK P8 C41H72N10O14 2 465.269 470.253 16.0-17.2 127 134 1.071 0.545 0.292 1.015 0.655 0.295 0.914 0.488 0.254 1.06 0.07 0.97 1.120 1.125 1.010 0.924 0.773 0.736 0.956 0.917 0.672 0.0018 0.0010 0.31
GLKMQLNDMGY P8 C54H88N14O17S2 2 635.302 642.281 18.2-19.6 137 147 0.936 0.287 0.054 1.080 0.372 0.058 0.984 0.257 0.084 2.29 0.13 0.98 1.075 1.053 0.869 0.954 0.782 0.694 0.970 0.898 0.608 0.0026 0.0008 0.60
MQLNDMGYR P8 C46H74N14O15S2 2 564.252 571.231 13.5-14.8 140 148 1.034 0.329 0.067 1.036 0.398 0.071 0.930 0.214 0.040 2.38 0.19 0.96 1.106 1.078 0.905 0.937 0.760 0.690 0.957 0.893 0.622 0.0024 0.0009 0.50
DSAFAVQYSLR P5 C56H85N15O18 2 628.817 636.295 17.2-18.5 4 14 0.878 0.410 0.261 1.243 0.773 0.517 0.87 0.30 0.68 0.928 0.933 0.805 1.143 1.045 0.717 0.0025 0.0008 0.73
ALGQK P5 15 19
VRADGVVGSETR P5 C50H88N18O19 3 415.890 421.871 8-8.5 20 31 0.913 0.329 0.254 0.962 0.395 0.243 1.125 0.371 0.306 1.10 0.14 0.89 0.873 0.847 0.764 1.050 0.588 0.599 1.076 0.911 0.711 0.0027 0.0011 0.47
ADGVVGSETR P5 C39H67N13O17 2 495.746 502.226 6.7-8.3 22 31 1.058 0.531 0.373 1.030 0.626 0.430 0.912 0.485 0.337 0.81 0.08 0.93 1.113 1.054 0.945 0.877 0.697 0.648 1.010 0.956 0.654 0.0023 0.0011 0.39
AALDALPENQKK P5 C56H96N16O19 3 433.242 438.559 10-12.1 32 43 0.970 0.508 0.370 1.058 0.647 0.439 0.973 0.533 0.361 0.79 0.07 0.94 1.093 1.038 0.925 0.915 0.742 0.682 0.993 0.944 0.633 0.0024 0.0009 0.48
AIVELQALLPK P5 C56H99N13O15 2 597.876 604.358 23.2-25 44 54 1.010 0.518 0.371 1.032 0.634 0.428 0.958 0.513 0.337 0.81 0.07 0.95 1.104 1.044 0.948 0.904 0.743 0.679 0.991 0.953 0.655 0.0022 0.0010 0.43
AQSVGNNR P5 55 62
FTTAEVDSAVAR P5 C54H87N15O20 2 633.820 641.297 13-16 65 76 1.000 0.519 0.372 1.033 0.631 0.432 0.967 0.505 0.341 0.81 0.08 0.94 1.090 1.052 0.951 0.927 0.737 0.680 0.983 0.949 0.658 0.0022 0.0010 0.43
QFLIPIENF P5 C55H81N11O14 2 560.806 566.289 24-26 89 97 1.065 0.520 0.381 0.975 0.615 0.398 0.961 0.512 0.332 0.83 0.07 0.96 1.083 1.023 0.967 0.920 0.741 0.666 0.997 0.950 0.600 0.0025 0.0010 0.44
VVAGGFETTVSGSF P5 98 111
GLGQFNR P5 C34H54N12O10 1 791.416 803.379 10.6-12 113 119 1.036 0.446 0.308 1.011 0.606 0.398 0.953 0.487 0.320 0.90 0.09 0.93 1.097 1.009 0.911 0.917 0.709 0.662 0.987 0.922 0.651 0.0024 0.0009 0.47
QTWDRLRRLGR P5 120 130
NLPAFEEGSAQLNASLYAIGFLYLENK P5 C137H206N32O42 3 991.506 1002.140 29.9-31 131 157 1.089 0.618 0.396 0.955 0.691 0.413 0.956 0.453 0.346 0.80 0.09 0.91 1.043 1.046 0.954 0.980 0.773 0.692 0.978 0.824 0.726 0.0018 0.0008 0.42
LENKRAY P5 C39H64N12O12 2 447.246 453.227 4-6.5 154 160 1.034 0.477 0.341 0.895 0.568 0.352 1.072 0.734 0.619 0.72 0.15 0.76 1.048 1.016 0.938 0.948 0.760 0.699 1.005 1.040 0.685 0.0021 0.0008 0.47
AYEASFK P5 C38H54N8O12 2 408.200 412.188 9.3-10.5 159 165 1.014 0.485 0.340 1.031 0.612 0.414 0.954 0.475 0.322 0.86 0.09 0.93 1.100 1.051 0.932 0.909 0.732 0.670 0.991 0.954 0.647 0.0023 0.0010 0.45
THEIAYL P5 C39H59N9O12 2 423.721 428.208 14.5-15.5 170 176 1.003 0.471 0.337 1.109 0.605 0.378 0.888 0.504 0.324 0.88 0.08 0.95 1.090 1.121 1.006 0.966 0.770 0.726 0.944 0.863 0.594 0.0022 0.0011 0.34
HNQGAPAAEQY P5 C50H72N16O18 2 593.268 601.244 8.3-9.5 178 188 1.027 0.527 0.375 1.028 0.631 0.434 0.945 0.522 0.368 0.78 0.07 0.95 1.107 1.065 0.927 0.922 0.768 0.679 0.971 0.929 0.610 0.0025 0.0010 0.49
LTSGRLVYPK P5 189 198
QSEAAVAAVAAAR P5 C50H87N17O18 2 607.828 616.302 12.5-15.5 199 211 1.031 0.537 0.380 1.051 0.654 0.440 0.918 0.511 0.356 0.78 0.08 0.94 1.097 1.048 0.939 0.919 0.755 0.695 0.984 0.922 0.661 0.0022 0.0009 0.45NaN NaN
NLKVKDL P1 C37H68N10O11 2 415.261 420.245 11-17.6 3 9 1.033 0.646 0.477 0.933 0.709 0.447 1.034 0.631 0.411 0.68 0.04 0.97 1.071 1.028 0.861 1.035 0.853 0.707 0.893 0.913 0.681 0.0023 0.0006 0.66
DLNGSAR P1 8 14
GLTQAFAIGELK P1 C57H94N14O17 2 624.353 631.332 20-22 15 26 1.077 0.654 0.437 1.001 0.725 0.439 0.922 0.576 0.369 0.73 0.06 0.95 1.073 1.081 0.981 0.972 0.818 0.769 0.955 0.918 0.685 0.0017 0.0008 0.40
KNQLSVGAL P1 C40H72N12O13 2 465.274 471.256 14-16 26 34 1.076 0.741 0.546 0.980 0.876 0.524 0.944 0.699 0.485 0.55 0.06 0.92 1.098 1.124 1.011 0.953 0.880 0.837 0.949 0.957 0.703 0.0014 0.0008 0.31
NQLSVGALQLPLQFTR P1 C80H133N23O23 2 893.005 904.469 24-25.5 27 42 1.078 0.648 0.449 1.008 0.781 0.438 0.914 0.458 0.341 0.75 0.12 0.85 1.096 1.110 1.003 0.942 0.799 0.763 0.962 0.919 0.675 0.0017 0.0009 0.33
TFSASMTSELLWEVGK P1 C80H124N18O26S1 2 893.440 902.412 26-27 43 58 1.254 0.450 0.223 0.939 0.156 0.054 0.807 0.085 0.054 2.02 0.47 0.73 0.992 1.022 1.020 1.075 0.897 0.863 0.932 0.886 0.772 0.0010 0.0006 0.27
LWEVGKGNIDPVMY P1 C75H113N17O21S1 2 810.908 819.382 20-22 53 66 1.046 0.202 na 0.998 0.217 na 0.956 0.084 na 3.12 0.51 0.90 0.923 1.035 0.966 1.055 0.932 0.831 1.022 0.967 0.671 0.0017 0.0007 0.45
AQAGGALSVDELVNQF P1 C70H111N19O25 2 809.907 819.380 23-25 74 89 1.248 0.910 0.660 0.863 0.919 0.593 0.889 0.754 0.560 0.41 0.10 0.71 1.092 1.024 0.962 0.980 0.888 0.805 0.928 0.886 0.651 0.0018 0.0008 0.44
HQSTACNPEIW P1 C57H83N17O19S1 2 671.796 679.771 13-16 93 103 1.048 0.225 0.101 1.011 0.318 0.107 0.941 0.202 0.107 1.88 0.14 0.96 1.066 1.051 0.909 0.952 0.795 0.699 0.982 0.925 0.595 0.0026 0.0009 0.55
LTAYITGSSNR P1 C50H83N15O18 2 591.809 599.287 11.5-12.5 106 116 1.143 0.663 0.461 0.976 0.705 0.431 0.881 0.499 0.333 0.75 0.10 0.88 1.153 1.166 1.043 0.950 0.759 0.645 0.897 0.915 0.631 0.0022 0.0013 0.31
AIKADAVGK P1 117 125
VPPTAILEQLR P1 C56H97N15O16 2 618.869 626.346 19-21 126 136 1.045 0.657 0.453 1.002 0.726 0.442 0.952 0.598 0.388 0.71 0.05 0.97 1.081 1.068 0.966 0.962 0.804 0.755 0.956 0.917 0.685 0.0018 0.0008 0.42
RTLAPSEHELF P1 136 146
HHITTDF P1 147 153
VCHVLSPLGF P1 154 163
ILPDAAYVY P1 164 172
TATYPNFYALVDCVR P1 C81H120N20O24S1 2 895.433 904.904 22.8-24 177 191 0.999 0.248 0.085 1.030 0.265 0.105 0.971 0.191 0.095 1.96 0.13 0.97 1.048 1.032 0.855 0.974 0.763 0.672 0.979 0.939 0.614 0.0027 0.0008 0.63
ALVDCVRASDL P1 C50H87N15O18S1 2 609.811 616.789 17-18 185 195 1.076 0.245 0.111 0.999 0.274 0.103 0.925 0.196 0.134 1.80 0.16 0.95 1.067 1.060 0.905 0.960 0.775 0.694 0.974 0.909 0.612 0.0025 0.0009 0.54
MLTALSSVDSK P1 C48H86N12O18S1 2 576.302 582.284 14.5-15.5 198 208 1.042 0.559 0.279 1.005 0.620 0.288 0.953 0.459 0.227 1.11 0.08 0.97 1.079 1.067 0.950 0.961 0.806 0.749 0.960 0.924 0.671 0.0019 0.0008 0.46
MLQATFK P1 C38H63N9O10S1 2 419.728 424.214 12-14.2 209 215 1.040 0.086 na 1.009 0.121 na 0.951 0.028 na 4.52 0.73 0.91 1.073 1.041 0.939 0.972 0.817 0.748 0.955 0.915 0.661 0.0020 0.0008 0.50
GALAPALISQHLANAATTAFER P1 C98H159N29O30 3 741.734 751.372 23.8-28 218 239 1.153 0.757 0.550 1.127 0.813 0.495 0.720 0.553 0.503 0.53 0.12 0.73 1.164 1.084 1.003 0.966 0.786 0.678 0.870 0.869 0.733 0.0017 0.0010 0.29
GNFDANAVVSSVLTILGR P1 C80H133N23O26 2 916.997 928.461 31-33 242 259 1.008 0.627 0.431 0.995 0.674 0.414 0.996 0.580 0.370 0.75 0.04 0.98 1.084 1.063 0.980 0.977 0.810 0.747 0.939 0.885 0.651 0.0019 0.0009 0.40
LWSPSTPK P1 C43H66N10O12 2 458.250 463.235 11-12.1 260 267 1.083 0.680 0.468 1.012 0.730 0.451 0.905 0.562 0.374 0.70 0.07 0.93 1.118 1.105 0.991 0.938 0.781 0.720 0.944 0.931 0.693 0.0018 0.0009 0.35
SPSTPKELDPSARL P1 C64H108N18O23 3 499.935 505.917 14-15.5 262 275 1.065 0.684 0.482 0.999 0.751 0.445 0.936 0.627 0.437 0.66 0.05 0.97 1.086 1.075 0.964 0.949 0.844 0.778 0.966 0.933 0.667 0.0018 0.0008 0.44
RNTNGIDQL P1 C41H71N15O16 2 515.767 523.245 11-12.5 276 284 1.070 0.653 0.481 0.978 0.763 0.467 0.952 0.625 0.445 0.64 0.05 0.96 1.084 1.093 0.983 0.953 0.846 0.803 0.962 0.922 0.681 0.0016 0.0008 0.38
NTNGIDQLR P1 C41H71N15O16 2 515.767 523.244 10-12.1 277 285 1.013 0.656 0.447 1.053 0.765 0.471 0.934 0.580 0.377 0.70 0.07 0.94 1.157 1.127 1.045 0.923 0.785 0.742 0.921 0.893 0.643 0.0018 0.0011 0.26
SNLALFIAYQDMVK P1 C74H117N17O21S1 2 806.924 815.398 23.5-25 286 299 1.125 0.573 0.308 0.983 0.680 0.315 0.892 0.469 0.234 1.05 0.10 0.94 1.082 1.100 0.990 0.981 0.882 0.804 0.937 0.879 0.696 0.0015 0.0008 0.36
AEVIFSDEELSSTIIPWFIEAMSEVSPFK P1 C153H229N31O48S1 3 1101.212 1111.515 35-37 304 332 1.120 0.692 0.402 0.967 0.710 0.401 0.913 0.559 0.326 0.81 0.08 0.94 1.127 1.105 0.973 0.913 0.842 0.812 0.960 0.886 0.689 0.0016 0.0008 0.33
KLRPINETTSY P1 C58H96N16O19 2 661.359 669.334 13.5-15 332 342 0.962 0.856 0.559 1.016 0.831 0.468 1.022 0.558 0.389 0.63 0.11 0.82 1.097 1.151 1.046 0.909 0.850 0.734 0.993 0.958 0.685 0.0017 0.0010 0.31
IGQTSAIDHMGQPSHVVVY P1 343 361
EDWQFAKEITAF P1 C70H97N15O21 2 742.856 750.334 22-24 362 373 1.053 0.707 0.442 0.947 0.577 0.426 0.69 0.07 0.96 1.157 1.061 1.056 0.938 0.839 0.735 0.905 0.870 0.637 0.0018 0.0011 0.29
EITAFTPVK P1 C47H76N10O14 2 503.284 508.269 14.5-16.3 369 377 1.061 0.655 0.445 0.995 0.730 0.439 0.944 0.589 0.383 0.72 0.05 0.96 1.078 1.087 0.995 0.963 0.813 0.769 0.958 0.917 0.693 0.0016 0.0008 0.36
LANNSNQR P1 C35H61N15O14 2 458.733 466.210 1.3-2.6 378 385 1.050 0.658 0.450 1.020 0.724 0.447 0.930 0.578 0.379 0.71 0.06 0.95 1.104 1.100 0.998 0.946 0.797 0.756 0.950 0.910 0.674 0.0017 0.0009 0.34
FLDVEPGISDR P1 C55H86N14O19 2 624.317 631.296 16.3-17.5 386 396 1.041 0.658 0.441 0.998 0.719 0.440 0.961 0.592 0.386 0.72 0.05 0.97 1.078 1.069 0.960 0.952 0.807 0.762 0.970 0.924 0.685 0.0018 0.0008 0.43
MSATLAPIGNTFAVSAFVK P1 C88H141N21O25S1 2 963.014 973.482 24-25.7 397 415 1.103 0.640 0.408 1.004 0.722 0.404 0.893 0.522 0.323 0.81 0.09 0.93 1.082 1.091 0.949 0.967 0.853 0.753 0.951 0.884 0.673 0.0019 0.0008 0.47
VKNRTAVY P1 C42H71N13O12 2 475.775 482.255 6.7-7.5 414 421 0.999 0.719 0.564 1.055 0.802 0.471 0.946 0.682 0.369 0.64 0.09 0.88 1.112 1.077 0.930 0.919 0.786 0.723 0.969 0.909 0.634 0.0022 0.0009 0.46
TAVYEAVSQR P1 C48H78N14O17 2 562.291 569.269 10-12.1 418 427 1.071 0.642 0.446 0.988 0.725 0.451 0.941 0.588 0.387 0.71 0.05 0.96 1.091 1.066 0.926 0.958 0.799 0.724 0.951 0.903 0.655 0.0021 0.0008 0.50
EAVSQRGTVNSNGAEM P1 C64H108N22O27S1 2 825.381 836.347 9.5-10.2 422 437 1.009 0.621 0.421 1.015 0.753 0.449 0.976 0.602 0.386 0.73 0.05 0.96 1.077 1.079 0.990 0.980 0.825 0.776 0.944 0.903 0.657 0.0018 0.0009 0.38
GTVNSNGAEMTLGFPSVVER P1 C87H141N25O31S1 3 689.005 697.313 20-22 428 447 0.994 0.588 0.359 1.096 0.767 0.414 0.910 0.509 0.304 0.86 0.10 0.91 1.099 1.075 0.954 0.955 0.809 0.751 0.946 0.921 0.678 0.0019 0.0008 0.44
DYALDRDPMVAIAALR P1 C78H128N22O24S1 3 597.314 604.624 22-24 448 463 1.110 0.045 na 1.066 0.036 na 0.824 0.008 na 6.25 0.93 0.92 1.061 1.037 0.871 0.977 0.763 0.707 0.962 0.878 0.633 0.0024 0.0008 0.58
RTGIVDESL P1 C41H72N12O16 2 495.267 501.248 8.5-9.3 463 471 1.053 0.513 0.212 1.014 0.624 0.248 0.933 0.444 0.181 1.29 0.10 0.96 1.110 1.100 1.010 0.958 0.847 0.765 0.932 0.903 0.643 0.0018 0.0009 0.35
EARASNDL P1 C34H58N12O15 2 438.215 444.196 5.5-6 472 479 1.056 0.681 0.484 1.016 0.829 0.522 0.928 0.597 0.403 0.63 0.08 0.90 1.073 1.085 0.988 0.955 0.827 0.767 0.972 0.928 0.664 0.0018 0.0008 0.40
ASNDLKR P1 C32H58N12O12 1 803.437 815.401 1.4-1.8 475 481 1.012 0.566 0.369 0.942 0.636 0.347 1.046 0.509 0.300 0.90 0.06 0.97 1.081 1.083 0.977 0.959 0.842 0.839 0.960 0.914 0.688 0.0015 0.0008 0.35
AAVMHY P1 488 493
AVAHNPEVVVSEHQGVAAEQGSLY P1 494 517
NVRTEL P1 521 526
IPVGYNAIEGGSIR P1 C64H104N18O20 2 723.391 732.363 16.5-18 528 541 1.084 0.615 0.423 0.989 0.698 0.436 0.927 0.551 0.367 0.75 0.06 0.95 1.094 1.113 1.033 0.961 0.817 0.771 0.945 0.923 0.707 0.0015 0.0009 0.29
TPEPLEAIAYNKPIQPSEVLQAK P1 C115H186N28O36 3 846.127 855.432 20-22 542 564 1.036 0.663 0.447 1.000 0.725 0.443 0.963 0.598 0.394 0.71 0.05 0.97 1.094 1.061 0.964 0.959 0.778 0.757 0.947 0.927 0.678 0.0018 0.0008 0.39
DLANHTTSIHIWPW P1 567 580
HEASTEF P1 C35H49N9O14 2 410.677 415.164 7.6-9 581 587 1.053 0.688 0.513 0.995 0.735 0.445 0.952 0.620 0.430 0.64 0.05 0.96 1.127 1.126 1.043 0.957 0.832 0.750 0.917 0.869 0.613 0.0019 0.0011 0.30
RYTAEVK P1 C38H63N11O12 2 433.740 439.223 4.5-6.5 601 607 1.130 0.674 0.519 1.051 0.763 0.463 0.819 0.528 0.418 0.63 0.10 0.85 1.094 1.092 0.972 0.875 0.785 0.668 1.031 0.967 0.721 0.0020 0.0010 0.38
EFELLGLGQR P1 C52H84N14O16 2 581.317 588.296 20-23 608 617 1.070 0.642 0.436 0.991 0.710 0.432 0.939 0.577 0.377 0.73 0.05 0.96 1.090 1.119 1.017 0.965 0.822 0.778 0.945 0.929 0.694 0.0016 0.0009 0.32
GQRRERVRILKPTVAHAIIQMW P1 615 636
SWFVEDDRTL P1 C57H82N14O19 2 634.301 641.280 19.4-20.4 638 647 1.059 0.688 0.499 0.978 0.747 0.470 0.963 0.642 0.464 0.61 0.04 0.98 1.083 1.074 0.922 0.973 0.845 0.731 0.945 0.879 0.630 0.0023 0.0008 0.52
TLAAAR P1 646 651
DDAEKLAIDGR P1 656 666
MQNAVTLLR P1 C44H80N14O13S1 2 523.295 530.273 15.5-17 668 676 1.064 0.295 0.049 0.997 0.353 0.050 0.939 0.169 0.031 2.63 0.19 0.96 1.086 1.062 0.933 0.963 0.795 0.718 0.951 0.904 0.654 0.0021 0.0008 0.49
IEMIGTTGIGASAVHLAQSR P1 C85H146N26O28S1 3 671.358 679.999 20.5-22 678 697 1.163 0.089 na 0.960 0.016 na 0.877 0.016 na 5.90 0.95 0.91 1.061 1.069 0.910 0.962 0.813 0.742 0.977 0.918 0.665 0.0021 0.0007 0.54
AQSRIVDQM P1 C42H74N14O15S1 2 524.266 531.245 10.8-11.4 694 702 1.060 0.479 0.230 0.992 0.529 0.228 0.948 0.368 0.184 1.29 0.09 0.97 1.083 1.074 0.922 0.973 0.845 0.731 0.945 0.879 0.630 0.0023 0.0008 0.52
IVDQMAGR P1 C36H64N12O12S1 2 445.232 451.213 8.1-9.5 698 705 1.054 0.464 0.213 1.000 0.516 0.220 0.945 0.351 0.170 1.34 0.09 0.97 1.083 1.071 0.964 0.963 0.805 0.754 0.954 0.922 0.686 0.0018 0.0008 0.42
AGRGLIDDSSDL P1 C49H83N15O21 2 609.802 617.279 15.8-16.4 703 714 1.072 0.480 0.238 1.001 0.540 0.232 0.927 0.364 0.201 1.25 0.09 0.97 1.109 1.062 0.960 0.965 0.831 0.778 0.925 0.904 0.656 0.0018 0.0008 0.42
GLIDDSSDLHVGINR P1 C67H111N21O25 3 537.609 544.589 18-19.5 706 720 1.212 0.681 0.471 0.948 0.722 0.446 0.839 0.536 0.394 0.68 0.10 0.88 1.137 1.132 1.055 0.966 0.883 0.822 0.897 0.886 0.730 0.0012 0.0009 0.20
IWAGLAVLQMMGLLSR P1 C80H135N21O19S2 2 879.992 890.460 30-32 725 740 1.181 0.618 0.391 0.974 0.667 0.389 0.846 0.467 0.308 0.84 0.10 0.90 1.197 1.216 1.096 0.915 0.814 0.794 0.889 0.865 0.718 0.0012 0.0012 0.12
SRSEAEAL P1 C34H59N11O15 2 431.717 437.200 7.7-8.5 739 746 1.071 0.643 0.469 0.995 0.727 0.449 0.934 0.591 0.424 0.67 0.05 0.96 1.078 1.080 0.998 0.977 0.865 0.801 0.945 0.930 0.689 0.0016 0.0008 0.38
SEAEALTK P1 C35H61N9O15 2 424.722 429.208 6.5-8 741 748 1.068 0.605 0.417 0.991 0.694 0.420 0.941 0.555 0.366 0.76 0.06 0.96 1.092 1.098 1.015 0.968 0.818 0.785 0.940 0.926 0.700 0.0015 0.0009 0.31
TKVLGDSNAL P1 C43H76N12O16 2 509.282 515.264 13.1-14 747 756 1.084 0.603 0.391 0.975 0.574 0.287 0.941 0.440 0.292 0.95 0.09 0.93 1.106 1.101 0.985 0.958 0.853 0.777 0.935 0.895 0.630 0.0019 0.0009 0.38
GMVVATTDIDPSL P1 C56H95N13O21S1 2 659.832 666.312 21-21.5 757 769 1.048 0.319 na 1.000 0.294 na 0.952 0.149 na 2.37 0.40 0.90 1.069 1.002 0.876 0.977 0.842 0.731 0.954 0.889 0.614 0.0024 0.0007 0.64
APAFPLSDIK P2 C50H79N11O14 2 529.798 535.282 17-19.8 5 14 1.052 0.489 0.323 0.863 0.596 0.314 1.017 0.375 0.227 1.03 0.12 0.91 1.047 1.209 1.018 0.888 0.750 0.727 1.065 0.860 0.603 0.0021 0.0013 0.28
AQMLFANNIK P2 C51H84N14O14S1 2 575.308 582.287 15-18 15 24 0.922 <0.129 na 1.078 <0.129 na >3.41 na na 1.116 1.033 0.902 0.947 0.709 0.607 0.938 0.922 0.622 0.0028 0.0010 0.50
KEGAIETY P2 C40H63N9O15 2 455.729 460.216 9.5-10.5 34 41 1.047 0.471 0.340 0.979 0.582 0.294 0.974 0.528 0.445 0.86 0.10 0.92 0.932 0.917 0.791 1.257 0.806 0.902 0.811 0.728 0.517 0.0023 0.0013 0.31
EGAIETYEGLLSVDPR P2 C76H121N19O28 2 874.939 884.410 21-23 35 50 0.974 0.465 0.321 1.040 0.519 0.285 0.986 0.452 0.310 0.99 0.06 0.97 1.116 1.018 0.945 0.947 0.777 0.692 0.937 0.939 0.599 0.0024 0.0010 0.47
SVDPRFL P2 C38H60N10O11 2 417.229 422.214 15-16 46 52 0.851 0.494 0.353 1.087 0.602 0.344 1.062 0.570 0.324 0.89 0.07 0.96 1.077 0.945 0.764 0.984 0.876 0.834 0.939 0.902 0.647 0.0023 0.0005 0.74
KNELSRY P2 55 61
LTDHFPANVDEY P2 C64H89N15O22 2 710.823 718.299 17-18.2 62 73 1.022 0.431 0.299 1.031 0.558 0.256 0.947 0.425 0.276 1.07 0.08 0.96 1.131 1.106 0.944 0.957 0.798 0.711 0.913 0.877 0.570 0.0025 0.0011 0.43
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GNGVRTNF P2 C36H57N13O12 2 432.720 439.200 9.8-10.5 78 85 0.963 0.466 0.430 1.083 0.540 0.359 0.954 0.508 0.412 0.76 0.10 0.90 1.087 1.127 0.946 1.007 0.829 0.691 0.905 0.857 0.666 0.0022 0.0009 0.45
TNFFGMR P2 C39H57N11O10S1 2 436.708 442.191 16-17.5 83 89 0.896 0.390 0.157 0.935 0.409 0.210 1.169 0.401 0.142 1.49 0.09 0.97 1.134 1.149 1.037 0.914 0.859 0.802 0.952 0.878 0.664 0.0015 0.0010 0.25
HMNGFPMIPATWPLASNLK P2 90 108
RADADLADGPVSER P2 C59H98N20O24 3 491.243 497.889 10.5-11.5 110 123 0.971 0.400 0.282 1.029 0.485 0.251 1.10 0.10 0.97 0.956 1.028 0.985 1.044 0.938 0.665 0.0017 0.0011 0.36
ADADLADGPVSER P2 C53H86N16O23 2 658.310 666.285 11.2-12.5 111 123 1.226 0.407 0.231 0.587 0.407 0.197 1.187 0.315 0.204 1.26 0.18 0.88 1.117 1.081 0.933 0.974 0.773 0.689 0.909 0.831 0.650 0.0022 0.0009 0.44
LMFSDLEPVPLK P2 C65H105N13O18S1 2 694.878 701.359 21.5-23.5 134 145 1.026 0.481 0.303 1.053 0.573 0.303 0.920 0.466 0.287 1.01 0.06 0.98 1.079 1.026 0.961 0.927 0.788 0.690 0.994 0.908 0.669 0.0021 0.0008 0.47
KGSSTCIPYFSNDMGTK P2 148 164
AEEAGNLMLQGK P2 175 186
FDDAYQLHQMGGAYYVVYR P2 187 205
RAQSTDAITL P2 C44H78N14O17 2 538.291 545.269 14.2-15 205 214 0.857 0.428 0.275 1.023 0.529 0.259 1.120 0.389 0.262 1.10 0.09 0.95 1.224 1.384 1.135 0.832 0.812 0.634 0.944 0.880 0.608 0.0022 0.0017 0.20
TGKFVSKDR P2 218 226
EYAVTGGEQGSLF P2 232 244
AASKDASRL P2 245 253
LKEQYGIDVPDGFFCER P2 253 269
TAMGGPFALNAPIMAVAQPVR P2 C94H154N26O25S2 3 704.708 713.348 23-24 272 292 1.045 0.265 0.056 1.010 0.338 0.019 0.945 0.185 0.019 3.00 0.30 0.93 1.054 1.161 1.009 1.001 0.717 0.761 0.945 0.878 0.654 0.0017 0.0011 0.26
YAYTFHHTTR P2 299 308
LNKEEKVK P2 309 316
EWSLCVATDVSDHDTFWPGWLR P2 317 338
DLICDELLNMGYAPWWVK P2 C103H151N23O28S2 3 741.692 749.003 27-29 339 356 0.937 0.135 0.051 1.063 0.075 0.043 2.54 0.41 0.90 0.909 0.594 0.641 0.999 0.833 0.766 1.091 1.024 0.581 0.0031 0.0011 0.53
LFETSLK P2 C39H64N8O12 2 419.239 423.227 14.5-15.5 357 363 1.072 0.470 0.303 0.866 0.516 0.342 1.062 0.469 0.314 0.95 0.08 0.96 1.299 1.287 1.072 0.942 0.853 0.807 0.759 0.713 0.592 0.0016 0.0017 0.11
VGAPAPEQGHTL P2 C51H81N15O17 2 588.804 596.281 11.2-12.5 368 379 1.030 0.506 0.348 1.020 0.588 0.324 0.950 0.515 0.349 0.90 0.05 0.98 1.076 1.057 0.970 0.969 0.847 0.733 0.954 0.908 0.646 0.0021 0.0008 0.47
LGDPSNPDLEVGL P2 C57H92N14O22 2 663.333 670.311 19.8-19.9 381 393 0.988 0.504 0.339 1.054 0.735 0.326 0.958 0.506 0.323 0.92 0.08 0.95 1.107 1.186 1.009 0.970 0.833 0.707 0.923 0.999 0.606 0.0023 0.0011 0.37
SSGQGATDLMGTLL P2 C55H95N15O22S1 2 675.832 683.309 22.4-23.5 393 406 1.063 0.454 0.283 0.911 0.542 0.272 1.026 0.515 0.323 1.02 0.06 0.98 1.090 1.060 0.883 0.938 0.812 0.728 0.972 0.878 0.595 0.0025 0.0008 0.56
MSITYLVMQLDHTAPHL P2 407 423
DMPSACR P2 429 435
FLDSYWQGHEEIR P2 C77H106N20O23 3 560.599 567.245 17-19.8 436 448 1.134 0.487 0.302 1.168 0.592 0.290 0.698 0.385 0.083 1.35 0.30 0.74 1.045 1.122 0.914 0.992 0.816 0.697 0.963 0.823 0.515 0.0030 0.0012 0.48
QISKSDDAILGWTK P2 449 462
ALVGGHRLFEMLK P2 465 477
VNPSPYMK P2 C42H66N10O12S1 2 468.236 473.221 9.7-11.5 481 488 0.971 0.506 0.288 1.071 0.563 0.281 0.958 0.446 0.247 1.09 0.06 0.98 1.183 1.183 1.038 0.804 0.831 0.750 1.013 0.964 0.698 0.0016 0.0011 0.21
 EHGGAF P2 492 496
LGDILLY P2 C39H63N7O11 1 806.466 813.445 20-22 498 504 0.997 0.506 0.314 1.088 0.566 0.276 0.915 0.466 0.350 0.97 0.07 0.96 1.050 1.054 1.014 0.989 0.836 0.737 0.961 0.965 0.631 0.0020 0.0009 0.41
DSRREPGSAIF P2 505 515
VGNINSML P2 C35H62N10O12S1 1 847.434 857.404 17.5-19 516 523 1.123 0.408 0.170 1.071 0.407 0.210 0.806 0.360 0.178 1.39 0.09 0.97 1.137 1.238 0.960 0.962 0.785 0.698 0.902 0.739 0.539 0.0026 0.0014 0.33
RPFPGLAWASMK P2 545 556
DTYGACPIYSDVLEAIER P2 557 574
CWWNAFGESYR P2 C68H86N18O18S1 2 738.312 746.785 20.5-22 575 585 0.809 0.124 0.037 1.191 0.280 0.115 2.26 0.45 0.86 1.304 1.268 1.088 0.843 0.629 0.421 0.853 0.842 0.396 0.0044 0.0024 0.32
AYREDMLKR P2 586 594
DTLELSR P2 C34H60N10O14 2 417.222 422.206 11.4-12 595 601 1.045 0.445 0.302 1.016 0.503 0.251 0.939 0.376 0.256 1.09 0.09 0.95 1.067 1.065 0.916 0.960 0.781 0.703 0.973 0.909 0.645 0.0023 0.0008 0.52
QAGLAELTPIDLEVLADPNKLQYK P2 C119H195N29O38 3 880.481 890.119 25.55-25.7 609 632 0.971 0.548 0.316 1.029 0.467 0.218 1.11 0.12 0.96 0.993 1.173 0.989 0.809 0.812 0.777 1.198 0.880 0.595 0.0020 0.0013 0.26
ADPNKLQY P2 C42H65N11O14 2 474.743 480.227 10.5-11 624 631 1.055 0.482 0.339 0.984 0.581 0.312 0.961 0.484 0.336 0.93 0.06 0.97 1.097 1.054 0.933 0.943 0.844 0.671 0.960 0.850 0.547 0.0028 0.0010 0.51
WTEADVSANIHEVLMHGVSVEK P2 633 654
LRSVMPR P2 659 665
PIVVTQAHIDR P4 C55H93N17O16 3 416.907 422.556 11.5-13.5 2 12 1.134 0.673 0.438 0.998 0.732 0.432 0.867 0.532 0.394 0.72 0.08 0.92 1.117 1.106 0.972 0.940 0.770 0.633 0.942 0.902 0.669 0.0023 0.0010 0.41
VGIAADLLDASPVSLQVLGRPTAINTVVIK P4 C136H236N36O41 3 1010.924 1022.888 21-29 13 42 1.009 0.655 0.499 0.953 0.794 0.458 1.038 0.648 0.416 0.65 0.06 0.95 1.106 1.132 1.032 0.882 0.822 0.822 1.013 0.869 0.612 0.0017 0.0011 0.24
TYIAAVMELASK P4 C58H97N13O18S1 2 648.847 655.327 22.5-23.5 43 54 1.207 0.596 0.251 1.039 0.687 0.267 0.755 0.391 0.160 1.24 0.18 0.87 1.115 1.159 1.064 0.974 0.852 0.809 0.911 0.861 0.692 0.0013 0.0010 0.20
QGGSLAGVDIRPSVLLK P4 C75H132N22O23 3 570.668 577.980 19-21 55 71 1.061 0.670 0.477 0.979 0.742 0.473 0.959 0.622 0.448 0.64 0.04 0.97 1.097 1.089 1.038 0.934 0.738 0.706 0.968 0.870 0.672 0.0018 0.0011 0.28
AGVDIRPSVL P4 C45H79N13O14 2 513.801 520.282 17-19 60 69 1.076 0.624 0.410 1.009 0.682 0.381 0.915 0.577 0.369 0.79 0.05 0.98 1.107 1.119 1.005 0.973 0.837 0.742 0.920 0.895 0.643 0.0019 0.0010 0.36
DTAIFTKPK P4 72 80
SADVESDVDVLDTGIYSVPGLAR P4 C102H164N26O39 3 793.396 802.036 24-26 83 105 1.011 0.592 0.367 0.993 0.649 0.372 0.997 0.561 0.329 0.86 0.04 0.99 1.087 1.129 1.037 0.957 0.814 0.753 0.956 0.913 0.663 0.0017 0.0010 0.31
KPVTHR P4 106 111
WPSEGIYSGVTALM P4 112 125
GATGSGKSITL P4 C41H74N12O16 2 496.275 502.257 11-13.2 126 136 1.048 0.478 0.279 1.015 0.684 0.349 0.937 0.481 0.270 1.01 0.09 0.94 1.100 1.096 1.005 0.972 0.858 0.767 0.927 0.899 0.649 0.0018 0.0009 0.36
SITLNEK P4 C34H61N9O13 2 402.727 407.213 9.3-10.5 133 139 1.047 0.615 0.387 1.011 0.713 0.388 0.941 0.569 0.345 0.82 0.05 0.97 1.108 1.117 1.013 0.938 0.785 0.747 0.954 0.913 0.668 0.0018 0.0010 0.31
NEKLRPDVL P4 C47H82N14O15 2 542.311 549.291 12-17.5 137 145 1.060 0.626 0.406 1.118 0.801 0.422 0.822 0.543 0.356 0.77 0.10 0.89 1.146 1.157 1.052 0.892 0.776 0.726 0.962 0.948 0.622 0.0020 0.0012 0.27
IRWGEVAEAY P4 C55H80N14O16 2 597.301 604.279 17.4-19 146 155 1.045 0.699 0.437 1.011 0.975 0.510 0.943 0.570 0.359 0.70 0.13 0.82 1.094 1.097 0.955 0.972 0.863 0.771 0.935 0.933 0.625 0.0021 0.0009 0.45
DELDTAVHISTLDEML P4 156 171
LIVCIGLGALGF P4 171 182
NVAVDSVRPL P4 C46H80N14O15 2 535.304 542.282 14-16 183 192 1.065 0.603 0.406 1.006 0.743 0.421 0.929 0.584 0.393 0.75 0.06 0.96 1.101 1.104 1.016 0.961 0.835 0.765 0.938 0.891 0.648 0.0018 0.0010 0.34
KGAASAGGIVAVFY P4 C61H95N15O17 2 655.859 663.336 20.95-24 197 210 1.104 0.771 0.452 0.896 0.587 0.492 0.62 0.10 0.90 1.144 1.212 1.061 0.993 0.995 0.775 0.863 0.814 0.600 0.0019 0.0013 0.24
SLLTDISNLF P4 C51H83N11O17 2 561.806 567.289 28.8-29.5 211 220 1.072 0.630 0.424 0.999 0.717 0.416 0.929 0.603 0.387 0.74 0.05 0.97 1.142 1.117 0.988 0.945 0.814 0.759 0.913 0.865 0.627 0.0019 0.0010 0.34
DCSVVM P4 224 229
VVNPMVDAEKIEY P4 C67H107N15O22S1 2 753.879 761.356 19-20 230 242 1.048 0.219 0.037 1.012 0.326 0.041 0.940 0.139 0.019 2.89 0.23 0.96 1.080 1.089 0.958 0.978 0.844 0.767 0.942 0.903 0.644 0.0020 0.0008 0.44
IEYVFGQVMASTVGAILCADGNVSR P4 C115H185N31O37S2 3 886.440 896.409 29.55-31.5 240 264 1.144 0.437 0.149 0.944 0.271 0.051 0.912 0.115 0.080 2.05 0.33 0.85 1.052 1.089 1.040 0.961 0.856 0.836 0.987 0.904 0.714 0.0012 0.0008 0.26
CADGNVSRTMF P4 C50H80N16O18S2 2 629.271 636.748 13.6-14.5 257 267 0.990 0.185 0.023 1.064 0.345 0.069 0.947 0.169 0.023 2.83 0.28 0.94 1.061 1.002 0.911 0.946 0.715 0.685 0.994 0.928 0.590 0.0026 0.0010 0.50
RTNKGRIF P4 268 275
IFNGAAPLAADTHMPSMDRPTSMK P4 274 297
AADTHMPSMDRPTSM P4 C65H106N20O24S3 3 549.902 556.549 13.4-14.6 282 296 1.026 <0.06 na 1.051 <0.06 na 0.922 <0.06 na >4.69 na na 1.080 1.007 0.820 0.962 0.800 0.654 0.958 0.872 0.547 0.0032 0.0008 0.69
ALDHTSIASVAPLER P4 C68H114N20O23 3 527.286 533.932 15-18 298 312 1.051 0.599 0.379 1.010 0.702 0.389 0.939 0.566 0.337 0.83 0.05 0.97 1.096 1.044 0.952 0.955 0.894 0.784 0.950 0.916 0.650 0.0019 0.0008 0.48
GSVDTDDR P4 C32H53N11O17 2 432.688 438.171 2.5-4.4 313 320 1.025 0.596 0.375 1.020 0.695 0.397 0.955 0.572 0.347 0.82 0.05 0.98 1.088 1.085 0.986 0.960 0.798 0.753 0.951 0.914 0.669 0.0018 0.0009 0.38
NSAPR P4 321 325
TLYLVPPLDSADK P7 C66H106N14O21 2 716.390 723.368 20-22 2 14 0.857 0.243 0.108 1.047 0.362 0.102 1.095 0.287 0.126 1.82 0.11 0.98 0.987 0.940 0.726 0.955 0.780 0.704 1.057 0.973 0.588 0.0032 0.0006 0.81
ELPALASK P7 C37H65N9O12 2 414.745 419.231 11.6-12.1 15 22 1.003 0.279 0.127 1.042 0.376 0.137 0.955 0.273 0.137 1.68 0.09 0.98 1.100 1.073 0.915 0.930 0.752 0.682 0.970 0.901 0.613 0.0025 0.0010 0.49
AGVTLLEIEF P7 23 32
LHELWPHLSGGQIVIAAL P7 33 50
NANNLAIL P7 C36H63N11O12 2 421.740 427.224 18.2-19.5 51 58 0.923 0.333 0.151 0.926 0.509 0.171 1.152 0.384 0.195 1.47 0.10 0.97 1.037 1.004 0.816 0.964 0.814 0.737 1.000 0.914 0.577 0.0028 0.0007 0.69
HMSTLLVELPVAVMAVPGASYR P7 61 82
SDWNMIAHALPSEDWITLSNK P7 83 103
SGLLANDTVQGEK P7 C55H94N16O22 2 666.344 674.319 12.5-14 107 119 0.977 0.265 0.110 1.061 0.381 0.128 0.962 0.265 0.128 1.75 0.10 0.98 1.087 1.057 0.886 0.916 0.748 0.657 0.997 0.899 0.573 0.0029 0.0010 0.54
ANDTVQGEKRSGAEPLSPNVY P7 C94H150N28O35 3 744.701 754.007 13.8-13.9 111 131 0.945 0.273 0.112 1.039 0.382 0.134 1.016 0.286 0.139 1.72 0.10 0.98 1.058 1.032 0.826 0.943 0.806 0.644 0.999 0.895 0.546 0.0033 0.0008 0.68
SGAEPLSPNVYTDALSR P7 C76H121N21O28 2 888.942 899.410 18.4-19.8 121 137 0.962 0.270 0.116 1.073 0.388 0.128 0.965 0.274 0.133 1.73 0.10 0.98 1.077 1.050 0.849 0.929 0.756 0.638 0.994 0.913 0.590 0.0030 0.0009 0.62
LGIATAHAIPVEPEQPFDVDEVSA P7 C112H173N27O38 3 835.755 844.728 21.9-24 138 161 0.968 0.261 0.119 1.036 0.403 0.127 0.996 0.286 0.144 1.70 0.11 0.97 1.061 1.042 0.863 0.939 0.759 0.631 1.001 0.920 0.578 0.0030 0.0009 0.61
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Appendix C.  Supplementary Information for Chapter 4 
 
Figure C-1 Multiple sequence alignment of MHV nucleoproteins for seven MHV strains on 
SwissProt, including MHV-A59 (P03146), MHV-3 (P18447), MHV-JHM (P03417), MHV-2 
(Q9PY96), MHV-1 (P18446), and MHV-S (P18448), and MHV-DVIM (Q83360). All detected 
peptides by LC-MS/MS were highlighted. 
 125 
 
 
 
 
Figure C-2 MHV propagation curves when the L2 culture system inoculated with MHV 
suspended in various aqueous environments, including media, concentrated wastewater influent 
(ww inf), and concentrated wastewater effluent (ww eff). 
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Figure C-3 Multiple sequence alignment of reovirus sigma-3 proteins. Sequence similarity: 
88.9%. 
 
 
10/3/2018 https://www.uniprot.org/align/A20181003A7434721E10EE6586998A056CCD0537EBA4EDAB.aln
https://www.uniprot.org/align/A20181003A7434721E10EE6586998A056CCD0537EBA4EDAB.aln 1/1
CLUSTAL O(1.2.4) multiple sequence alignment 
 
SP|P03527|SIGM3_REOVD MEVCLPNGHQVVDLINNAFEGRVSIYSAQEGWDKTISAQPDMMVCGGAVVCMHCLGVVGS 60 
SP|P07939|SIGM3_REOVL MEVCLPNGHQIVDLINNAFEGRVSIYSAQEGWDKTISAQPDMMVCGGAVVCMHCLGVVGS 60 
SP|P30211|SIGM3_REOVJ MEVCLPNGHQIVDWINNAFEGRVSIYSAQQGWDKTISAQPDMMVCGGAVVCMHCLGVVGS 60 
                      **********:** ***************:****************************** 
 
SP|P03527|SIGM3_REOVD LQRKLKHLPHHRCNQQIRHQDYVDVQFADRVTAHWKRGMLSFVAQMHEMMNDVSPDDLDR 120 
SP|P07939|SIGM3_REOVL LQRKLKHLPHHRCNQQIRHQDYVDVQFADRVTAHWKRGMLSFVAQMHAMMNDVSPEDLDR 120 
SP|P30211|SIGM3_REOVJ LQRKLKHLPHHKCNQQLRQQDYVDVQFADRVTAHWKRGMLSFVSQMHAIMNDVTPEELER 120 
                      ***********:****:*:************************:*** :****:*::*:* 
 
SP|P03527|SIGM3_REOVD VRTEGGSLVELNWLQVDPNSMFRSIHSSWTDPLQVVDDLDTKLDQYWTALNLMIDSSDLI 180 
SP|P07939|SIGM3_REOVL VRTEGGSLVELNWLQVDPNSMFRSIHSSWTDPLQVVDDLDTKLDQYWTALNLMIDSSDLV 180 
SP|P30211|SIGM3_REOVJ VRTDGGSLAELNWLQVDPGSMFRSIHSSWTDPLQVVEDLDTQLDRYWTALNLMIDSSDLV 180 
                      ***:****.*********.*****************:****:**:**************: 
 
SP|P03527|SIGM3_REOVD PNFMMRDPSHAFNGVKLGGDARQTQFSRTFDSRSSLEWGVMVYDYSELEHDPSKGRAYRK 240 
SP|P07939|SIGM3_REOVL PNFMMRDPSHAFNGVRLEGDARQTQFSRTFDSRSSLEWGVMVYDYSELEHDPSKGRAYRK 240 
SP|P30211|SIGM3_REOVJ PNFMMRDPSHAFNGVKLEGEARQTQFSRTFDSRSNLEWGVMIYDYSELERDPLKGRAYRK 240 
                      ***************:* *:**************.******:*******:** ******* 
 
SP|P03527|SIGM3_REOVD ELVTPARDFGHFGLSHYSRATTPILGKMPAVFSGMLTGNCKMYPFIKGTAKLKTVRKLVE 300 
SP|P07939|SIGM3_REOVL ELVTPARDFGHFGLSHYSRATTPILGKMPAVFSGMLTGNCKMYPFIKGTAKLKTVRKLVD 300 
SP|P30211|SIGM3_REOVJ EVVTPARDFGHFGLSHYSRATTPILGKMPAVFSGMLTGNCKMYPFIKGTAKLRTVKKLVD 300 
                      *:**************************************************:**:***: 
 
SP|P03527|SIGM3_REOVD AVNHAWGVEKIRYALGPGGMTGWYNRTMQQAPIVLTPAALTMFPDTIKFGDLNYPVMIGD 360 
SP|P07939|SIGM3_REOVL SVNHAWGVEKIRYALGPGGMTGWYDRTMQQAPIVLTPAALTMFSDTTKFGDLDYPVMIGD 360 
SP|P30211|SIGM3_REOVJ AVNHTWGSEKIRYALGPGGMTGWYNRTMQQAPIVLTPAALTMFPDMTKFGDLQYPIMIGD 360 
                      :***:** ****************:****************** *  *****:**:**** 
 
SP|P03527|SIGM3_REOVD PMILG 365 
SP|P07939|SIGM3_REOVL PMILG 365 
SP|P30211|SIGM3_REOVJ PAVLG 365 
                      * :** 
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Figure C-4 Multiple sequence alignment of reovirus mu-1 proteins. Sequence similarity: 96.2%. 
 
 
 
 
 
 
 
10/5/2018 https://www.uniprot.org/align/A20181006AAFB7E4D2F1D05654627429E83DA5CCE0FC933A.aln
https://www.uniprot.org/align/A20181006AAFB7E4D2F1D05654627429E83DA5CCE0FC933A.aln 1/1
CLUSTAL O(1.2.4) multiple sequence alignment 
 
SP|P11078|MU1_REOVD MGNASSIVQTINVTGDGNVFKPSAETSSTAVPSLSLSPGMLNPGGVPWIAVGDETSVTSP 60 
SP|P11077|MU1_REOVL MGNASSIVQTINVTGDGNVFKPSAETSSTAVPSLSLSPGMLNPGGVPWIAIGDETSVTSP 60 
SP|P12397|MU1_REOVJ MGNASSIVQTINVTGDGNVFKPSAETSSTAVPSLSLSPGMLNPGGVPWIAIGDETSVTSP 60 
                    **************************************************:********* 
 
SP|P11078|MU1_REOVD GALRRMTSKDIPETAIINTDNSSGAVPSESALVPYIDEPLVVVTEHAITNFTKAEMALEF 120 
SP|P11077|MU1_REOVL GALRRMTSKDIPETAIINTDNSSGAVPSESALVPYNDEPLVVVTEHAIANFTKAEMALEF 120 
SP|P12397|MU1_REOVJ GALRRMTSKDIPETAIINTDNSSGAVPSESALVPYNDEPLVVVTEHAIANFTKAEMALEF 120 
                    *********************************** ************:*********** 
 
SP|P11078|MU1_REOVD NREFLDKMRVLSVSPKYSDLLTYVDCYVGVSARQALNNFQKQVPVITPTRQTMYVDSIQA 180 
SP|P11077|MU1_REOVL NREFLDKLRVLSVSPKYSDLLTYVDCYVGVSARQALNNFQKQVPVITPTRQTMYVDSIQA 180 
SP|P12397|MU1_REOVJ NREFLDKLRVLSVSPKYSDLLTYVDCYVGVSARQALNNFQKQVPVITPTRQTMYVDSIQA 180 
                    *******:**************************************************** 
 
SP|P11078|MU1_REOVD ALKALEKWEIDLRVAQTLLPTNVPIGEVSCPMQSVVKLLDDQLPDDSLIRRYPKEAAVAL 240 
SP|P11077|MU1_REOVL ALKALEKWEIDLRVAQTLLPTNVPIGEVSCPMQSVVKLLDDQLPDDSLIRRYPKEAAVAL 240 
SP|P12397|MU1_REOVJ ALKALEKWEIDLRVAQTLLPTNVPIGEVSCPMQSVVKLLDDQLPDDSLIRRYPKEAAVAL 240 
                    ************************************************************ 
 
SP|P11078|MU1_REOVD AKRNGGIQWMDVSEGTVMNEAVNAVAASALAPSASAPPLEEKSKLTEQAMDLVTAAEPEI 300 
SP|P11077|MU1_REOVL AKRNGGIQWMDVSEGTVMNEAVNAVAASALAPSASAPPLEEKSKLTEQAMDLVTAAEPEI 300 
SP|P12397|MU1_REOVJ AKRNGGIQWMDVSEGTVMNEAVNAVAASALAPSASAPPLEEKSKLTEQAMDLVTAAEPEI 300 
                    ************************************************************ 
 
SP|P11078|MU1_REOVD IASLAPVPAPVFAIPPKPADYNVRTLRIDEATWLRMIPKSMNTPFQIQVTDNTGTNWHLN 360 
SP|P11077|MU1_REOVL IASLVPVPAPVFAIPPKPADYNVRTLKIDEATWLRMIPKTMGTPFQIQVTDNTGTNWHLN 360 
SP|P12397|MU1_REOVJ IASLVPVPAPVFAIPPKPADYNVRTLKIDEATWLRMIPKTMNTPFQIQVTDNTGTSWHMN 360 
                    ****.*********************:************:*.*************.**:* 
 
SP|P11078|MU1_REOVD LRGGTRVVNLDQIAPMRFVLDLGGKSYKETSWDPNGKKVGFIVFQSKIPFELWTAASQIG 420 
SP|P11077|MU1_REOVL LRGGTRVVNLDQIAPMRFVLDLGGKSYKETSWDPNGKKVGFIVFQSKIPFELWTAASQIG 420 
SP|P12397|MU1_REOVJ LRGGTRVVNLDQIAPMRFVLDLGGKSYKETSWDPNGKKVGFIVFQSKIPFELWTAASQIG 420 
                    ************************************************************ 
 
SP|P11078|MU1_REOVD QATVVNYVQLYAEDSSFTAQSIIATTSLAYNYEPEQLNKTDPEMNYYLLATFIDSAAITP 480 
SP|P11077|MU1_REOVL QATVVNYVQLYAEDSSFTAQSIIATTSLAYNYEPEQLNKTDPEMNYYLLATFIDSAAITP 480 
SP|P12397|MU1_REOVJ QATVVNYVQLYAEDSSFTAQSIIATTSLAYNYEPEQLNKTDPEMNYYLLAAFIDSAAIST 480 
                    **************************************************:*******:  
 
SP|P11078|MU1_REOVD TNMTQPDVWDALLTMSPLSAGEVTVKGAVVSEVVPADLIGSYTPESLNASLPNDAARCMI 540 
SP|P11077|MU1_REOVL TNMTQPDVWDALLTMSPLSAGEVTVKGAVVSEVVPAELIGSYTPESLNASLPNDAARCMI 540 
SP|P12397|MU1_REOVJ SNMTQPDVWDALLTMSPLSAGEVTVKGAVVSEVIPADLVGSYTPESLNASLPNDAARCMI 540 
                    :********************************:**:*:********************* 
 
SP|P11078|MU1_REOVD DRASKIAEAIKIDDDAGPDEYSPNSVPIQGQLAISQLETGYGVRIFNPKGILSKIASRAM 600 
SP|P11077|MU1_REOVL DRASKIAEAIKIDDDAGPDEYSPNSVPIQGQLAISQLETGYGVRIFNPKGILSKIASRAM 600 
SP|P12397|MU1_REOVJ DRASKIAEAIKIDDDAGPDEYSPNSVPIQGQLAISQLETGYGVRIFNPKGILSKIASRAM 600 
                    ************************************************************ 
 
SP|P11078|MU1_REOVD QAFIGDPSTIITQAAPVLSDKNNWIALAQGVKTSLRTKSLSAGVKTAVSKLSSSESIQNW 660 
SP|P11077|MU1_REOVL QAFIGDPSTIITQAAPVLSDKNNWIALAQGVKTSLRTKSLSAGVKTAVSKLSSSESIQNW 660 
SP|P12397|MU1_REOVJ QAFIGDPSTIITQAAPVLSDKNNWIALAQGVKTSLRTKSLSAGVKTAVSKLSSSESIQSW 660 
                    **********************************************************.* 
 
SP|P11078|MU1_REOVD TQGFLDKVSAHFPAPKPDCPTSGDSGESSNRRVKRDSYAGVVKRGYTR 708 
SP|P11077|MU1_REOVL TQGFLDKVSTHFPAPKPDCPTNGDGSEPSARRVKRDSYAGVVKRGYTR 708 
SP|P12397|MU1_REOVJ TQGFLDKVSTHFPAPKPDCPQSGDSGDGSARRLKRDSYAGVVKRGYTR 708 
                    *********:********** .**..: * **:*************** 
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Table C-1 Cell lines and viruses used in this study. 
Cell 
line 
Cell type Source  Example viruses that can be 
cultured 
Citations 
L2 Mouse lung 
epithelial cells 
Dr. Julian Leibowitz’s lab at Texas A&M 
Health Science Center College of Medicine  
murine hepatitis virus  
DBT Mouse lung 
epithelial cells 
Dr. Julian Leibowitz’s lab at Texas A&M 
Health Science Center College of Medicine  
murine hepatitis virus  
Vero Monkey 
kidney 
epithelial cells 
Dr. Michael J. Imperiale’s lab, University of 
Michigan 
poliovirus, coxsackie virus, 
echovirus, reovirus, 
adenovirus, picornavirus 
simian virus 40 
1,2 
BSC-1 Monkey 
kidney 
epithelial cells 
Dr. Michael J. Imperiale’s lab, University of 
Michigan 
poliovirus, coxsackie virus, 
echovirus, reovirus, 
hepatitis A virus, simian 
virus 40 
1,3,4 
Virus     
Murine hepatitis virus 
strain A59 
Dr. Julian Leibowitz’s lab at Texas A&M 
Health Science Center College of Medicine 
  
 
 
Table C-2 MS instrument settings for ICC-MS proteomics analysis. 
Peptides (positive mode)  
Sheath gas flow rate 24 
Auxiliary gas flow rate 8 
Sweep gas flow rate 1 
Spray voltage 3 kV 
Capillary temp. 300 °C 
S-len RF level 50.0 
Aux gas heater temp. 275 °C 
Column temperature 25 °C 
Full MS settings  
Resolution 70,000 
AGC target 5e5 
Max IT 200 ms 
Scan range 400-1800 m/z 
dd-MS2 settings 
Resolution 35,000 
AGC target 2e5 
Max IT 100 ms 
Loop count 20 
Isolation window 1.6 Da 
NCE 30 
Intensity threshold  2e4 
Charge exclusion:  Unassigned, 1 
Dynamic exclusion 20 sec 
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Table C-3 Viral peptides detected by LC-MS/MS in MHV control experiments, where MHV was 
added to culture media. Nucleoproteins of MHV strains A59 and 3 were confidently identified. 
Peptides that differentiate strains are highlighted. A protein score greater than 76 was considered 
significant identification. 
  Hours post infection Identified Protein Detected peptides Protein sequence coverage Protein score 
300 PFU/mL, 1.2 
mL inoculum 
12 h  N.A. N.A. N.A. 
18 h Nucleoprotein (MHV-A59, MHV-3) 
TTWADQTER 
9% 120 DPSSHEAIPTR SFVPGQENAGGR 
FAPGTVLPQGFYVEGSGR 
26 h 
Nucleoprotein 
(MHV-A59, MHV-3) 
TTWADQTER 
25% 509 
DPSSHEAIPTR 
SFVPGQENAGGR 
VLNENLNAYQK 
GPNQNFGGSEMLK 
DVYELQYSGAVR 
KDEVDNVSVAKPK 
FAPGTVLPQGFYVEGSGR 
LGTSDPQFPILAELAPTVGAFFFGSK 
Spike glycoprotein 
(Coronavirus) SAIEDLLFDK 0.7% 76 
26 h Nucleoprotein (MHV-A59, MHV-3) 
DPSSHEAIPTR 
28% 469 
SFVPGQENAGGR 
VLNENLNAYQK 
DGGADVVSPKPQR 
GPNQNFGGSEMLK 
DVYELQYSGAVR 
FDSTLPGFETIMK 
FAPGTVLPQGFYVEGSGR 
LGTSDPQFPILAELAPTVGAFFFGSK 
30 PFU/mL, 1.2 
mL inoculum 
18 h  N.A. N.A. N.A. 
24 h Nucleoprotein (MHV-A59, MHV-3) 
TTWADQTER 
12% 
  
77 
  
SFVPGQENAGGR 
FAPGTVLPQGFYVEGSGR 
LGTSDPQFPILAELAPTVGAFFFGSK 
30 h Nucleoprotein (MHV-A59, MHV-3) 
DPSSHEAIPTR 9% 
  
113 
  SFVPGQENAGGR FAPGTVLPQGFYVEGSGR 
37 h Nucleoprotein (MHV-A59, MHV-3) 
TTWADQTER 
11% 
  
242 
  
DPSSHEAIPTR 
SFVPGQENAGGR 
FAPGTVLPQGFYVEGSGR 
37 h 
  
Nucleoprotein 
(MHV-A59, MHV-3) 
DPSSHEAIPTR 
33% 
  
593 
  
SFVPGQENAGGR 
DGGADVVSPKPQR 
GPNQNFGGSEMLK 
DVYELQYSGAVR 
KDEVDNVSVAKPK 
FDSTLPGFETIMK 
RGPNQNFGGSEMLK 
FAPGTVLPQGFYVEGSGR 
QPASTVKPDMAEEIAALVLAK 
LGTSDPQFPILAELAPTVGAFFFGSK 
3 PFU/mL, 1.2 
mL inoculum 
30 h  N.A. N.A. N.A. 
36 h Nucleoprotein (MHV-A59, MHV-3) 
DPSSHEAIPTR 2% 40 SFVPGQENAGGR 
42 h Nucleoprotein (MHV-A59, MHV-3) 
DPSSHEAIPTR 
12% 263 
SFVPGQENAGGR 
VLNENLNAYQK 
GPNQNFGGSEMLK 
FAPGTVLPQGFYVEGSGR 
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Table C-4 Viral peptides detected by LC-MS/MS in MHV wastewater experiments.  
Wastewater influent 
  Hours post infection Identified Protein Detected peptides 
Protein 
sequence 
coverage 
Protein 
score 
300 PFU/mL, 1.2 
mL inoculum 
18 h Nucleoprotein (MHV-A59, MHV-3)  
TTWADQTER 
12% 249 
DPSSHEAIPTR 
SFVPGQENAGGR 
GPNQNFGGSEMLK 
FAPGTVLPQGFYVEGSGR 
24 h 
Nucleoprotein (MHV-
A59, MHV-3)  
TTWADQTER 
40% 640 
DPSSHEAIPTR 
SFVPGQENAGGR 
DEVDNVSVAKPK 
VLNENLNAYQK 
DGGADVVSPKPQR 
GPNQNFGGSEMLK 
DVYELQYSGAVR 
KDEVDNVSVAKPK 
FDSTLPGFETIMK 
FAPGTVLPQGFYVEGSGR 
QPASTVKPDMAEEIAALVLAK 
EFQFAEGQGVPIANGIPASEQK 
LGTSDPQFPILAELAPTVGAFFFGSK 
Spike glycoprotein 
(MHV) 
SAIEDLLFDK 2% 98 FGAISASLQEILTR 
30 PFU/mL, 1.2 
mL inoculum 
30 h Nucleoprotein (MHV-A59, MHV-3)  
TTWADQTER 
25% 645 
DPSSHEAIPTR 
SFVPGQENAGGR 
VLNENLNAYQK 
GPNQNFGGSEMLK 
DVYELQYSGAVR 
FAPGTVLPQGFYVEGSGR 
LGTSDPQFPILAELAPTVGAFFFGSK 
36 h 
Nucleoprotein (MHV-
A59, MHV-3)  
DPSSHEAIPTR 
40% 761 
SFVPGQENAGGR 
DEVDNVSVAKPK 
VLNENLNAYQK 
DGGADVVSPKPQR 
GPNQNFGGSEMLK 
DVYELQYSGAVR 
KDEVDNVSVAKPK 
FDSTLPGFETIMK 
FAPGTVLPQGFYVEGSGR 
QPASTVKPDMAEEIAALVLAK 
EFQFAEGQGVPIANGIPASEQK 
EFQFAEGQGVPIANGIPASEQK 
LGTSDPQFPILAELAPTVGAFFFGSK 
Spike glycoprotein 
(MHV) 
CFGSISVDK 
5% 239 
SAIEDLLFDK 
SVPSPLNWER 
YDLYGITGQGEILTR 
FGAISASLQEILTR 
VANLPACNIEEWLTAR 
3 PFU/mL, 1.2 
mL inoculum 
42 h 
Nucleoprotein (MHV-
A59, MHV-3, MHV-S, 
RCV-NJ) 
DPSSHEAIPTR 
9% 168 VLNENLNAYQK GPNQNFGGSEMLK 
FAPGTVLPQGFYVEGSGR 
48 h 
Nucleoprotein (MHV-
A59, MHV-3)  
TTWADQTER 
35% 642 
DPSSHEAIPTR 
SFVPGQENAGGR 
VLNENLNAYQK 
DGGADVVSPKPQR 
GPNQNFGGSEMLK 
DVYELQYSGAVR 
FAPGTVLPQGFYVEGSGR 
QPASTVKPDMAEEIAALVLAK 
EFQFAEGQGVPIANGIPASEQK 
LGTSDPQFPILAELAPTVGAFFFGSK 
Spike glycoprotein 
(coronavirus) SAIEDLLFDK 0.7% 88 
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Table C-4 Continued. 
Wastewater effluent 
  Hours post infection Identified Protein Detected peptides 
Protein 
sequence 
coverage 
Protein 
score 
300 PFU/mL, 1.2 
mL inoculum 
18 h Nucleoprotein (MHV-A59, MHV-3)  
TTWADQTER 
14% 386 
DPSSHEAIPTR 
SFVPGQENAGGR 
VLNENLNAYQK 
GPNQNFGGSEMLK 
FAPGTVLPQGFYVEGSGR 
24 h Nucleoprotein (MHV-A59, MHV-3)  
DPSSHEAIPTR 
20% 355 
SFVPGQENAGGR 
VLNENLNAYQK 
DGGADVVSPKPQR 
GPNQNFGGSEMLK 
FDSTLPGFETIMK 
FAPGTVLPQGFYVEGSGR 
30 PFU/mL, 1.2 
mL inoculum 
30 h Nucleoprotein (MHV-A59, MHV-3)  
ELTPEDR 
9% 265 DPSSHEAIPTR SFVPGQENAGGR 
FAPGTVLPQGFYVEGSGR 
36 h Nucleoprotein (MHV-A59, MHV-3)  
TTWADQTER 
17% 577 
DPSSHEAIPTR 
SFVPGQENAGGR 
DGGADVVSPKPQR 
GPNQNFGGSEMLK 
FDSTLPGFETIMK 
FAPGTVLPQGFYVEGSGR 
3 PFU/mL, 1.2 
mL inoculum 
42 h Nucleoprotein (MHV-A59, MHV-3) 
DPSSHEAIPTR 
20% 210 
VLNENLNAYQK 
GPNQNFGGSEMLK 
FDSTLPGFETIMK 
FAPGTVLPQGFYVEGSGR 
LGTSDPQFPILAELAPTVGAFFFGSK 
48 h 
Nucleoprotein (MHV-
A59, MHV-3) 
ELTPEDR 
36% 740 
TTWADQTER 
DPSSHEAIPTR 
SFVPGQENAGGR 
DEVDNVSVAKPK 
DGGADVVSPKPQR 
GPNQNFGGSEMLK 
DVYELQYSGAVR 
KDEVDNVSVAKPK 
FDSTLPGFETIMK 
FAPGTVLPQGFYVEGSGR 
EFQFAEGQGVPIANGIPASEQK 
LGTSDPQFPILAELAPTVGAFFFGSK 
Spike glycoprotein 
(MHV) 
SAIEDLLFDK 
SVPSPLNWER 
FGAISASLQEILTR 
2% 205 
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Table C-5 Proteins in reovirus virion. 
Location Protein Molecule copies in 
reovirus virion5 
Outer capsid mu-1 600 
sigma-3 600 
lambda-2 60 
sigma-1 36-48 
Inner capsid (core) sigma-2 150 
lambda-1 120 
lambda-3 12 
mu-2 12 
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